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ABSTRACT	
		 Regulation	of	gene	expression	by	small	non-coding	RNAs	is	ubiquitous	in	all	domains	of	life.		In	bacteria,	small	RNAs	are	known	regulators	of	various	stress	responses.	Diverse	mechanisms	employed	by	small	RNAs	demonstrate	multi-faceted	nature	of	gene	regulation,	tailored	to	respond	to	stress	with	optimal	efficiency.	Likewise,	the	Escherichia	coli	small	RNA	SgrS	controls	a	response	to	metabolic	stress	that	occurs	upon	cytoplasmic	accumulation	of	glucose-phosphates	due	to	mutations	in	glycolysis	(e.g.	in	pgi)	or	when	cells	take	up	glucose-analogs	α-methyl-D-glucoside	(αMG)	and	2-deoxyglucoside	(2DG).	SgrS	base	pairs	with	and	represses	translation	of	ptsG	and	manXYZ	mRNAs,	which	encode	sugar	transporters,	and	activates	translation	of	yigL	mRNA,	encoding	a	sugar	phosphatase.	In	this	study,	transcriptomic	analyses	along	with	genetics	and	biochemistry	defined	four	new	direct	targets	of	E.	coli	SgrS.	These	new	target	mRNAs,	asd,	adiY,	folE	and	purR,	encode	transcription	factors	or	enzymes	of	diverse	metabolic	pathways,	including	aspartate	semialdehyde	dehydrogenase,	arginine	decarboxylase	gene	activator,	GTP	cyclohydrolase	I	and	a	repressor	of	purine	biosynthesis,	respectively.	SgrS	represses	translation	of	each	of	the	four	target	mRNAs	via	distinct	mechanisms.	SgrS	binding	sites	overlapping	the	Shine-Dalgarno	sequences	of	adiY	and	folE	mRNAs	suggest	that	SgrS	pairing	with	these	targets	directly	occludes	ribosome	binding	and	prevents	translation	initiation.	SgrS	binding	within	the	purR	coding	sequence	recruits	the	RNA	chaperone	Hfq	to	directly	repress	purR	translation.	Two	separate	SgrS	binding	sites	were	found	on	asd	mRNA,	and	both	are	required	for	full	translational	repression.	Ectopic	overexpression	of	asd,	adiY	and	folE	is	specifically	detrimental	to	cells	experiencing	glucose-phosphate	stress,	suggesting	that	SgrS-dependent	repression	of	the	metabolic	functions	encoded	by	these	targets	promotes	recovery	from	glucose-phosphate	stress.		 Further	studies	determined	that	SgrS	regulates	its	targets	with	different	efficiencies.	We	showed	that	SgrS	establishes	a	hierarchy	of	targets	by	prioritizing	regulation	of	targets	in	the	following	order:	1/2)	ptsG	and	yigL	3)	asd	4)	manX,	5)	
purR.	However,	SgrS	binding	strength	to	the	target	mRNAs	is	not	the	sole	
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determinant	of	regulatory	efficiency	or	prioritization.	Looking	more	carefully	at	what	determines	efficiency	of	SgrS	regulation	of	asd	mRNA,	we	discovered	that	SgrS	binds	cooperatively	at	the	two	stem	structures	within	asd	mRNA.	SgrS	binding	at	both	sites	is	not	only	required	for	optimal	repression	of	asd	translation,	but	also	changes	its	priority	within	the	regulatory	hierarchy.			 Besides	SgrS	regulatory	mechanisms,	this	study	provides	additional	insights	into	the	nature	of	glucose-phosphate	stress.	Growth	experiments	in	the	minimal	media	demonstrate	some	differences	in	toxicity	of	αMG	and	2DG.	Importantly,	the	simultaneous	presence	of	both	glucose	analogs	results	in	a	synthetic	phenotype,	highly	indicative	of	αMG	and	2DG	affecting	different	pathways.																						
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CHAPTER	1		
BACKGROUND1	
	
1.1	Escherichia	coli	as	a	Model	Organism	
1.1.1	Historical	perspective	In	1884,	the	German	scientist	and	pediatrician	Theodor	Escherich	performed	studies	to	isolate	and	characterize	infant	gut	microbes,	which	let	him	to	discovery	of	a	fast	growing	rod-shaped	bacterium	he	named	Bacterium	coli	commune	[64].	After	his	death,	the	bacterium	was	renamed	to	Escherichia	coli,	in	honor	of	the	founder.	This	organism’s	non-pathogenic	nature,	presence	in	the	lower	intestines	of	humans	as	well	as	other	warm-blooded	organisms,	and	ability	to	rapidly	grow	without	clumping	on	many	different	nutrient	sources	made	it	a	favorite	amongst	early	20th	century	microbiologists.	By	the	1940s,	its	versatility	and	use	in	many	foundational	studies	of	bacterial	physiology,	genetics	and	phages	[27,	62,	279]	securely	established	E.	coli	as	the	bacterial	“model	organism”	of	choice.		Since	the	onset	of	the	molecular	revolution	many	features	fundamental	to	all	living	organisms	were	first	discovered	and	studied	in	E.	coli.	Among	these	are	seminal	studies	on	genetic	code	[47,	185],	DNA	replication	[136],	evolution	[133,	137,	145],	transcription	[245],	gene	regulation	[101],	bacterial	conjugation	[134]	and	bacteriophage	biology	[62,	146].		With	the	discovery	of	restriction	enzymes	[164],	recombinant	DNA	technology	[42]	and	allelic	replacement	[139],	E.	coli	proved	to	be	an	invaluable	tool	not	only	in	research	but	in	the	growing	biotechnology	industry.	Today,	E.	coli	is	widely	used	for	pharmaceutical	protein	overexpression	[109],	one	example	being	recombinant	insulin	[106],	or	for	production	of	economically	important	chemicals	[39]	and	biofuels	[102].	Considering	the	long	history	of	discovery	associated	with	E.	coli,	the	value	and	service	of	this	model	organism	to	advancement	of	our	fundamental	understanding	of	life	cannot	be	overstated.																																																										1	Chapter	contains	material	from	the	following	publications:	Bobrovskyy	M.,	Vanderpool	C.K.,	Richards	G.R.,	Microbiology	Spectrum,	2015	Bobrovskyy	M.,	Vanderpool	C.K.,	Frontiers	in	Cell	and	Infectious	Microbiology,	2014	Bobrovskyy	M.,	Vanderpool	C.K.,	Annual	Review	Genetics,	2013	
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1.1.2	E.	coli	K-12	MG1655	
	 E.	coli	constitutes	about	0.1%	of	human	intestinal	microbiota	[61].	It	is	a	Gram-negative	facultative	anaerobe	in	the	family	Enterobacteriaceae,	which	includes	important	pathogenic	species	such	as	Yersinia,	Salmonella,	Klebsiella	and	
Shigella.	The	laboratory	strain	of	E.	coli	K-12	MG1655	has	a	circular	chromosome	of	4.6	million	base	pairs,	and	was	one	of	the	first	bacterial	genomes	to	be	fully	sequenced	[18].	Protein-coding	genes	account	for	87.8%	of	the	genome	with	the	rest	comprised	of	regulatory	sequences,	non-coding	RNAs	or	various	other	sequence	elements	[18].	MG1655	genome	is	predicted	to	contain	at	least	4288	protein-coding	genes,	about	one	third	of	which	are	functionally	uncharacterized,	7	ribosomal	RNA	operons,	and	86	transfer	RNA	genes	[18,	112].	In	addition,	the	genome	also	contains	a	variety	of	insertion	sequence	elements	and	phage	remnants,	pointing	towards	horizontal	sequence	acquisition	[18].	Since	the	divergence	from	its	close	relative	
Salmonella,	an	estimated	18%	of	the	E.	coli	K-12	MG1655	genome	was	horizontally	acquired	[131].	Plasticity	of	the	E.	coli	genome	is	fascinating,	with	only	20%	of	genes	being	shared	between	61	different	strains	sequenced	to	date	[144].	Some	strains	of	
E.	coli	acquired	virulence	genes	and	can	cause	gastroenteritis,	urinary	tract	infections	and	neonatal	meningitis	[110].	
	
1.2	Gene	Regulation	with	Small	RNAs	in	Bacteria	
1.2.1	Short	history	of	regulatory	RNAs		 Since	1956,	when	Francis	Crick	proposed	the	central	dogma	of	molecular	biology,	the	RNA	was	known	to	be	the	messenger	relaying	genetic	information	from	DNA	to	protein.	While	this	remains	true	for	mRNAs,	a	plethora	of	new	functional	RNA	molecules	have	been	discovered	since.	RNAs	are	now	known	to	have	enzymatic	functions,	serve	as	scaffolds	for	proteins	and	regulate	gene	expression	at	all	levels.	While	functional	RNAs	are	ubiquitous	in	all	domains	of	life,	we	will	focus	on	bacterial	small	RNAs	(sRNAs)	as	they	pertain	to	the	study	at	hand.		The	first	sRNA	in	bacteria,	RNA	I,	was	discovered	in	1981	and	is	produced	by	the	ColE1	plasmid.	RNA	I	base	pairs	and	negatively	regulates	the	transcript	that	produces	a	replication	primer,	in	turn	repressing	ColE1	plasmid	replication	[258].	
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Three	years	later,	the	sRNA	MicF	was	discovered	to	be	encoded	on	the	E.	coli	chromosome.	MicF	was	found	to	inhibit	translation	of	the	major	outer	membrane	porin	OmpF	by	base	pairing	with	its	mRNA	[169].	A	diverse	palette	of	novel	small	regulatory	RNAs	has	been	identified	in	bacteria	in	recent	years,	and	many	play	important	roles	in	regulating	gene	expression	and	adaptation	to	constantly	changing	physiological	and	metabolic	needs.	To	date,	more	than	a	hundred	sRNAs	have	been	identified	and	characterized	in	gram-negative	bacteria,	with	crucial	and	sometimes	global	regulatory	functions	such	as	energy	metabolism	[171],	iron	homeostasis	[159,	160],	cell	cycle	[214],	motility	[255],	secretion	systems	[225],	stress	responses	[4]	and	pathogenesis	[26].		
1.2.2	Base	pairing-dependent	sRNA	regulation	The	most	studied	and	widely	dispersed	class	of	sRNAs	in	gram-negative	bacteria	act	post-transcriptionally	by	base	pairing	to	target	mRNAs	in	order	to	confer	positive	or	negative	regulatory	outcomes.	Base	pairing	sRNAs	are	broadly	assigned	into	two	main	groups	based	on	their	location	on	the	chromosome	relative	to	the	genes	they	regulate.	Those	sRNAs	encoded	at	loci	distinct	from	their	regulated	genes	are	said	to	be	trans-encoded,	and	are	characterized	by	limited	and	imperfect	base	pairing	interactions	with	the	transcripts	they	target.	Trans-encoded	sRNAs	are	usually	50-300	nt	long	and	are	expressed	in	response	to	specific	physiological,	metabolic,	and/or	stress	signals	such	as	iron	limitation	[160],	sugar-phosphate	overload	[268],	oxidative	stress	[4],	growth-phase	transition	[74],	anaerobiasis	[25]	and	many	others	[90,	210,	249].	sRNAs	encoded	on	the	DNA	strand	directly	opposite	their	targets	(antisense)	are	known	as	cis-encoded	sRNAs	(often	referred	to	as	asRNAs	for	antisense	sRNA)	and	share	a	region	of	perfect	complementarity	with	the	genes	they	regulate.	Cis-encoded	sRNAs	vary	greatly	in	size,	ranging	from	100	to	7000	nt	in	length	[116,	135,	188,	244,	257,	287].	Cis-encoded	sRNAs	on	plasmids,	phages	and	transposons	were	among	the	first	regulatory	RNAs	identified.	Later,	sRNAs	encoded	in	cis	were	found	on	the	chromosomes	of	many	bacteria.	Several	are	encoded	antisense	to	transposase	genes	and	inhibit	transposition	when	expressed	[130,	190,	231,	257,	277].	Other	cis-encoded	sRNAs	act	as	antitoxins	by	regulating	
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expression	of	small	hydrophobic	proteins	toxic	to	bacterial	cells	if	they	accumulate	to	high	levels	[70,	71,	116].	Together,	trans-	and	cis-encoded	sRNAs	are	now	known	to	regulate	countless	mRNA	targets	and	to	play	a	role	in	most	global	regulatory	responses	in	bacteria.	Both	trans-	and	cis-encoded	sRNAs	base	pair	with	target	mRNAs	and	regulate	their	expression	at	the	level	of	translation	and/or	mRNA	stability	[79,	249].		sRNA-mRNA	complex	formation	often	involves	rearrangements	of	the	secondary	structure	of	each	individual	interacting	RNA	molecule	[249].	For	trans-encoded	sRNAs,	RNA	stability	and	secondary	structure	rearrangements	that	allow	annealing	with	mRNA	targets	often	depend	on	a	conserved	and	abundant	RNA	chaperone	Hfq,	described	in	more	detail	below.	In	contrast,	cis-encoded	sRNAs	usually	do	not	rely	on	Hfq	for	stability	or	to	facilitate	base	pairing,	potentially	due	to	their	extensive	complementarity	with	their	target	transcripts.		
	
1.2.2.1	Post-transcriptional	activation	by	base	pairing	sRNAs		Post-transcriptional	activation	of	gene	expression	by	sRNAs	is	achieved	via	stimulation	of	translation	or	stabilization	of	the	target	transcript.	Leader	sequences	in	the	5’	untranslated	regions	(UTRs)	of	some	mRNAs	form	secondary	structures	that	occlude	ribosome	binding	sites	(RBS)	or	translational	enhancer	elements.	The	binding	of	an	sRNA	to	complementary	sequences	within	such	5’	UTRs	can	prevent	formation	of	the	translation-inhibitory	structure	and	allow	enhanced	translation	of	the	mRNA	[132,	173,	201].		Post-transcriptional	regulation	of	the	stationary	phase	sigma	factor	(σS),	encoded	by	rpoS,	is	the	paradigm	for	positive	regulation	by	sRNAs	in	enteric	bacteria	such	as	E.	coli.	Three	Hfq-dependent	sRNAs,	DsrA,	RprA	and	ArcZ,	activate	translation	of	rpoS	under	conditions	of	low-temperature,	osmotic	shock,	and	aerobic	stationary	phase	growth,	respectively	[149,	157,	235].	The	long	5’	UTR	of	rpoS	mRNA	folds	into	a	stem-loop	structure	that	inhibits	translation	of	the	message	[28,	48].	Each	of	the	three	sRNAs	can	base	pair	with	sequences	in	the	rpoS	5’	UTR	to	prevent	formation	of	the	inhibitory	hairpin	structure	and	allow	ribosomes	to	access	the	RBS	[149-151,	157,	235].		 	
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	 Recently,	examples	of	translation-independent	activation	of	gene	expression	by	sRNAs	have	been	reported.		In	these	cases,	the	sRNA	does	not	directly	stimulate	translation,	but	rather	stabilizes	the	mRNA	[75,	147,	196].		For	example,	the	sRNA	SgrS,	the	master	regulator	of	the	glucose-phosphate	stress	response,	stabilizes	yigL	mRNA,	which	codes	for	a	haloacid	dehalogenase	(HAD)-like	sugar	phosphatase	[123,	196].	A	dicistronic	mRNA,	pldB-yigL	is	processed	by	RNase	E,	cleaving	the	transcript	within	the	pldB	coding	sequence	(~200	nt	upstream	of	yigL	start	codon).		In	the	absence	of	SgrS,	processed	fragments	are	further	degraded.	When	present,	SgrS	base	pairs	at	a	site	downstream	of	the	processing	site	(within	the	3’	region	of	
pldB)	and	prevents	further	RNaseE-mediated	degradation,	thus	stabilizing	the	‘pldB-
yigL	mRNA.	In	essence,	SgrS	competes	with	RNase	E	and	stabilizes	the	yigL	mRNA,	allowing	more	rounds	of	translation	and	increased	production	of	YigL	protein	[196].	Another	sRNA,	RydC,	post-transcriptionally	activates	cfa,	a	gene	encoding	cyclopropane	fatty	acid	synthase,	by	a	similar	mechanism.	RydC	stabilizes	cfa	mRNA	by	interfering	with	the	RNase	E-dependent	degradation	[75].	It	is	likely	that	even	more	examples	of	stability-dependent	activation	by	sRNAs	will	be	emerging	because	ribonucleolytic	decay	can	be	readily	interfered	with	through	sRNA-mediated	occlusion	of	processing	sites	recognized	by	various	endoribonucleases.		
	
1.2.2.2	Post-transcriptional	repression	by	base	pairing	sRNAs		Negative	regulation	of	gene	expression	by	sRNAs	is	highly	prevalent	in	bacteria	and	has	been	well	documented.	The	canonical	mechanism	of	repression	involves	sRNA	interference	with	translation	initiation	of	the	target	mRNA.	The	translation	initiation	region	(TIR)	of	the	mRNA	may	consist	of	several	cis-elements	important	for	translation,	namely	the	RBS	[179],	translation	enhancer	element	[226,	288],	ribosome	standby	site	[49]	and	leader	open	reading	frame	(ORF)	[269],	any	of	which	may	be	targeted	for	inhibition	by	sRNAs.		Many	sRNAs	base	pair	within	the	leader	sequence	(5’	UTR)	of	the	mRNA	target	and	inhibit	translation	by	blocking	the	RBS.	Established	boundaries	of	the	ribosome	footprint	are	15	nt	upstream	and	20	nt	downstream	of	the	start	codon	[17,	96],	and	sRNA	pairing	within	this	region	results	in	inhibition	of	translation	
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initiation.	For	example,	the	sRNA	SgrS	(described	in	more	detail	below)	regulates	
ptsG	mRNA	by	pairing	at	the	RBS	and	blocking	ribosome	access,	successfully	inhibiting	synthesis	of	PtsG	protein	[179].	However,	sRNAs	binding	outside	of	this	region	have	been	reported	to	inhibit	translation	in	Escherichia	coli	and	Salmonella	[24,	49,	92,	226].	RBS	occlusion	can	occur	via	sRNA	binding	at	a	distance	via	the	Hfq	protein	[56].	Alternatively,	some	sRNAs	target	enhancer	elements	to	reduce	translation	initiation	[55].		The	best	characterized	example	of	this	is	the	sRNA	GcvB	(discussed	more	below),	which	inhibits	translation	of	several	mRNAs	by	base	pairing	at	C/A-rich	regions	upstream	of	the	RBS	that	were	shown	to	enhance	translation	[226,	288].	Repression	by	sRNA	occlusion	of	other	elements	in	the	translation	initiation	region,	such	as	putative	ribosome	standby	sites	[49]	or	leader	ORFs	[239]	are	not	well-characterized,	but	have	been	described	as	mechanisms	of	post-transcriptional	control	[55].	Although	translation	inhibition	alone	is	often	sufficient	to	achieve	gene	silencing	[179],	the	sRNA-mRNA	duplexes	formed	to	cause	translational	repression	are	also	typically	targeted	for	degradation	[158,	159,	178].	Few	cases	are	known	where	an	sRNA	acts	solely	by	either	translational	repression	[171]	or	by	directly	promoting	degradation	[198].	In	E.	coli	and	related	organisms,	duplex	decay	is	mediated	by	recruiting	the	endoribonuclease	RNase	E,	a	major	component	of	the	degradosome	often	involved	in	trans-encoded	sRNA-mediated	regulation	[135,	158,	159,	178]	or	RNase	III,	an	endoribonuclease	that	recognizes	double-stranded	RNA	as	substrate	for	processing	[34,	272].	Together,	translation	inhibition	and	duplex	destabilization	provide	an	effective	and	irreversible	system	for	post-transcriptional	repression	of	gene	expression	in	bacteria.	
	
1.2.2.3	Transcriptional	regulation	by	cis-encoded	sRNAs	Transcriptional	regulation	by	cis-encoded	sRNAs	can	occur	via	transcription	interference	or	attenuation.	Transcription	interference	takes	place	when	transcription	from	one	gene	is	inhibited	by	transcription	from	the	cis-encoded,	convergently	oriented	gene	on	the	opposite	strand.	In	contrast	to	post-transcriptional	regulatory	mechanisms	and	transcription	attenuation,	transcription	
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interference	does	not	require	direct	interaction	between	the	sRNA	and	a	cognate	mRNA.	Rather,	premature	termination	of	transcription	can	occur	when	convergently	replicating	RNA	polymerases	collide,	resulting	in	dissociation,	backtracking,	or	stalling	of	one	or	both	polymerase	complexes	[45,	237].	Mathematical	models	predict	additional	mechanisms	of	interference	where	elongating	RNA	polymerase	can	collide	with	a	separate	polymerase	open	complex	at	the	“sensitive”	promoter	and	prevent	it	from	proceeding	to	elongation	[31],	or	where	the	promoter	of	one	gene	is	blocked	by	the	pausing	of	the	polymerase	bound	to	the	gene	on	the	opposite	strand	[191].	A	transcription	interference	mechanism	has	been	suggested	for	the	sRNA	encoded	antisense	to	the	ubiG-mccBA	operon	involved	in	methionine	to	cysteine	conversion	in	Clostridium	acetobutylicum	[5].	Transcription	attenuation,	on	the	other	hand,	requires	base	pairing	between	the	sRNA	and	an	mRNA	target.		Attenuation	occurs	when	the	sRNA	binds	to	the	elongating	mRNA	and	induces	secondary	structural	rearrangements	that	inhibit	the	formation	of	an	antiterminator	structure	and	favor	the	formation	of	a	terminator	hairpin	[80,	247].	In	Vibrio	anguillarum	species	a	non-coding	sRNA,	RNAβ,	interferes	with	transcription	of	angR	by	pairing	within	the	intergenic	region	of	fatA-angR	mRNA,	which	results	in	premature	transcription	termination	[247].	
	
1.2.2.4	Dual-function	sRNAs	Small	regulatory	RNAs	were	believed	to	be	non-coding	in	nature	and	act	solely	by	base	pairing	mechanism	to	regulate	their	target	transcripts.	However,	the	recent	explosion	in	sRNA	discovery	and	characterization	efforts	uncovered	sRNAs	with	additional	functions.	These	dual-function	sRNAs,	besides	regulating	genes	via	base	pairing	(riboregulation),	also	serve	as	mRNAs	and	encode	small	peptides	[266].	In	some	instances	the	peptide-encoding	open	reading	frame	(ORF)	overlaps	with	the	sequence	participating	in	riboregulation	[81,	173].	Sometimes	the	region	responsible	for	base	pairing	is	spatially	distinct	from	the	ORF,	highlighting	their	divergent	functions	[239,	240,	275].	The	effect	of	translation	of	the	ORF	on	the	regulation	by	base	pairing,	and	vise	versa,	is	not	well	understood.	Most	known	dual-function	sRNAs	are	trans-encoded.	For	example	Staphylococcus	aureus	
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long	known	to	encode	δ-hemolysin	(hld	gene),	a	small,	secreted	peptide	that	targets	host	cell	membranes.	Only	recently	it	was	discovered	that	RNAIII	regulates	a	number	of	genes	involved	in	virulence	at	the	post-transcriptional	level.	RNAIII	negatively	regulates	rot	mRNA,	a	repressor	of	several	exotoxin	encoding	genes,	by	occluding	the	RBS	and	targeting	it	for	degradation	[22,	78].	Additionally,	RNAIII	is	known	to	positively	regulate	hla	mRNA	encoding	α-hemolysin.	Base	pairing	of	RNAIII	with	the	5’UTR	of	hla	removes	the	translation-inhibitory	structure,	which	results	in	enhanced	expression	[173,	186].	As	evident,	the	RNAIII	base	pairing	region	and	encoded	protein	have	distinct	yet	complementary	functions.	A	recently	discovered	cis-encoded	antisense	RNA	(asRNA)	in	Pseudomonas	fluorescens	also	encodes	a	small	protein	[230].	Similarly,	Anabaena	sp.	PCC7120	asRNA	alr1690-α-
furA	is	predicted	to	encode	a	peptide	[89,	143].	The	latest	transcriptomic	analysis	of	
Listeria	monocytogenes	identified	a	class	of	dual-function	long	asRNAs,	termed	excludons,	which	span	whole	operons	and	encompass	the	sense	gene	encoded	in	the	opposite	direction.	These	dual-function	long	asRNAs	are	suggested	to	act	as	switches	that	ensure	expression	from	the	mRNA	component	while	repressing	the	adjacent	sense	gene	via	antisense	mechanism	[224,	257,	287].	However,	limited	experimental	characterization	calls	for	further	study	of	these	long	asRNAs	to	uncover	potentially	new	regulatory	mechanisms.	Identification	of	dual-function	sRNAs	poses	a	new	challenge	because	any	known	mRNA	has	an	intrinsic	ability	to	regulate	genes	via	base	pairing	interactions	like	sRNAs.			
1.2.2.5	sRNA	sponges	
	 sRNAs	are	characterized	by	their	ability	to	quickly	respond	to	stress	and	regulate	target	genes	because	they	do	not	have	to	be	translated,	unlike	protein	factors	that	take	more	time	to	be	produced	[228].	While	this	is	beneficial	when	rapid	response	to	stress	is	required	for	survival,	transcriptional	noise	from	such	fast	acting	sRNA	promoters	might	result	in	unwanted	regulatory	outcomes	and	metabolic	changes.	Recent	developments	in	sRNA	research	uncovered	small	RNA	molecules	that	act	as	a	cushion	to	dampen	transcriptional	noise	and	were	named	sRNA	sponges,	based	on	the	model	that	they	“soak	up”	sRNAs	produced	from	noisy	
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transcription	[128].	In	the	search	for	novel	targets	of	two	small	RNAs,	RyhB	and	RybB,	a	set	of	novel	binding	partners	has	been	found	within	the	polycistronic	tRNA	transcript	glyW-cysT-leuZ.	Specifically,	the	3’	external	transcribed	spacer	(ETS)	of	
leuZ	was	shown	to	reduce	transcriptional	noise	from	RyhB	and	RybB	promoters.	The	3’ETS	of	leuZ	base-pairs	and	inhibits	activity	of	RyhB	and	RybB	sRNAs	to	suppress	their	leaky	expression,	which	otherwise	leads	to	unwanted	remodeling	of	tricarboxylic	acid	(TCA)	cycle	fluxes	and	decreased	sensitivity	to	antibiotics	[129].	Fascinating	is	the	potential	wide-spread	nature	of	sRNA	sponges	derived	from	tRNA	encoding	genes,	as	suggested	by	the	co-purification	of	sRNAs	RybB	and	MicF	with	internally	transcribed	sequences	(ITS)	of	metZ-metW	and	metW-metV,	as	well	as	conservation	of	tRNA	ETSs	and	ITSs	in	many	bacterial	species	[129].	There	are	also	sRNA	sponges	that	are	derived	from	transcripts	other	than	tRNAs.	For	example	sRNA	sponge	SroC	is	a	stable	byproduct	of	gltI	mRNA	degradation	induced	by	GcvB	sRNA,	a	major	regulator	of	amino	acid	transport	in	E.	coli.	The	SroC	sponge	in	turn	base	pairs	and	destabilizes	GcvB	sRNA,	impeding	its	activity.	Such	a	feed-forward	loop	allows	SroC	to	indirectly	activate	genes	in	the	GcvB	regulon,	as	well	as	its	parental	gltI	mRNA	[168].	sRNA	sponges	provide	novel	variations	on	RNA-mediated	regulation	in	bacteria	and	surely	will	be	within	the	scope	of	sRNA	research	in	the	future.		
1.2.3	Base	pairing-independent	sRNA	regulation	
1.2.3.1	Protein-binding	sRNAs	While	the	vast	majority	of	characterized	sRNAs	utilize	base	pairing	as	the	means	of	regulating	gene	expression,	a	few	sRNAs	are	known	to	bind	and	modulate	protein	activity.	A	subset	of	such	sRNAs	modifies	activity	and	abundance	of	the	proteins	that	bind	nucleic	acid	substrates	by	mimicking	structures	of	their	cognate	targets.	6S	RNA	is	a	well-characterized	example	of	this	category	of	sRNAs,	and	is	highly	conserved	in	a	wide	variety	of	bacteria,	including	gram-negative	bacteria	like	
Escherichia	coli,	Pseudomonas	aeruginosa	and	Haemophilus	influenzae	[14,	276].	E.	
coli	6S	RNA	preferentially	binds	and	inhibits	RNA	polymerase	holoenzyme	containing	the	housekeeping	sigma	factor,	σ70	[261,	276].	6S	RNA	possesses	a	highly	
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conserved	secondary	structure	that	consists	of	a	double-stranded	RNA	hairpin	with	a	bubble	that	resembles	the	open	complex	of	DNA	promoters.		It	is	this	mimicry	that	enables	6S	RNA	to	fit	into	the	active	site	of	the	RNA	polymerase,	preventing	it	from	initiating	transcription	on	chromosomal	promoters	[14].	Expression	of	6S	RNA	increases	in	the	stationary	phase	of	growth	and	is	highest	in	late-stationary	phase,	when	it	inhibits	transcription	from	a	subset	of	σ70	promoters	[37,	120,	260,	276].	While	6S	RNA	sequesters	σ70		holoenzyme	and	inhibits	expression	from	some	σ70-dependent	promoters,	expression	of	the	alternative	sigma	factor	σS	is	upregulated	and	induces	transcription	of	genes	necessary	for	stationary	phase	growth	[260].	In	this	way,	6S	RNA	is	thought	to	help	mediate	a	switch	in	sigma	factor	usage	in	late	stationary	phase.		 Another	class	of	protein-binding	sRNAs	is	exemplified	by	transfer-messenger	RNA	(tmRNA)	involved	in	trans-translation,	a	mechanism	to	rescue	stalled	ribosomes	in	bacteria	[60,	229].		Defective	mRNAs	that	lack	the	termination	signals	allowing	ribosome	release	cause	stalling	of	the	ribosomes	and	results	in	a	general	loss	of	translational	efficiency,	and	accumulation	of	aberrant	mRNAs	and	nascent	peptides	[117,	284].	The	tmRNA	can	be	charged	with	alanine	and	also	contains	a	short	open	reading	frame	[66,	121,	282].	tmRNA	enters	the	ribosomal	A-site	on	stalled	ribosomes,	and	translation	then	proceeds	using	the	tmRNA	as	a	template.		Translation	terminates	at	the	tmRNA-encoded	stop	codon,	and	the	defective	mRNA	and	polypeptide	“tagged”	with	tmRNA-encoded	sequence	are	released	from	the	ribosome.	The	tagged	polypeptide	is	targeted	for	degradation	and	the	ribosome	is	free	to	participate	in	further	rounds	of	translation	[60,	113,	117,	229].			 Yet	another	distinct	class	of	protein-binding	RNAs	includes	two	sRNAs	CsrB	and	CsrC	found	in	E.	coli	and	related	bacteria	[6].	These	sRNAs	act	by	binding	to	and	sequestering	the	translational	regulator	CsrA,	which	regulates	a	large	number	of	genes	related	to	carbon	storage	and	metabolism	[256].		The	CsrB/C	family	of	sRNAs	will	be	discussed	in	more	detail	below.	These	examples	provide	just	a	glimpse	into	the	variety	of	mechanisms	by	which	bacterial	sRNAs	can	modulate	activity,	sequester	or	provide	structural	scaffolding	to	target	proteins.	It	is	conceivable	that	a	
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much	greater	variety	exists	and	will	be	uncovered	by	further	searches	for	novel	protein-binding	sRNAs.		
	
1.2.3.2	Riboswitches	Bacterial	riboswitches	are	cis-encoded	and	cis-acting	regulatory	elements	located	in	the	leader	sequences	of	mRNAs.	Riboswitches	directly	sense	physiological	changes	and	respond	by	mediating	expression	of	the	downstream	gene.	Riboswitch	RNA	elements	regulate	a	broad	number	of	genes	in	bacteria	and	are	classified	according	to	the	signal	they	sense.	Many	riboswitches	respond	to	signal	molecules	such	as	amino	acids	[82],	carbohydrates	[13],	nucleotides	[154],	tRNA	[83],	cofactors	and	metal	ions	[204].	Others	sense	physico-chemical	perturbations	such	as	changes	in	pH	[184]	and	temperature	(thermosensors)	[174].	Some	transcripts	contain	tandem	riboswitches	that	sense	and	integrate	distinct	physiological	signals	[243,	250].	Robust	regulation	of	gene	expression	is	possible	when	tandem	riboswitches	that	bind	the	same	ligand	in	a	cooperative	fashion	are	present	[155].	Ribozymes	are	fascinating	riboswitches	with	intrinsic	enzymatic	activity.	One	example	is	glmS	mRNA	that	initiates	self-cleavage	in	response	to	glucosamine-6-phosphate	binding	at	the	aptamer	domain	within	the	glmS	leader	riboswitch	[43].	Most	riboswitches	share	a	common	structure	comprised	of	aptamer	domain	responsible	for	ligand	binding	or	signal	sensing,	and	gene	expression	domain	that	mediates	the	regulatory	effects	on	the	downstream	gene.	Aptamers	provide	specificity	for	ligand	binding	and	are	highly	conserved	in	sequence	and	structure	[12].	Signal	sensing	induces	conformational	changes	in	the	aptamer	domain	of	the	riboswitch,	which	mediates	downstream	gene	expression	at	the	level	of	transcription	or	translation.	Ligand	binding	during	transcription	can	stimulate	structural	rearrangements	in	the	aptamer	that	promote	formation	of	the	Rho-independent	terminator	or	antiterminator	hairpins,	which	respectively,	attenuate	or	promote	transcription	[82].	Fascinating	enough,	transcription	attenuation	generates	abortive	transcripts	corresponding	to	the	aptamer	sequence,	which	have	a	regulatory	potential.	However	the	exact	function	of	aborted	aptamer	RNAs	is	not	yet	understood	[15].	Translational	regulation	by	the	riboswitches	is	achieved	by	
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sequestering	RBS	in	a	secondary	structure	that	forms	as	a	result	of	ligand	binding	to	the	aptamer	domain.		It	has	been	noted	that	riboswitches	of	Gram-negative	bacteria	usually	mediate	translation	of	the	downstream	genes,	whereas	the	bulk	of	riboswitches	in	Gram-positives	regulate	genes	at	the	level	of	transcription	[187].	In	general,	riboswitch	elements	are	not	numerous	in	Gram-negative	bacteria,	where	the	majority	of	RNA-mediated	post-transcriptional	control	characterized	to	date	is	attributed	to	base	pairing	sRNAs.			
1.2.4	Protein	factors	involved	in	sRNA-dependent	regulation	
1.2.4.1	Hfq	As	previously	mentioned,	Hfq	is	a	widely	conserved	and	highly	abundant	(reported	estimates	vary	from	~400	[32]	to	10,000	[3,	108]	hexamers	per	E.	coli	cell)	RNA	chaperone	protein	involved	in	regulation	by	sRNAs	in	bacteria	[278].	Hfq	(host	factor	for	Qβ)	was	first	identified	as	a	bacterial	host	factor	involved	in	the	replication	of	the	Qβ	phage	in	E.	coli	[72].	It	binds	the	3’	end	of	the	viral	plus-strand	RNA	and	is	required	for	minus-strand	synthesis	by	Qβ	replicase	[73].	A	much	broader	function	for	Hfq	was	recognized	when	its	inactivation	in	E.	coli	and	
Salmonella	resulted	in	pleiotropic	growth	and	virulence	phenotypes	[88,	233,	263],	in	addition	to	a	general	deregulation	of	~20%	of	Salmonella	genome	[232].	Of	interest	was	that	E.	coli	hfq	mutants	adjusted	poorly	to	environmental	stresses	such	as	stationary	phase	growth,	osmotic	imbalance,	oxidation	and	others	[181,	262,	273].		These	defective	stress	phenotypes	were	later	found	to	be	due	to	the	vital	role	of	Hfq	in	the	sRNA	regulatory	network	responding	to	a	variety	of	stresses	and	growth	conditions.	Hfq	regulates	its	own	expression	at	the	post-transcriptional	level	by	binding	within	the	hfq	mRNA	leader	sequence,	which	interferes	with	translation	initiation	[270].	This	phenomenon	is	particularly	of	note	because	normally	sRNAs	associated	with	Hfq	determine	the	specificity	of	regulation;	in	this	case,	Hfq	seems	to	act	alone	to	alter	translation	of	hfq	mRNA.	Hfq	may	in	fact	act	alone	on	a	number	of	other	mRNA	targets	as	evidenced	by	a	recent	study	showing	that	Hfq	binds	and	inhibits	translation	of	cirA	mRNA,	encoding	a	siderophore	transporter	(and	colicin	Ia	receptor),	in	the	absence	of	an	sRNA	[219].	
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	 A	great	deal	has	been	learned	about	the	function	of	Hfq	by	studying	its	structure.		Hfq	is	a	member	of	the	Sm-like	(LSm)	protein	family,	which	is	conserved	in	all	domains	of	life.	A	distinct	protein	fold	called	“LSm-domain”	and	the	ability	to	interact	with	nucleic	acids	characterize	the	proteins	of	this	family.	The	LSm-domain	structure	is	partially	conserved	in	bacterial	Hfq	monomers	and	consists	of	five	antiparallel	β-strands	forming	a	β-sheet,	with	an	α-helix	stacked	on	top	[221].	Hfq	monomers	in	E.	coli	and	related	species	assemble	into	homohexameric	rings.		Both	forms	likely	exist	in	equilibrium	within	the	cell,	with	hexamers	being	most	active	in	RNA	binding	and	annealing	[194].	In	E.	coli,	the	Hfq	ring	contains	sRNA-binding	sites	on	the	so-called	proximal	(the	side	of	the	ring	and	inner	rim	of	the	central	cavity	containing	α-helixes)	and	lateral	(outer	rim	of	the	ring)	faces,	and	an	mRNA-binding	region	on	the	distal	(surface	opposite	to	the	proximal	side	containing	β-sheets)	face	of	the	ring	[140,	166,	213,	222,	292].	Hfq	was	shown	to	preferentially	recognize	a	common	sRNA	structure:		an	A/U	rich	sequence	followed	by	a	Rho-independent	terminator	hairpin	and	a	3'	poly-U	tail	[99,	189,	265].	Similarly,	an	Hfq-binding	element	called	the	(ARN)x	motif	is	found	in	the	leader	sequences	of	many	sRNA-regulated	mRNAs.	It	consists	of	an	A-rich	sequence	flanked	by	highly	structured	regions	shown	to	specifically	interact	with	Hfq.	Recognition	of	(ARN)x-containing	mRNAs	occurs	through	A-R-E	motifs	present	on	each	Hfq	monomer	(six	motifs	overall)	that	allow	Hfq	hexamer	to	bind	up	to	six	ARN	repeats	simultaneously	[140,	217,	218,	242].		Functionally,	Hfq	binds	and	protects	sRNAs	from	nucleolytic	decay	[171,	236]	and	facilitates	their	base	pairing	to	target	mRNAs	[171,	293].	Binding	of	Hfq	to	both	sRNA	and	mRNA	increases	their	local	concentrations,	stimulates	structural	remodeling	to	facilitate	pairing	and	increases	annealing	rates	of	cognate	pairs	[67,	93,	152,	241].		While	Hfq	is	quite	abundant,	several	recent	studies	have	demonstrated	that	there	is	competition	between	sRNAs	for	binding	of	Hfq	[1,	95,	172].	Due	to	the	abundance	of	sRNAs	that	compete	for	binding,	Hfq	structure	and	function	are	highly	optimized,	allowing	binding	of	several	RNA	molecules	and	having	rapid	RNA	dissociation	rate	to	cycle	between	many	different	combinations	of	sRNAs	and	mRNAs	in	order	to	form	a	productive	interaction	of	the	two	[1].	While	such	features	provide	for	a	robust	regulatory	response,	it	was	recently	shown	that	
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abnormally	high	levels	of	one	sRNA	could	effectively	disrupt	regulation	by	other	sRNAs	in	vivo	[95].	Overexpression	of	one	sRNA	decreases	stability	and	accumulation	of	other	sRNAs,	as	well	as	reduces	their	binding	to	Hfq,	which	causes	perturbations	in	the	regulation	of	target	mRNAs	and	changes	the	outcome	of	gene	regulation	[172].	While	competition	between	sRNAs	for	Hfq	binding	is	concentration-dependent	[67],	different	sRNAs	compete	with	different	efficiencies	[172],	likely	determined	by	the	intrinsic	properties	of	each	sRNA,	which	further	complicates	RNA	regulatory	networks	and	their	study.		 In	addition	to	binding	RNAs,	Hfq	is	also	known	to	directly	interact	with	a	number	of	protein	factors	such	as	RNA	polymerase	[251],	Rho	factor	[202],	poly-A	polymerase	I	[87],	RNase	E	[97]	and	PNPase	[53,	170].	Of	particular	interest	are	Hfq	associations	with	the	components	of	the	degradosome:	RNase	E	and	PNPase,	and	the	role	of	Hfq	in	recruiting	these	proteins	during	sRNA-mediated	regulation	of	target	transcripts	[10].	Hfq	likely	serves	as	a	scaffold	for	sRNA-mRNA	interactions	and	a	platform	for	recruiting	protein	factors	important	for	robust	regulation.	
	
1.2.4.2	RNase	E	and	the	RNA	degradosome	Many	base	pairing	sRNAs	modulate	stability	of	their	mRNA	targets.	RNase	E	is	a	single-strand-specific	endoribonuclease	involved	in	the	regulatory	mechanisms	of	trans-encoded	sRNAs	[158,	159,	178]	and	also	plays	important	roles	in	RNA	processing	and	bulk	mRNA	turnover	in	E.	coli	and	related	organisms	[16,	33].	The	active	enzyme	is	a	homotetramer	composed	of	catalytic,	RNA	binding	and	protein	binding	domains.	The	C-terminal	protein	binding	domain	of	RNase	E	serves	as	a	scaffold	upon	which	other	components,	namely	polynucleotide	phosphorylase	(PNPase),	RNase	helicase	B	(RhlB)	and	the	glycolytic	enzyme	enolase,	assemble	to	form	a	large	RNA	degrading	complex	called	the	degradosome	[33].	Importantly,	the	catalytic	domain	and	C-terminal	scaffold	domain	are	both	necessary	for	sRNA-targeted	mRNA	degradation.			 Hfq	interacts	with	RNase	E	in	a	large	ribonucleoprotein	complex.	Exposed	A/U-rich	single-stranded	RNA	regions	are	preferentially	recognized	by	RNase	E,	which	is	stimulated	by	the	5’-terminal	monophosphate	of	the	sRNA	to	cleave	its	RNA	
	 15	
substrates	[11,	16,	34,	104,	135].	Regulatory	sRNAs	might	stimulate	degradation	of	their	target	mRNAs	by	promoting	structural	remodeling	that	exposes	A/U-rich	recognition	sequences	and/or	by	providing	a	5’-teminal	monophosphate	to	stimulate	RNase	E-mediated	cleavage.	Although	not	experimentally	demonstrated,	the	helicase	(RhlB)	associated	with	the	degradosome	might	facilitate	unwinding	of	the	sRNA-mRNA	duplex	or	remodeling	secondary	structure	that	occludes	RNase	E	recognition	sequences.	Additionally,	sRNA-mediated	translation	inhibition	of	mRNAs	frees	these	mRNAs	from	ribosomes,	which	otherwise	protect	mRNAs	from	RNase	E-mediated	cleavage	[54,	59,	107,	200].	
	
1.2.4.3	YbeY	ribonuclease		YbeY	is	a	novel	bacterial	exoribonuclease	that	was	recently	implicated	in	regulation	by	sRNAs.	The	ybeY	gene	is	highly	conserved	and	found	in	nearly	every	sequenced	bacterial	species	[52,	271].		YbeY	is	a	17-kDa	exoribonuclease	that	bears	a	close	resemblance	to	eukaryotic	Argonaute	(AGO)	proteins,	which	are	principal	components	of	the	RNA-induced	silencing	complex	[100,	163].	YbeY	specifically	binds	single-stranded	RNA	and	together	with	other	ribonucleases	like	RNase	R	and	PNPase,	it	mediates	processing	required	for	the	maturation	of	rRNAs	[51,	271].	YbeY	also	functions	in	controlling	the	quality	of	the	70S	subunit	after	it	has	been	assembled	in	order	to	prevent	protein	mistranslation	[100].			 An	alternative	and	less	understood	function	of	YbeY	is	in	sRNA-mediated	regulation.	Gram-negative	Sinorhizobium	meliloti	ybeY	mutants	exhibit	a	pleiotropic	phenotype	of	poor	growth	under	a	variety	of	stress	conditions,	very	similar	to	S.	
meliloti	hfq	mutants	[192].	Moreover,	altered	levels	of	at	least	nine	sRNAs	and	their	respective	target	mRNAs	were	seen	in	both	S.	meliloti	ybeY	and	hfq	mutants	[192].	Studies	performed	in	E.	coli	suggest	that	YbeY	modulates	levels	of	many	sRNAs	and	their	cognate	targets	under	certain	stress	conditions,	independent	of	sRNA	requirements	for	Hfq	[193].	Another	recent	study	demonstrated	that	YbeY,	besides	its	role	in	rRNA	maturation,	also	affects	regulation	of	virulence	and	stress	response-associated	sRNAs	in	Vibrio	cholerae	[271].	Taken	together,	these	studies	suggest	that	YbeY	plays	a	general	and	important	role	in	sRNA	regulatory	processes.	
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However,	current	understanding	of	the	basis	for	regulation	by	this	novel	RNase	is	limited	and	additional	research	efforts	are	needed.	
	
1.3	SgrS	sRNA:	Master	Regulator	of	Glucose-Phosphate	Stress	Response		 SgrS	(Sugar	Transport-Related	sRNA)	was	first	identified	in	2003,	as	an	Hfq-binding	sRNA	in	a	global	co-immunoprecipitation	study	in	E.	coli	[294].		The	first	hints	that	SgrS	was	involved	in	sugar	metabolism	came	with	the	observation	that	E.	
coli	cells	overexpressing	SgrS	experienced	strong	growth	inhibition	on	glucose	and	mannose	supplemented	minimal	media.	SgrS	is	a	trans-encoded,	227-nt	long,	dual-function	sRNA	involved	in	the	response	to	glucose-phosphate	stress	[267,	275].	During	stress	a	transcription	factor	SgrR	is	activated	and	induces	expression	of	SgrS	sRNA.	Both	factors	are	essential	for	survival	during	stress;	mutants	of	SgrR	and	SgrS	are	severely	growth	inhibited	under	the	glucose-phosphate	stress	conditions	[267].	SgrS	regulates	a	number	of	mRNA	targets	through	base	pairing	interactions,	and	it	also	encodes	a	small	protein	called	SgrT	[275].	Remarkably,	both	SgrS	and	SgrT	utilize	independent	regulatory	mechanisms	to	act	in	the	same	physiological	pathway,	namely	glucose-phosphate	stress	response.		
1.3.1	Glucose-phosphate	stress	physiology		 Sugars	are	excellent	sources	of	carbon	and	energy	for	many	bacteria.	Central	metabolism	is	finely	tuned	to	respond	to	sugar	availability,	where	glucose	is	a	primary	nutrient	taken	up	and	metabolized	by	the	cell,	in	preference	to	other	sugars	like	fructose,	mannose,	arabinose,	glycerol	and	other	carbohydrates.	Although	necessary	for	survival,	excessive	accumulation	of	phosphorylated	sugars	can	be	detrimental	to	the	cell	and	result	in	growth	stagnation	[63]	or	death	[98,	289].			 In	E.	coli,	perturbations	in	the	glycolytic	flux	or	uptake	of	certain	nonmetabolizable	sugar	analogs	result	in	growth	inhibition;	this	specific	condition	is	termed	glucose-phosphate	stress	[267].	Transport	of	these	sugars	is	achieved	by	the	phosphoenolpyruvate-dependent	phosphotransferase	system	(PEP-PTS)	[199,	212].	During	translocation	into	the	cell,	glucose	or	its	analogs	α-methyl	glucoside	(αMG)	and	2-deoxyglucose	(2DG)	are	phosphorylated	by	sugar-specific	PEP-PTS	
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components	EIICBglc	(PtsG)	and	EIICman	(ManY)	respectively	(Figure	1.1A).	A	mutation	in	pgi,	a	gene	encoding	the	glycolytic	enzyme	phosphoglucose	isomerase,	results	in	intracellular	accumulation	of	glucose-6-phosphate	(G6P)	[119,	175].	Similarly,	glucose	analogs	α-methylglucoside-6-phosphate	(αMG6P)	and	2-deoxyglucose-6-phosphate	(2DG6P)	cannot	be	metabolized	by	E.	coli	and	accumulate	in	the	cytoplasm	[124,	267].	Interestingly,	the	mechanism	of	growth	inhibition	due	to	accumulation	of	phosphorylated	sugars	is	largely	unknown.			 In	order	to	investigate	the	effects	of	changes	in	glycolytic	flux,	Aiba	and	colleagues	measured	glucose-phosphate	stress	induction	in	cells	lacking	individual	glycolytic	enzymes	[175,	267].	Mutations	in	upper	glycolytic	genes	encoding	phosphoglucose	isomerase	(pgi),	phosphofructokinase	(pfkA)	and	fructose	bisphosphate	aldolase	(fbaA)	all	resulted	in	stress	induction.	Supplementation	with	glycolytic	intermediates	immediately	downstream	of	the	block	relieved	the	stress.	Similarly,	glucose-phosphate	stress	was	induced	in	the	wild-type	strain	by	the	addition	of	αMG	to	the	growth	medium;	the	nonmetabolizable	nature	of	this	glucose	analog	might	mimic	a	mutational	block	in	early	glycolysis	[175].			 Recent	studies	by	our	group	demonstrate	that	supplementing	early	glycolytic	intermediates	G6P,	F6P	and	fructose-1,6-bisphosphate	(FBP)	rescue	the	growth	defect	of	an	sgrS	mutant	during	αMG-induced	glucose-phosphate	stress	[208].	Consistent	with	these	results,	addition	of	early	glycolytic	intermediates	results	in	reduced	induction	of	glucose-phosphate	stress	response,	which	was	determined	by	monitoring	activation	of	sgrS	promoter	(PsgrS-lacZ)	[208].	Surprisingly,	addition	of	pyruvate	during	glucose-phosphate	stress	has	an	opposite	effect	and	results	in	cell	death	(not	the	usual	growth	inhibition)	of	sgrS	mutants.	Addition	of	pyruvate,	however,	did	not	effect	expression	of	PsgrS-lacZ	suggesting	that	the	lethal	phenotype	is	not	due	to	exacerbation	of	the	stress	condition	but	rather	to	an	independent	mechanism	[208].	Overexpression	of	PpsA	confers	resistance	to	pyruvate-induced	lysis	during	stress	by	converting	pyruvate	into	PEP.	Importantly,	ppsA	overexpression	improved	growth	of	the	sgrS	mutant	during	αMG-induced	stress	without	addition	of	pyruvate	[208].	Consistent	with	the	previous	observations	that	
E.	coli	lacking	phosphoenolpyruvate	(PEP)	synthetase	(PpsA)	are	sensitive	to	the	
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presence	of	nonmetabolizable	glucose	analog	2DG	[124].	2DG	is	phosphorylated	during	transport	into	the	cell	by	PEP-PTS	that	relays	phosphate	from	PEP	to	the	incoming	sugar.	Phosphorylation	of	2DG	results	in	the	depletion	of	PEP,	because	2DG6P	does	not	flow	through	glycolysis	to	replenish	the	depleted	intermediate.	Depletion	of	PEP	is	exacerbated	by	the	lack	of	PpsA,	which	would	normally	use	pyruvate	to	replenish	PEP.	Moreover,	supplementing	aspartate	as	a	sole	nitrogen	source	reduces	2DG	sensitivity	of	the	ppsA	mutant	strain	[124].	Addition	of	aspartate	might	rescue	growth	on	2DG	because	aspartate	transaminase	(AspC)	converts	aspartate	into	oxaloacetate	(OAA),	which	in	turn	is	used	by	PEP	carboxykinase	(Pck)	to	replenish	PEP.	Together,	it	is	clear	that	balanced	glycolytic	flux	maintains	appropriate	levels	of	PEP	in	the	cell,	but	uptake	and	accumulation	of	non-metabolizable	sugar	analogs	may	lead	to	depletion	of	these	essential	intermediates	resulting	in	stress.		 While	glucose-phosphate	stress	condition	is	closely	associated	with	glycolysis,	a	new	link	to	phosphate	metabolism	has	been	recently	uncovered.	Mutation	of	pitA,	one	of	the	two	major	Pi	transporters	of	E.	coli,	partially	suppresses	growth	inhibition	phenotype	of	sgrS	mutants	during	glucose-phosphate	stress	[209].		Mutation	of	pitA	results	in	the	induction	of	the	phosphate	(Pho)	starvation	regulon	and	activation	of	many	genes	involved	in	phosphate	uptake	and	metabolism.	None	of	the	individual	members	of	Pho	regulon	are	responsible	for	the	suppression	of	the	
sgrS	growth	defect	during	stress.	However,	direct	induction	of	the	Pho	regulon,	independent	of	pitA,	is	sufficient	to	partially	suppress	the	glucose-phosphate	growth	defect	of	sgrS	mutant.	Changes	in	external	Pi	concentrations	have	no	effect,	suggesting	the	phenotypes	observed	are	not	dependent	on	phosphate	availability	[209].	It	is	yet	unclear	how	induction	of	the	Pho	regulon	relieves	stress,	but	it	might	confer	overall	growth	advantage	that	improves	stress	recovery.	The	Pho	regulon	is	known	to	play	a	role	in	the	cellular	responses	to	oxidative	and	acid	stresses,	as	well	as	pathogenesis	[46].			 Extensive	studies	probed	the	underlying	causes	of	glucose	phosphate	stress,	but	the	definitive	mechanism	for	this	physiological	condition	is	still	not	clear.	Taken	together	these	studies	indicate	that	glucose-phosphate	stress	in	E.	coli	is	a	result	of	
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perturbations	in	glycolytic	flux	and	imbalance	or	depletion	of	glycolytic	intermediates.	Accumulation	of	early	glycolytic	intermediates	G6P	and	F6P,	as	well	as	ratio	of	PEP	to	pyruvate	may	be	important	factors	involved	in	the	stress	mechanism.	Pleiotropic	effects	of	the	Pho	regulon	in	stress	recovery	are	not	clear,	but	sufficient	to	confer	growth	advantage	during	glucose-phosphate	stress.		
	
1.3.2	SgrS	expression		 SgrS	sRNA	is	highly	expressed	when	bacterial	cells	experience	glucose-phosphate	stress.	It	is	also	essential	for	growth	during	glucose-phosphate	stress,	and	sgrS	mutants	are	growth	inhibited	in	the	presence	of	nonmetabilizable	glucose	analogs	αMG	and	2DG	[267].	In	response	to	glucose-phosphate	stress,	transcription	of	sgrS	is	activated	by	SgrR	(Figure	1.1A),	a	551	aa	protein	with	a	molecular	mass	of	65	kDa.	It	contains	two	domains,	an	N-terminal	winged	helix	DNA	binding	domain	and	C-terminal	solute-binding	domain	[268].	sgrR	is	encoded	divergently	and	directly	upstream	of	sgrS.	Promoter	regions	of	the	two	genes	overlap,	with	coding	sequences	separated	by	only	67	nt.	Overlapping	promoters	allow	SgrR	to	activate	
sgrS	transcription	while	negatively	autoregulating	its	own	expression.	The	intergenic	sequence	from	-65	to	the	sgrS	transcription	start	site	is	sufficient	for	SgrR-dependent	activation	of	sgrS	transcription,	but	not	autorepression.	SgrR	binding	at	another	site	within	sgrR	coding	sequence	is	important	for	full	autoregulation	of	sgrR	transcription.	Importantly,	unlike	activation	of	sgrS	transcription,	autorepression	by	SgrR	is	independent	of	glucose-phosphate	stress	[268].	Although	autoregulation	of	sgrR	is	important,	its	expression	might	be	controlled	at	another,	yet	unknown,	level.	When	sequences	required	for	SgrR	autoregulation	were	mutated,	the	levels	of	SgrR	protein	were	not	significantly	affected,	with	SgrS	levels	normally	being	limited	[268].	Why	the	tight	regulation	of	SgrR	levels	is	so	critical	and	what	other	tier	of	regulation	is	involved	is	not	known.	The	signal	that	activates	SgrR	is	also	undetermined,	but	does	not	appear	to	be	phosphosugars	per	se.	It	was	previously	hypothesized	that	SgrR	might	be	activated	through	G6P	or	αMG6P	interaction	with	the	C-terminal	solute-binding	domain,	however	this	has	not	been	determined.	It	is	worth	noting	that	besides	sgrS,	SgrR	
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also	activates	transcription	of	alaC,	a	gene	encoding	a	major	glutamate-pyruvate	aminotransferase.	Transcription	of	alaC	might	be	activated	from	two	alternate	promoters,	one	SgrR	dependent	and	one	SgrR	independent	[268].	Regulation	of	alaC	by	SgrR	and	its	potential	role,	if	any,	in	glucose-phosphate	stress	response	is	still	unknown.			 Additionally,	SgrR	activates	expression	of	setA,	a	proton	motive	force-driven	efflux	pump	capable	of	transporting	a	wide	variety	of	substrates	[141,	253].	setA	is	located	directly	downstream	of	sgrS	and	both	genes	are	co-transcribed.	Although	
sgrS	contains	a	Rho-independent	terminator	at	the	5’	end,	the	presence	of	polycistronic	sgrS-setA	species	indicates	transcriptional	read	through	takes	place.	The	read	through	is	rare,	because	under	the	stress	conditions	steady-state	levels	of	the	sgrS	transcript	are	~600-fold	higher	than	those	of	the	sgrS-setA	bicistronic	mRNA.	Interestingly,	setA	mutants	experience	a	mild	defect	during	glucose-phosphate	stress	[253].	SetA	was	hypothesized	to	pump	out	detrimental	phosphosugars	that	cause	glucose-phosphate	stress,	but	efflux	assays	did	not	uphold	this	hypothesis.	In	addition,	unidentified	CRP-regulated	promoter	might	control	setA	transcription,	because	CRP	affects	basal	levels	of	setA	in	an	SgrR-independent	fashion	[253].	Deletion	of	setA	also	affects	signaling	through	SgrR	in	a	medium-specific	manner	[253].		Overall,	it	appears	that	setA	is	not	crucial,	but	does	play	a	minor	unknown	role	during	the	glucose-phosphate	stress	response.			
1.3.3	SgrS-mediated	gene	regulation	during	glucose-phosphate	stress		
1.3.3.1	Repression	of	sugar	transport	
	 E.	coli	EIICBglc	(PtsG)	mediates	transport	and	phosphorylation	of	glucose	and	its	analogue	αMG.	Accumulation	of	these	phosphorylated	sugars	under	certain	conditions	results	in	glucose-phosphate	stress.	SgrS	prevents	synthesis	of	new	EIICBglc	by	riboregulating	ptsG	mRNA,	therefore	decreasing	accumulation	of	toxic	glucose	analogues.	SgrS	negatively	regulates	ptsG	mRNA	by	base	pairing	interactions	mediated	by	Hfq	and	degradation	of	the	target	mRNA	in	an	RNase	E-dependent	fashion	(Figure	1.1B).	SgrS	contains	a	stretch	of	20	nt	(nucleotides	+168	to	+187)	that	base	pair	imperfectly	with	the	5’	UTR	of	ptsG	mRNA	(nucleotides	+76	to	+95),	
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covering	the	RBS	and	start	codon	[267]	(Figure	1.2C).	A	proposed	6	nt	seed	sequence	of	SgrS	(nucleotides	+174	to	+179)	complementary	to	the	ptsG	RBS	plays	a	crucial	role	in	the	ability	of	the	sRNA	to	regulate	its	target	[114].	Mutations	G176C	and	G178C	within	the	seed	region	eliminate	SgrS	regulation	of	ptsG	mRNA,	highlighting	the	importance	of	these	nucleotides	in	the	base	pairing	interaction	[153].		 Interactions	between	SgrS	and	ptsG	mRNA	are	mediated	by	the	RNA	chaperone	Hfq,	which	accelerates	the	rate	of	duplex	formation	[114].	While	SgrS	stability	is	greatly	altered	in	the	hfq	mutant	strain,	making	it	too	short-lived	to	exert	any	regulatory	action	[115],	in	vitro	studies	showed	that	SgrS	base	pairing	with	ptsG	mRNA	in	the	absence	of	Hfq	is	sufficient	for	translational	inhibition	[153].	Hfq	specifically	recognizes	a	double	hairpin	structure	in	SgrS	that	consists	of	an	internal	stem-loop	preceded	by	a	U-rich	sequence	and	a	downstream	Rho-independent	terminator	hairpin	followed	by	a	long	poly(U)	tail	(Figure	1.2A).	It	was	established	
in	vivo	and	in	vitro	that	both	of	these	structures	are	necessary	and	sufficient	for	Hfq	binding	to	SgrS	[99,	189].	Another	important	role	of	Hfq	is	to	recruit	RNase	E	to	actively	degrade	the	SgrS-ptsG	duplex	following	translation	inhibition	[178,	267].	Although	RNase	E-dependent	degradation	is	not	necessary	for	ptsG	regulation,	it	is	believed	to	increase	the	robustness,	making	repression	irreversible	[179].	In	addition,	ptsG	mRNA	localization	to	the	membrane,	due	to	membrane	targeting	of	the	translated	protein,	is	somehow	important	for	the	degradation	of	the	SgrS-ptsG	duplex	[115],	but	the	mechanistic	details	of	this	phenomenon	are	not	fully	understood.		 In	addition	to	blocking	transport	of	glucose	and	αMG	by	regulating	EIICBglc,	SgrS	represses	another	transporter	EIIman	(ManXYZ)	that	selectively	transports	glucose	analogue	2DG	[207].	Remarkably,	E.	coli	SgrS	negatively	regulates	manXYZ	at	the	post-transcriptional	level	using	multiple	binding	sites	on	the	polycistronic	transcript	(Figure	1.1B).	Firstly,	SgrS	base	pairs	within	the	manX	CDS	(nucletides	+139	to	+152)	(Figure	1.2C)	and	inhibits	translation	by	yet	unknown	mechanism	[207].	This	interaction	is	downstream	of	the	ribosome	binding	window	(-20	to	+15	relative	to	manX	start	codon),	therefore	SgrS	may	not	inhibit	translation	directly	via	
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steric	hindrance,	posing	a	question	as	to	how	this	regulation	occurs.	Secondly,	SgrS	binds	in	the	manX-manY	intergenic	region	(nucleotides	-44	to	-30	relative	to	manY	start	codon)	(Figure	1.2C)	and	inhibits	translation	of	manY	(and	manZ	since	they	are	translationally	coupled).	Translation	of	manZ	is	dependent	on	regulation	of	manY	because	the	two	genes	are	separated	by	only	3	nt	and	are	translationally	coupled.		Regulation	of	manYZ	translation,	however,	is	independent	from	regulation	of	manX	[206].	It	is	interesting	that	binding	of	SgrS	at	each	site	individually	does	not	promote	
manXYZ	degradation,	while	pairing	at	both	sites	simultaneously	targets	the	transcript	for	degradation	by	RNase	E.	Similar	to	ptsG,	degradation	is	not	necessary	for	translation	inhibition	of	manX	or	manYZ	[206].	Moreover,	translation	inhibition	by	pairing	at	a	single	site	was	sufficient	to	allow	partial	recovery	from	GP	stress,	but	pairing	at	both	sites	simultaneously	enhanced	stress	recovery	possibly	by	improving	efficiency	of	regulation	[206].		
1.3.3.2	Stimulation	of	sugar	dephosphorylation	and	efflux		 Phosphorylation	of	incoming	sugars	during	transport	prevents	their	diffusion	back	across	the	cell	membrane	due	to	the	negatively	charged	phosphate	group.	Excess	accumulation	of	phosphorylated	sugars	such	as	G6P,	αMG	and	2DG	result	in	glucose-phosphate	stress	and	growth	inhibition	[63],	therefore	it	is	crucial	for	the	cell	to	rid	the	cytoplasm	from	these	metabolites	and	stimulate	their	efflux.	Although	SgrS	prevents	synthesis	of	new	sugar	transporters	by	regulating	their	mRNA	translation	and	stability,	this	is	not	sufficient	to	prevent	uptake	of	phosphosugars	through	the	existing	transporter	proteins	already	in	the	membrane.	This	is	supported	by	the	fact	that	ptsG	mRNA	half-life	is	decreased	~10-fold	in	response	to	glucose-phosphate	stress	[119,	175],	whereas	PtsG	protein	remains	stable	with	half-life	of	80	min.	It	was	previously	noted	in	bacteria	that	carbohydrate	dephosphorylation	by	specific	bacterial	phosphatases	is	a	prerequisite	for	efflux	[86,	283].	This	suggested	a	hypothetical	dephosphorylation–dependent	efflux	mechanism	of	accumulated	sugar-phosphates	during	SgrS-mediated	stress	response.	
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	 A	screen	to	identify	targets	of	SgrS	in	Salmonella	revealed	an	upregulation	of	
yigL	mRNA,	and	this	regulation	was	conserved	between	E.	coli	and	Salmonella	[196].	YigL	protein	(encoded	by	yigL)	belongs	to	a	large	family	of	haloacid	dehalogenase	(HAD)-like	phosphatases	[123].	In	vitro,	purified	YigL	and	several	other	members	of	the	HAD	phosphatase	family	have	high	affinity	for	phosphorylated	sugars	[127].	Synthesis	of	YigL	protein	is	induced	in	an	SgrS-dependent	manner	in	response	to	glucose-phosphate	stress.	Moreover,	a	Salmonella	yigL	mutant	is	severely	growth	inhibited	under	αMG	and	2DG	stress	conditions	[196].	yigL	is	co-transcribed	with	the	upstream	gene	pldB	as	a	dicistronic	mRNA,	however	SgrS	upregulated	yigL	expression	by	~14.5-fold	while	pldB	was	unaffected.	Normally,	RNase	E	cleaves	dicistronic	pldB-yigL	transcript	at	position	+841	within	pldB	coding	sequence	(~200	nt	upstream	of	yigL	start	codon)	followed	by	the	degradation	of	the	resulting	intermediate	fragments.	After	RNase	E	cleavage,	the	downstream	fragment	is	stabilized	by	SgrS	directly	base	pairing	at	positions	+935	to	+955	(Figure	1.2C),	a	sequence	downstream	of	the	processing	site.	Importantly,	initial	RNase	E	processing	of	the	dicistronic	mRNA	was	necessary	for	the	upregulation	of	yigL	and	precedes	SgrS	binding	because	presence	of	the	translating	ribosomes	on	the	full-length	pldB-
yigL	transcript	hinders	accessability	for	SgrS.	In	other	words,	only	the	processed	mRNA	intermediate	is	accessible	for	SgrS	base	pairing	and	stabilization	(Figure	1.1B).	In	vitro	assays	indicate	competition	between	SgrS	and	RNase	E	for	the	processed	mRNA	fragment.	An	RNase	E-deficient	strain	is	unable	to	fully	upregulate	
yigL,	in	vivo	[196].	SgrS	stabilization	of	the	processing	intermediate	resulted	in	higher	levels	of	translation	and	increased	YigL	production.	Monitoring	efflux	rates	indicated	that	SgrS-dependent	upregulation	of	yigL	is	necessary	for	efficient	efflux	of	αMG	[196].	As	was	hypothesized,	besides	downregulating	production	of	sugar	transporters,	SgrS	positively	regulates	production	of	YigL,	a	novel	phosphatase	that	helps	alleviate	glucose-phosphate	stress	by	dephosphorylating	accumulated	phosphosugars	and	stimulating	their	efflux	from	the	cell	(Figure	1.1A).	This	raises	a	new	question	of	how	dephosphorylated	sugars	leave	the	cell	and	what	kind	of	an	exporter	protein	might	be	responsible.		
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1.3.3.3	Consequences	of	target	regulation	for	stress	recovery		 To	understand	the	contribution	of	target	regulation	to	stress	recovery,	competition	assays	were	performed	using	SgrS	mutants	with	variable	ability	to	regulate	three	known	targets	ptsG,	manX	and	yigL	[252].	Regulation	of	ptsG	mRNA	by	SgrS	is	sufficient	to	recover	from	αMG-induced	stress	in	rich	medium	(LB).	On	the	contrary,	repression	of	ptsG	alone	is	not	enough	to	rescue	growth	inhibition	during	αMG	stress	in	minimal	medium.	While	regulation	of	ptsG	and	yigL	is	necessary,	it	is	not	sufficient	for	full	growth	rescue	during	αMG	stress	in	minimal	medium	[252].	This	result	suggests	the	existence	of	yet	unknown	targets	controlled	by	SgrS	and	highlights	their	importance	during	αMG	stress	recovery.	Note	that	regulation	of	
manXYZ	mRNA	during	αMG	stress	has	no	effect	on	growth	because	EIIman	does	not	transport	αMG	but	has	high	specificity	for	a	different	glucose	analogue	2DG	[207].	As	expected,	regulation	of	manXYZ	is	essential	for	growth	recovery	under	2DG-induced	stress	in	rich	as	well	as	minimal	media.	Moreover,	regulation	of	ptsG	and	
yigL	is	dispensable	under	2DG	growth	conditions	[252].	Undeniably	glucose-phosphate	stress	results	in	more	severe	inhibition	when	cells	are	growing	in	minimal	medium	compared	to	rich	medium.	One	difference	between	the	two	media	is	that	while	growing	in	LB,	E.	coli	primarily	utilizes	amino	acids	as	the	carbon	source.	On	the	other	hand,	growth	on	minimal	medium	requires	utilization	of	supplemented	carbon	source	(glycerol	or	fructose)	and	de	novo	production	of	essential	amino	acids.	As	previously	described,	depletion	of	the	glycolytic	intermediates	is	one	of	the	factors	causing	glucose-phosphate	stress.	It	is	hypothesized	that	cells	stressed	with	αMG	or	2DG	are	severely	growth	inhibited	in	minimal	medium	because	they	have	to	generate	amino	acids	from	glycolytic	intermediates,	which	further	exacerbates	the	stress.	Supplementation	with	Casamino	Acids	(CAA)	improves	stress	recovery	in	minimal	medium,	confirming	the	above	predictions	[252].		
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1.3.4	SgrT:	a	small	protein	encoded	by	SgrS		
1.3.4.1	Role	of	SgrT	in	glucose-phosphate	stress	response	SgrS	is	a	dual-function	sRNA	and	encodes	a	conserved	ORF	(positions	+22	to	+153)	located	at	the	5’	end,	upstream	of	the	sequence	required	for	target	mRNA	riboregulation	(Figure	1.2A).	It	encodes	a	small	43	aa	polypeptide	named	SgrT	[275].	Although	these	functional	regions	are	distinct,	the	distance	between	the	two	is	only	~15	nts,	which	includes	the	sequence	occupied	by	the	ribosome	at	the	sgrT	stop	codon.	Whilst	expression	of	SgrT	alone	from	the	E.	coli	chromosome	is	not	sufficient	to	counter	glucose-phosphate	stress,	ectopic	overexpression	of	this	small	protein	allows	for	successful	stress	recovery.	Expression	of	SgrS	and	SgrT	independently	is	also	sufficient	to	inhibit	growth	on	minimal	medium	with	glucose	and	mannose,	similar	to	wild-type	SgrS	[275].	Although	SgrS	riboregulation	alone	is	necessary	and	sufficient	to	prevent	growth	inhibition	during	stress	[9],	SgrT	can	clearly	affect	transport	of	sugars	through	PEP-PTS	without	participating	in	post-transcriptional	regulation	of	mRNA	targets	[275].	Ratios	of	SgrS	sRNA	to	SgrT	protein	vary	during	the	course	of	the	stress	response,	with	SgrS	levels	increasing	immediately	following	stress	induction	and	rapidly	accumulating	relative	to	SgrT.	Later,	at	~40	min	after	stress	induction,	SgrT	accumulates	temporarily	and	its	levels	decrease	again	at	~180	min.	It	is	suggested	that	SgrS	provides	immediate	and	prolonged	remedy	for	stress	through	riboregulation	of	the	mRNA	targats,	whereas	SgrT	acts	later	during	stress	[9].	It	is	evident	that	SgrT	protein	and	SgrS	base	pairing	functions	utilize	different	mechanisms	to	act	redundantly	in	the	same	physiological	pathway.	This	signifies	that	redundancy	at	two	mechanistically	different	levels	of	regulation	might	be	important	for	tight	control	and	timely	response	under	stress	inducing	environmental	conditions.		
	
1.3.4.2	Interplay	between	SgrT	translation	and	SgrS	riboregulation		 SgrS	has	dual	functions	as	a	translated	mRNA	and	a	base	pairing	sRNA	[275]	(Figure	1.2A).	In	Salmonella,	similar	to	its	close	relative	E.	coli,	either	SgrT	protein	or	SgrS	riboregulation	independently	rescue	growth	under	the	glucose-phosphate	
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stress	conditions	[9].	Both	of	these	functions	require	association	with	different	subsets	of	protein	and	RNA	cofactors.	As	previously	noted,	SgrS	pairing	with	target	mRNAs	is	dependent	on	Hfq,	whereas	degradation	of	the	formed	duplex	occurs	via	recruitment	of	the	degradosome	components	[178].	Likewise,	sgrT	translation	involves	ribosome	binding	to	SgrS,	which	could	potentially	interfere	with	the	base	pairing	function	of	SgrS.	The	ability	of	SgrS	to	regulate	its	mRNA	targets	ptsG,	manX	and	yigL	is	not	affected	by	the	mutations	that	impair	sgrT	translation	or	change	the	distance	between	sgrT	and	the	sequence	involved	in	riboregulation.	On	the	contrary,	production	of	SgrT	increased	when	the	base	pairing	region	was	mutated	[9].	Target	regulation	via	base	pairing	is	terminal	for	SgrS	because	RNase	E	degrades	the	formed	duplex.	Inactivation	of	RNase	E	also	increases	SgrT	protein	levels,	suggesting	that	stabilization	of	SgrS	makes	it	available	for	ribosome	binding	[9].	SgrS	paired	to	its	target	mRNA	exists	in	a	complex	with	Hfq	chaperone	and	the	degradosome	[178].	This	complex	with	Hfq	is	likely	to	form	even	in	the	absence	of	RNase	E	activity,	which	would	still	make	SgrS	unavailable	for	sgrT	translation.	As	expected,	Salmonella	Hfq	deficiency	results	in	failure	of	SgrS	to	pair	and	regulate	its	mRNA	targets.	Importantly,	improved	SgrT	translation	is	observed	because	more	SgrS	molecules	become	available	for	ribosome	binding	[9].	This	idea	is	further	supported	by	the	fact	that	E.	coli	SgrS	is	unstable	in	the	absence	of	Hfq,	unlike	
Salmonella	SgrS	which	does	not	fully	rely	on	Hfq	for	stability.	E.	coli	SgrS	naturally	produces	little	SgrT	due	to	an	inhibitory	hairpin	structure	blocking	translation	[94,	274],	whereas	ribosomes	actively	translating	SgrT	in	Salmonella	provide	protection	from	rapid	nucleolytic	decay	[9].		
1.3.5	Distribution	and	function	of	SgrS	in	γ-proteobacteria	
1.3.5.1	Identification	of	SgrS	in	enteric	bacteria		 Identification	of	homologous	sRNAs	even	in	genomes	of	relatively	closely	related	enteric	bacteria	is	challenging	because	of	low	primary	sequence	conservation	of	most	sRNAs.		However,	the	location	of	the	sgrR	gene	immediately	adjacent	to	sgrS,	facilitated	identification	of	SgrS	homologs	in	many	γ-proteobacteria,	including	Escherichia	sp.,	Salmonella	sp.,	Shigella	sp.,	Yersinia	sp,	
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Serratia	sp.,	Klebsiella	pneumoniae	and	Erwinia	sp.	[94].	The	sgrR-sgrS	intergenic	region	(containing	the	sgrS	promoter)	is	highly	conserved,	suggesting	that	SgrR	regulates	sgrS	expression	similarly	in	all	these	organisms.		All	identified	SgrS	homologs	contain	a	Rho-independent	terminator	and	most	possess	an	additional	stem-loop	structure	upstream	of	the	terminator;	these	two	structures	are	important	for	Hfq	binding	to	SgrS	[94,	99,	189].	While	the	primary	sequence	across	the	length	of	SgrS	is	not	well	conserved,	a	short	stretch	of	~13	nts	near	the	SgrS	3'	end	is	nearly	invariant	(Figure	1.2B).	This	SgrS	sequence	(5’-CUGAGUAxUGGUG-3’)	is	complementary	to	the	translation	initiation	regions	of	ptsG	mRNAs	in	all	species	where	an	SgrS	homolog	was	found	[94].		Mutation	of	residues	G176	and	G178	within	the	conserved	region	of	E.	coli	SgrS	abrogates	SgrS-mediated	repression	of	ptsG	mRNA	and	prevents	recovery	from	glucose-phosphate	stress	[153].	Introduction	of	analogous	mutations	in	the	conserved	regions	of	SgrS	homologs	from	Salmonella,	E.	
carotovora,	Y.	pestis	and	K.	pneumoniae	similarly	prevented	regulation	of	ptsG	[274].		Regulation	of	other	targets	is	less	well	conserved	among	SgrS	homologs.		The	SgrS	sequences	required	for	base	pairing	with	manXYZ	are	upstream	of	the	conserved	region	and	are	poorly	conserved	among	SgrS	homologs.	SgrS	homologs	from	
Salmonella	and	K.	pneumoniae	have	the	same	predicted	SgrS-manX	base	pairing	interaction	and	manX	translation	is	regulated	as	expected.	In	contrast,	E.	carotovora	and	Y.	pestis	SgrS	homologs	have	changes	in	the	manX	pairing	site	resulting	in	loss	of	complementarity	to	their	cognate	manX	and	were	accordingly	shown	not	to	regulate	
manX	translation	[207].		
	
1.3.5.2	Conservation	of	SgrT		 Most	SgrS	homologs	that	have	been	identified	contain	open	reading	frames	similar	in	size	to	E.	coli	SgrT	(43	aa)	[94].	While	the	primary	amino	acid	sequence	of	putative	SgrT	homologs	was	not	well	conserved,	homologs	from	Salmonella,	
Klebsiella	and	Erwinia	were	functional	when	expressed	in	an	E.	coli	sgrST	mutant	[274].		Interestingly,	some	species	that	possess	SgrS	homologs	appear	to	lack	a	functional	equivalent	of	SgrT.		In	Yersinia	sp.,	SgrS	appears	to	be	truncated	at	the	5'	end,	and	SgrS	from	Yersinia	species	ranges	in	size	from	~85	to	140	nt	and	lacks	the	
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sgrT	open	reading	frame.		In	pathogenic	E.	coli	of	the	O157:H7	lineage,	a	point	mutation	in	the	SgrS	5'	region	alters	the	sgrT	start	codon,	presumably	abrogating	SgrT	coding	capacity	in	these	strains.		Differential	presence	and	absence	of	SgrT	in	these	enteric	pathogens	led	to	a	closer	comparison	of	SgrT	in	E.	coli	K-12	and	
Salmonella.				 Expression	of	SgrT	is	maintained	in	several	species;	for	example	Salmonella	SgrT	is	expressed	at	much	higher	levels	than	that	of	E.	coli	during	glucose-phosphate	stress.	In	the	absence	of	target	base	pairing	capabilities,	chromosomally	expressed	
E.	coli	SgrT	cannot	fully	restore	growth	under	stress	conditions	due	to	low	expression.	On	the	other	hand	chromosomally	expressed	Salmonella	SgrT	is	expressed	at	much	higher	levels	and	is	able	to	complement	growth	defect	during	stress.	Worth	noting	that	in	the	absence	of	the	target	base	pairing,	overexpression	of	SgrT	orthologs	from	E.	coli,	Salmonella,	E.	carotovora,	and	K.	pneumoniae	rescues	growth	during	glucose-phosphate	stress	[274].	To	summarize,	although	functionally	conserved,	SgrT	translation	profiles	vary	among	bacteria.	SgrS	target	range	is	not	absolutely	preserved	and	may	utilize	less	conserved	sequence	outside	of	the	13	nt	consensus	for	target	mRNA	riboregulation.	Base	pairing	function	appears	to	be	more	conserved	than	that	of	the	protein.	Loss	of	SgrT	expression	might	be	indicative	of	its	non-essential	or	redundant	role	in	the	response	to	glucose-phosphate	stress.	It	is	clear	however	that	both	functions	evolved	divergently	to	fit	the	physiology	of	the	different	organisms.	
	
1.3.5.3	SgrS	regulation	of	sopD	mRNA	in	Salmonella		 Although	SgrS	is	conserved	among	enteric	bacteria,	evolving	divergence	in	sequence	and	function	is	evident.	Like	other	trans-encoded	sRNAs,	SgrS	does	not	require	perfect	complementarity	to	regulate	its	target	genes.	Target	discrimination	is	dependent	on	sRNA	and	mRNA	sequences	which	allows	for	the	gain	or	loss	of	interaction.	Such	sequence-based	regulation	allows	evolution	of	species	specific	mRNA	targets.			 Global	microarray	analysis	in	Salmonella	identified	sopD	as	a	potential	mRNA	target	of	SgrS	[195].	Salmonella-specific	gene	sopD	encodes	a	general	virulence	
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factor	involved	in	development	of	gastroenteritis	and	systemic	infection	in	mice	[8,	105].	SopD	is	also	an	effector	protein	deliver	to	the	host	through	Type	3	Secretion	Systems	(T3SSs)	encoded	on	Salmonella	pathogenisity	island	(SPI)-1	and	late	infection	SPI-2	[29].	Biological	significance	of	sopD	regulation	by	SgrS	in	Salmonella	is	not	clear,	because	most	studies	implicate	SgrS	in	the	response	to	glucose-phosphate	stress.	However,	SgrS	is	expressed	under	SPI-1	inducing	conditions	(high	salt	and	low	oxygen)	that	activate	Salmonella	invasion	genes.	It	is	conceivable	that	
Salmonella	may	utilize	SgrS	sensing	of	glycolytic	flux	to	differentiate	between	cell	types	or	various	environments	inside	the	host.			 The	conserved	region	of	SgrS	pairs	with	the	early	coding	sequence	of	sopD	mRNA	at	positions	+1	to	+11	from	AUG	translational	start	codon	(Figure	1.2C)	and	prevents	translation.	The	SgrS-sopD	duplex	is	subsequently	degraded	[195],	most	likely	in	the	RNase	E-dependent	fashion.	A	critical	SgrS	mutation	at	G176C	is	important	for	regulation	of	sopD,	as	well	as	previously	described	ptsG	mRNA	[195].	Interestingly,	Salmonella	encodes	a	homologous	sopD2	effector	protein	with	42%	identity	to	sopD.	It	likely	arose	due	to	a	duplication	of	a	sopD	gene	that	evolved	a	divergent	function	[105].		SgrS	is	predicted	to	form	a	duplex	with	sopD2,	which	only	differs	by	U	instead	of	C	opposite	SgrS	G172	in	SgrS-sopD	duplex.	This	nearly	identical	interaction	that	only	differs	by	one	wobble	pair	does	not	result	in	regulation	of	sopD2	by	SgrS	[195].		Introduction	of	mutations	to	generate	G:C	interaction	instead	of	wobble	G:U	pair	results	in	artificially	induced	regulation	of	
sopD2	translation	[195].	SgrS	can	discriminate	between	sopD	and	sopD2	with	an	impressive	single	hydrogen	bond	resolution.	In	other	words,	a	single	G:U	wobble	pair	disables	regulation	of	sopD2	by	SgrS.	In	vitro	and	in	silico	studies	of	minimum	free	energy	of	hybridization	indicate	that	positional	constraints,	rather	then	average	duplex	strength,	are	important	for	productive	regulation	and	discrimination	between	target	mRNAs	[195].	
	
1.4	Aim	of	This	Study		 Trans-encoded	sRNAs	commonly	regulate	multiple	target	genes,	and	in	fact	many	of	them	have	rather	wide	regulons.	While	SgrS	is	known	to	regulate	three	
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targets	in	E.	coli,	their	regulation	is	not	sufficient	to	fully	recover	from	glucose-phosphates	stress	[252].	Previously	obtained	microarray	data	(Rice	and	Vanderpool,	unpublished)	suggested	deregulation	of	many	genes	in	response	to	pulse	expression	of	SgrS.	These	findings	lead	us	to	further	investigate	SgrS	regulated	genes	to	potentially	uncover	novel	mechanisms	of	post-transcriptional	control.	Additionally,	we	will	consider	the	different	mechanisms	SgrS	employs	to	regulate	its	target	mRNAs	and	the	steps	or	factors	involved.	Diversity	in	regulatory	mechanisms	may	have	implications	in	how	SgrS	prioritizes	between	its	targets	and	consequently	forms	a	temporal	or	spatial	regulatory	hierarchy.	Finally,	understanding	full	breadth	of	SgrS	regulon	would	provide	additional	insights	into	the	nature	of	glucose-phosphate	stress,	which	remain	a	poorly	understood	phenomenon	in	bacteria.		
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1.5	Figures	
	
Figure	1.1	Current	model	for	the	role	of	SgrS	in	the	glucose-phosphate	stress	
response.		A.		Uptake	and	accumulation	of	phosphorylated	glucose	species	results	in	activation	of	transcription	factor	SgrR,	which	in	turn	activates	expression	of	SgrS,		
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Figure	1.1	(cont.)		
	as	well	as	a	small	peptide	SgrT,	encoded	within	SgrS	sRNA.	Synthesis	of	new	sugar	transporters	encoded	by	ptsG	and	manXYZ	is	repressed	by	SgrS,	while	efflux	of	sugars	dephosphorylated	by	yigL	is	readily	promoted.	Simultaneously,	small	protein	SgrT	is	expressed	and	inhibits	activity	of	EIICBglc	(ptsG),	which	blocks	further	uptake	and	accumulation	of	phosphosugars.	B.	SgrS	base	pairs	and	inhibits	translation	of	
ptsG	and	manXYZ	mRNAs	by	hindering	ribosome	access	to	the	RBS	and	subsequently	targeting	them	for	cleavage	by	RNase	E	and	the	degradosome.	SgrS	discoordinately	regulates	manX	and	manYZ	within	the	manXYZ	polycistron	by	base	pairing	at	two	distinct	sites.	In	addition,	SgrS	stabilizes	processed	‘pldB-yigL	transcript	by	pairing	within	pldB	coding	sequence	and	preventing	cleavage	by	RNase	E,	which	promotes	translation	of	sugar	phosphatase	YigL.	
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Figure	1.2	Characteristics	of	SgrS	and	base	pairing	interactions	with	target	
mRNAs.		A.	The	main	functional	domains	of	SgrS	are	illustrated.		The	sgrT	open	reading	frame	is	located	at	the	5'	end,	the	conserved	base	pairing	region	is	downstream	of	sgrT	and	upstream	of	the	intrinsic	terminator	hairpin	(which	comprises	the	Hfq-binding	domain).		B.	Alignment	of	the	base	pairing	region	of	SgrS		
SgrSEc! 3-…ACUAAAAUGUGGUUAUGAGUC___AGUGUGUACUACGU…-5!
5’-…AUUGUGUUGAUUAUCACUCAGUUUUCACACUUAAGUCU…-3’!manYEc!
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Figure	1.2	(cont.)		homologs	from	enteric	species.		The	most	conserved	region	is	indicated	by	asterisks	below	the	alignment	and	in	red	for	the	E.	coli	(Ec)	homolog.		Abbreviations	for	other	species:	Sf,	Shigella	flexneri;	St,	Salmonella	enterica	serovar	Typhimurium;	Kp,	
Klebsiella	pneumoniae;	Erc,	Erwinia	carotovora;	Yp,	Yersinia	pestis;	Sm,	Serratia	
marcescens.		C.	SgrS-mRNA	base	pairing	interactions.		Interactions	with	each	confirmed	SgrS	target	are	shown	(species	abbreviations	are	as	in	B).	Watson-Crick	base	interactions	G-C	and	A-U	are	indicated	with	vertical	lines	and	non-canonical	G-U	pairs	are	denoted	with	two	dots.		The	conserved	SgrS	base	pairing	region	is	indicated	in	red.		Start	codons	are	indicated	in	green	and	underlined.		Ribosome	binding	sites	(RBS)	are	bold	and	underlined.	
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CHAPTER	2	
MATERIALS	AND	METHODS	
	
2.1	Strain	and	Plasmid	Construction	
	 Strains	used	in	this	study	are	listed	in	Table	2.1	and	plasmids	in	Table	2.2.	All	strains	used	in	this	study	are	derivatives	of	E.	coli	K-12	strain	MG1655.	Oligonucleotide	primers	and	5'-biotinylated	probes	used	in	this	study	are	listed	in	Table	2.3	and	were	acquired	from	Integrated	DNA	Technologies.	Chromosomal	mutations	were	made	by	λ	Red	recombination	[50,	290]	and	marked	alleles	were	moved	between	strains	by	P1	vir	transduction	[167].		Alleles	kanR::Cp19-asd,	kanR::Cp19-adiY,	kanR::Cp19-folE	and	kanR::Cp19-
purR	were	constructed	by	PCR	amplifying	kanR-linked	Cp19	constitutive	promoter	from	JNB024	chromosomal	DNA	using	oligonucleotides	MBP23F/MBP23R,	MBP24F/MBP24R,	MBP25F/MBP25R,	MBP181F/MBP181R	containing	asd,	adiY,	
folE	or	purR	homologies,	respectively	(previously	described	in	[207].	PCR	products	were	recombined	into	NM200	strain.	The	resulting	alleles	were	moved	by	transduction	into	wild-type	(DJ480)	and	ΔsgrS	(JH111),	or	rne131	(JH256)	backgrounds	to	generate	desired	strains	(Table	2.2).		FLAG-tagged	alleles	were	constructed	by	amplifying	3xFLAG::FRT-kanR-FRT	cassette	from	pSUB11	using	primers	MBP204F2/MBP204R2	and	MBP211F/	MBP211R	containing	overhangs	homologous	to	purR	and	ptsG,	respectively.	PCR	products	were	recombined	into	NM200	strain	to	produce	MB138	and	MB158	strains.	Translational	lacZ	reporter	fusions	under	the	control	of	the	PBAD	promoter	were	constructed	by	PCR	amplifying	fragment	of	interest	using	primers	containing	5'	homologies	to	PBAD	and	lacZ	(Table	2.3).	PCR	products	were	recombined	into	PM1205	using	λ	Red	homologous	recombination	and	counter-selection	against	sacB	as	described	previously	[156].	Plasmids	harboring	sgrS	orthologs	under	the	control	of	the	PLtetO-1	promoter	were	constructed	by	PCR	amplifying	sgrS	from	E.	coli	MG1655,	Yersinia	pestis,	
Klebsiella	pneumoniae,	Erwinia	carotovora	and	Citrobacter	koseri	chromosomal	DNA	
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using	oligonucleotides	containing	NdeI	and	BamHI	restriction	sites	(Table	2.3).	PCR	products	and	vector	pZA31R	[138]	were	digested	with	NdeI	and	BamHI	(New	England	Biolabs)	restriction	endonucleases.	Digestion	products	were	ligated	using	DNA	Ligase	(New	England	Biolabs)	to	produce	plasmids	containing	PLtetO-1-sgrS	alleles	(Table	2.2).		Plasmid	pZEMB8	containing	PLlacO-1-ptsG-gfp	was	constructed	by	PCR	amplifying	ptsG	from	MG1655	chromosomal	DNA	using	oligos	MBP1L	and	MBP1R10	containing	EcoRI	and	KpnI	restriction	sites,	respectively.	The	PCR	product	and	vector	pZE12S	[138]	were	digested	with	KpnI	and	EcoRI	restriction	endonucleases.	Digestion	products	were	ligated	using	DNA	ligase	to	produce	pZEMB2.	Superfolder	
gfp	(gfpsf)	was	amplified	from	pXG10-SF	[44]	using	oligonucleotides	gfpsf-F	and	gfpsf-R,	respectively	containing	KpnI	and	XbaI	restriction	sites.	pZEMB2	and	the	resulting	PCR	product	were	digested	with	KpnI	and	XbaI,	and	ligated	with	DNA	Ligase	to	produce	pZEMB8.	Plasmids	with	translational	reporter	fusions	Plac0-1-
manX-gfp	(pZEMB10),	Plac0-1-yigL-gfp	(pZEMB15),	Plac0-1-adiY-gfp	(pZEMB18),	Plac0-1-
folE-gfp	(pZEMB22),	Plac0-1-purR-gfp	(pZEMB25),	Plac0-1-asdI-gfp	(pZEMB26)	and	Plac0-1-asdI-II-gfp	(pZEMB27)	were	constructed	by	restriction	cloning	into	pZEMB8	using	KpnI	and	EcoRI	restriction	endonucleases	(Table	2.2).	Plasmids	containing	mutant	alleles	were	generated	by	QuikChange	mutagenesis	procedure	using	oligonucleotides	with	mismatched	bases	at	desired	locations	(Table	2.3).		Overexpression	plasmids	containing	full-length	asd,	adiY,	folE	and	purR	genes	under	the	control	of	the	Plac	promoter	were	constructed	by	PCR	amplifying	genes	of	interest	using	(respectively)	oligonucleotides	MBP138F/MBP138R,	MBP152F/MBP152R,	MBP153F/MBP153R	and	MBP154F/MBP154R,	and	restriction	cloning	into	pBRCS12	using	BamHI	and	HindIII	restriction	endonucleases	(Tables	2.2	and	2.3).		
	
2.2	Media	and	Reagents		 Bacteria	were	cultured	in	Luria-Bertani	(LB)	broth	medium	or	on	LB	agar	plates	at	37°C,	unless	stated	otherwise.	Bacteria	were	grown	in	MOPS	(morpholine-
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propanesulfonic	acid)	rich	defined	medium	(Teknova)	with	0.2%	fructose	for	reporter	fluorescence	assays	and	LB	medium	for	Northern	blot	experiments.	M63	minimal	medium	supplemented	with	0.4%	glycerol	was	used	for	plate	assays	and	M63	minimal	medium	with	0.2%	fructose	was	used	for	growth	curves.	Where	necessary,	media	were	supplemented	with	antibiotics	at	following	concentrations:	100	µg	ml-1	ampicillin	(Amp),	25	µg	ml-1	chloramphenicol	(Cm),	25	µg	ml-1	kanamycin	(Kan).	Isopropyl	β-D-1-thiogalactopyranoside	(IPTG)	was	used	at	concentrations	of	0.1-1.5	mM	for	induction	of	Plac0-1	promoter,	anhydrotetracycline	(aTc)	0-50	ng/ml	for	induction	of	Ptet0-1	promoter	and	0.000002%-0.2%	L-arabinose	for	induction	of	PBAD	promoter.		Glucose-phosphate	stress	was	induced	where	appropriate	using	0.5%	αMG	or	60	µM	2DG,	unless	stated	otherwise.	
	
2.3	RNA-Seq	Analysis		
	 E.	coli	strain	CV104	(ΔsgrS)	harboring	vector	(pHDB3)	or	Plac-sgrS	(pLCV1)	plasmid	was	grown	to	OD600~0.5	in	MOPS	rich	medium	supplemented	with	0.2%	D-glucose	and	exposed	to	0.1	mM		IPTG	for	10	minutes.	The	previously	described	hot	phenol	method	[2]	was	used	to	extract	total	RNA,	which	was	treated	with	TURBO™	DNase	(Ambion)	according	to	manufacturer’s	protocol	and	resolved	by	electrophoresis	on	a	1.2	%	agarose	gel	to	confirm	integrity.	Ribosomal	RNA	removal,	library	construction	and	sequencing	were	performed	at	the	W.	M.	Keck	Center	for	Comparative	and	Functional	Genomics	at	the	University	of	Illinois	at	Urbana-Champaign.	Ribosomal	RNA	was	removed	from	1	µg	of	total	RNA	using	Ribozero	rRNA	Removal	Meta-Bacteria	Kit	(Epicentre	Biotechnologies)	and	the	mRNA-enriched	fraction	was	converted	to	indexed	RNA-Seq	libraries	with	the	ScriptSeq™	v2	RNA-Seq	Library	Preparation	Kit	(Epicentre	Biotechnologies).	The	libraries	were	pooled	in	equimolar	concentrations	and	were	quantitated	by	qPCR	with	the	Library	Quantification	kit	Illumina	compatible	(Kapa	Biosystems)	and	sequenced	for	101	cycles	plus	7	cycles	for	the	index	read	on	a	HiSeq2000	using	TruSeq	SBS	version	3	reagents.	The	output	fastq	files	were	generated	using	Casava	1.8.2	(Illumina)	and	
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analyzed	with	Rockhopper	[161]	for	computational	analysis	of	bacterial	RNA-Seq	data.		
2.4	Reporter	Fluorescence	Assay	
	 Bacterial	strains	were	cultured	overnight	in	MOPS	rich	medium	supplemented	with	0.2%	fructose,	Amp,	Cm	and	subcultured	1:100	to	fresh	medium	with	appropriate	inducers	(IPTG,	aTc)	in	48	well	plates.	For	end	point	experiments,	relative	fluorescence	units	(RFU)	and	optical	density	(OD600)	were	measured	during	mid-exponential	phase	of	growth.	RFU	normalized	to	OD600	was	calculated	and	plotted	relative	to	IPTG	only	control	(RFU/OD600).	For	target	prioritization	experiments,	relative	fluorescence	units	(RFU)	and	optical	density	(OD600)	were	measured	over	time.	“Regulated	activity”	was	calculated	by	plotting	RFU	over	OD600	and	determining	the	slopes	of	linear	regression	plots	for	each	IPTG	concentration	in	exponentially	growing	cells	in	the	presence	of	aTc	to	induce	SgrS	expression.	“Basal	activity”	was	calculated	by	plotting	RFU	over	OD600	and	determining	the	slopes	of	linear	regression	plots	for	each	IPTG	concentration	in	exponentially	growing	cells,	in	the	absence	of	aTc.	
	
2.5	β-Galactosidase	Assay	
	 Bacterial	strains	were	cultured	overnight	in	Terrific	Broth	(TB)	with	Amp	and	subcultured	1:100	to	fresh	TB	medium	containing	Amp	and	0.002%	L-arabinose.	Cells	were	grown	at	37°C	with	shaking	to	OD600~0.15	and	0.1	mM	IPTG	was	added	to	induce	expression	from	the	plasmid	and	cells	grown	for	another	hour	to	OD600~0.5-0.6.	β-galactosidase	assays	were	then	performed	according	to	previously	described	protocol	[167].	
	
2.6	Quantitative	Real	Time	Polymerase	Chain	Reaction	(RT-qPCR)	
	 E.	coli	strain	CV104	(ΔsgrS)	harboring	vector	(pHDB3)	or	Plac-sgrS	(pLCV1)	plasmids	were	cultured	in	MOPS	rich	medium	with	0.2%	D-glucose	to	OD600~0.5	and	total	RNA	extracted	[2]	at	10	minutes	after	addition	of	0.1	mM	IPTG.	As	an	
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exception,	total	RNA	for	detection	of	adiY	expression	was	extracted	from	still	cultures,	due	to	higher	adiY	expression	in	partially	anaerobic	conditions.	cDNA	was	generated	from	2	µg	of	RNA	in	a	reverse	transcriptase	PCR	reaction	primed	with	Random	Hexamers	(Roche).	Sample	preparation	was	performed	according	to	Power	SYBR	Green	PCR	Master	Mix	(Applied	Biosystems)	specifications	and	qPCR	was	used	to	analyze	relative	expression	levels	using	gene-specific	primers	(Table	2.3).	Software	supplemented	with	Mastercycler	ep	realplex	(Eppendorf)	thermocycler	was	used	for	relative	quantification	of	expression.	The	relative	mRNA	levels	were	normalized	to	a	housekeeping	gene	rrsA	encoding	16S	rRNA	in	E.	coli.	
	
2.7	Northern	Blot	Analysis	
	 Bacterial	strains	were	cultured	in	LB	medium	to	OD600~0.4.	Total	RNA	was	extracted	as	described	previously	[2]	at	specified	times	after	addition	of	0.5%	αMG	to	induce	stress	or	0.1	mM	IPTG	to	induce	expression	of	SgrS	from	the	plasmid.	RNA	concentrations	were	measured	spectrophotometrically	and	15	µg	of	RNA	were	resolved	using	1.2	%	agarose	gel	electrophoresis	at	90	V	for	1.5	h.	For	detection	of	SgrS,	10	µg	of	RNA	were	resolved	on	8%	polyacrylamide	urea	gels	ran	at	100	V	for	1	h.	RNA	was	transferred	to	0.2	µm	pore-size	Nytran	N	(Whatman)	membrane	as	described	previously	[149].	Membrane	was	prehybridized	for	45	min	in	ULTRAhyb	(Ambion)	solution	at	42°C.	Blots	were	hybridized	overnight	with	5'-biotinylated	ryaA1-bio,	MBP-asd-bio,	MBP-adiY-bio,	MBP-folE-bio,	MBP-purR-bio2	or	ssrA-bio	probes	specific	for	SgrS,	asd,	adiY,	folE,	purR	and	ssrA	respectively	(Table	2.3).	BrightStar	BioDetect	kit	(Ambion)	was	used	for	detection.		
	
2.8	In	Vitro	Transcription	and	Radiolabeling	
	 Template	DNA	for	in	vitro	transcription	was	generated	by	PCR	using	gene-specific	oligonucleotides	containing	the	T7	promoter	sequence.	Following	oligonucleotides	were	used	to	generate	specific	template	DNA	for	experiments	in	Chapter	3:	MBP56F/MBP56R–asd	(+1	to	+179),	MBP57F/MBP57R–adiY	(+1	to	+233),	MBP94F/MBP94R–folE	(+112	to	+300),	MBP65F/MBP65R–purR-long	(+1	to	
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+299),	MBP65F/MBP174R–purR-medium	(+1	to	+230),	MBP65F/MBP178R–purR-
short	(+1	to	+158),	MBP65F/MBP205R2–purR-3xFLAG,	MBP84F/MBP205R2–ptsG-3xFLAG,	O-SA070/	O-SA071–gfp	and	O-JH219/O-JH119	were	used	to	generate	full-length	sgrS	template	DNA	(Table	2.3).			 The	following	oligonucleotides	were	used	to	generate	specific	template	DNAs	for	experiments	in	Chapter	4:	MBP84F/MBP213R–ptsG	(+1	to	+240),	O-JH218/MBP214R–manX	(+1	to	+240),	MBP56F/MBP215R–asdI-II	(+1	to	+240),	MBP56F/MBP222R–asdI	(+1	to	+110),	MBP226F/MBP226R–asdII	(+71	to	+310),	MBP65F/MBP174R–purR	(+1	to	+230),	MBP216F/MBP216R–yigL	(-191	to	+50	relative	to	ATG	translation	start	of	yigL)	MBP234F/MBP234R–gfp	(+1	to	+240)	and	O-JH219/O-JH119	were	used	to	generate	full-length	sgrS	template	DNA	(Table	2.3).	
In	vitro	transcription	of	DNA	templates	was	performed	according	to	specifications	of	MEGAscript	T7	Kit	(Ambion).	In	vitro	transcribed	RNA	was	5'-end	labeled	with	radioisotope	32P	(γ-32P	ATP,	Perkin	Elmer)	using	the	KinaseMax	Kit	(Ambion).	Samples	were	cleaned	by	passing	through	Illustra	ProbeQuant	G-50	Micro	Columns	(GE	Healthcare).	Then	samples	were	cleaned	once	more	with	phenol-chloroform:	isoamyl	alcohol	(Ambion)	and	labeled	RNA	precipitated	with	Ethanol:3M	NaAc	(30:1).	
	
2.9	In	Vitro	Translation	and	Western	Blot	Analysis	
	 In	vitro	transcribed	RNA	was	denatured	by	mixing	1	pmol	of	purR	or	ptsG	with	10	pmol	of	SgrS	and	0.5	pmol	of	gfp	(control),	and	incubated	at	65°C	for	5	min.	Samples	were	placed	on	ice	for	5	minutes	and	4	units	of	SUPERase-In	(Ambion)	and	10	pmol	of	Hfq	were	added	to	the	reactions.	RNA	was	preincubated	with	3.5	µl	of	2x	binding	buffer	(20	mM	Tris·HCl,	pH	8.0;	1	mM	DTT;	1	mM	MgCl2;	20	mM	KCl;	and	10	mM	Na2HPO4–NaH2PO4,	pH	8.0)	for	30	min	at	37°C	(modified	from	[153]	and	translation	was	performed	using	PURExpress	In	Vitro	Protein	Synthesis	Kit	(New	England	Biolabs),	according	to	manufacturer’s	protocol.	Translation	reactions	were	terminated	by	adding	Laemmli	sample	buffer	(Bio-Rad)	and	heated	to	95°C	for	10	min.	Synthesized	proteins	were	resolved	for	45	min	at	150	V	on	NuPAGE	4-12%	Bis-
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Tris	Gel	(Life	Technologies)	and	transferred	to	Immobilon-PSQ	membrane	(Millipore).	The	membranes	were	treated	with	monoclonal	anti-FLAG	M2	antibody	(Sigma-Aldrich)	or	polyclonal	anti-GFP	antibody	(Thermo	Scientific).	Signals	were	visualized	by	Pierce	ECL	Western	blotting	substrate	(Thermo	Scientific).	Band	densities	were	measured	using	ImageJ	(http://imagej.nih.gov/ij/).	
	
2.10	RNA-RNA	Gel	Electromobility	Shift	Assay	
	 In	vitro	transcribed	RNA	was	5'-end	labeled	with	radioisotope	32P	using	the	KinaseMax	Kit	(Ambion).	Appropriate	concentrations	of	unlabeled	RNA	were	mixed	with	0.1	pmol	or	0.02	pmol	of	5'-end	labeled	RNA.	Samples	were	denatured	at	95°C	for	1	min,	placed	on	ice	for	5	min,	and	incubated	at	37°C	for	30	minutes	in	1x	binding	buffer	(20mM	Tris-HCL	(pH	8.0),	1mM	DTT,	1mM	MgCl2,	20	mM	KCl,	10mM	Na2HPO4	(pH	8.0))	[177].	Non-denaturing	loading	buffer	was	added	and	samples	resolved	for	6	h	at	40	V	on	native	5.6%	PAGE.	
	
2.11	Protein-RNA	Gel	Electromobility	Shift	Assay			 0.02	pmol	of	5'-end	labeled	RNA	was	denatured	at	95°C	for	1	min.,	placed	on	ice	for	5	min..	Appropriate	concentrations	of	purified	Hfq	protein	(His-tagged)	were	added.	Samples	were	incubated	at	37°C	for	30	min	in	1x	binding	buffer	(20mM	Tris-HCL	(pH	8.0),	1mM	DTT,	1mM	MgCl2,	20	mM	KCl,	10mM	Na2HPO4	(pH	8.0)).	Non-denaturing	loading	buffer	was	added	and	samples	resolved	for	1.5	h	at	20	mA	on	native	4.0%	PAGE	[177].	
	
2.12	RNA-RNA	Footprinting	Analysis	
	 In	vitro	transcribed	RNA	was	5'-end	labeled	with	radioisotope	32P	using	the	KinaseMax	Kit	(Ambion).	Footprinting	reactions	were	performed	according	to	previously	published	protocol	[58]	with	the	following	modifications:	20	pmol	of	unlabeled	SgrS	or	asd	RNA	were	incubated	with	0.1	pmol	of	5’-end	labeled	asd	or	SgrS	RNA	respectively,	at	37°C	for	30	min	in	1x	Structure	Buffer	(Ambion).	Also,	20	
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pmol	and	100	pmol	of	unlabeled	SgrS	RNA	were	incubated	at	37°C	for	30	min	in	1x	Structure	Buffer	(Ambion)	with	0.1	pmol	of	5’-end	labeled	adiY	RNA.		
	
2.13	Selective	2′-Hydroxyl	Acylation	Analyzed	by	Primer	Extension	(SHAPE)		 SHAPE	experiments	were	performed	as	previously	described	[162,	180,	281],	with	minor	modifications.	asdI-II	RNA	(150	nM)	and	SgrS	RNA	(75	nM,	150	nM,	or	300	nM)	were	folded	separately;	each	RNA	was	diluted	in	0.5X	TE	buffer,	heated	to	95°C	for	two	min,	snap	cooled,	and	SHAPE	buffer	(100	mM	HEPES	[pH	8.0],	2	mM	MgCl2,	40	mM	NaCl)	was	added.	SgrS	RNA	at	10X,	or	20X	the	concentration	of	the	
asdI-II	RNA	or	the	equivalent	volume	of	0.5X	TE	was	added	to	the	asdI-II	RNA	and	the	samples	were	incubated	at	37°C	for	30	min.	Each	sample	was	then	split	and	N-methylisatoic	anhydride	(NMIA,	2	mM;	Sigma-Aldrich)	was	added	to	half	and	the	same	volume	of	dimethyl	sulfoxide	(DMSO;	Sigma-Aldrich)	was	added	to	the	other	half.	The	reactions	were	then	incubated	at	37°C	for	45	min.	Modified	RNA	was	collected	by	ethanol	precipitation	and	resuspended	in	10	µL	0.5X	TE.		 Primer	extension	reactions	were	performed	using	a	primer	labeled	with	the	VIC	fluorophore	(5′-AGATCAAAGGCATCCTGAAG;	Applied	Biosystems,	ThermoFisher	Scientific).	Samples	were	heated	to	95°C	for	3	min	and	snap	cooled	on	ice	prior	to	addition	of	the	primer,	to	denature	the	RNA	and	prevent	RT	pausing	at	stable	structural	elements.	The	primer	(22.5	nM)	was	annealed	by	incubating	samples	at	65°C	for	5	min,	35°C	for	5	min,	and	samples	were	then	cooled	to	4°C.	Samples	were	combined	with	SHAPE	enzyme	mix	(10	mM	KCl,	50	mM	Tris	HCl	[pH	8.3],	0.5	mM	each	dNTP,	5	mM	DTT,	3	mM	MgCl2)	and	incubated	at	52°C	for	1	min.	SuperScript	III	Reverse	Transcriptase	(200U/reaction;	Invitrogen,	ThermoFisher	Scientific)	was	added	and	the	reaction	was	incubated	at	52°C	for	20	min,	followed	by	5	min	at	65°C,	to	facilitate	readthrough	of	pause	sites.	Reactions	were	quenched	with	EDTA	(8.3	mM,	pH	8.0).	A	sequencing	reaction	was	also	performed	using	the	same	protocol	with	the	primer	labeled	with	the	NED	fluorophore	(45	nM)	and	ddGTP	(25	µM)	added	to	the	SHAPE	enzyme	mix.	Each	primer	extension	reaction	was	combined	with	an	equal	volume	of	sequencing	reaction,	for	analysis	by	capillary	
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electrophoresis,	and	cDNAs	were	collected	by	ethanol	precipitation	and	resuspended	in	10	µL	deionized	formamide.	Samples	were	analyzed	on	the	3730	DNA	Analyzer	(Applied	Biosystems,	Inc.)	and	data	were	processed	using	QuShape	software	[111].	Data	were	averaged	with	statistical	outliers	removed	and	normalized	to	the	average	2%	highest	reactivities,	excluding	outliers.	
	
2.14	Tables	
Table	2.1	Strains	
	
Strain	 Background	 Genotype	 Source	or	Reference	DJ480	 MG1655		 ∆lac	X74	 D.	Jin,	NCI*	JH111	 CS104	 λattB::lacIq-	PN25tetR-specR	 [275]	NM200	 MG1655		 ∆lac	X74,	mini	λ::cat	 N.	Majdalani,	NCI**	CV108	 MG1655	 ∆sgrS::kanR	 [267]	PM1205	 PM1203	 lacI’::	PBAD-cat-sacB-lacZ,	miniλtetR,	∆araBAD	araC+,	
mal::lacIq	 [156]	MJ2	 PM1205	 PBAD-folE'-'lacZ	 This	study	MB4	 DJ480	 kanR::Cp19::asd	 This	study	MB5	 DJ480	 kanR::Cp19::adiY	 This	study	MB6	 DJ480	 kanR::Cp19::folE	 This	study	MB7	 JH111	 ∆sgrS,		λattB::lacIq-PN25tetR-specR,	kanR::Cp19'-'asd	 This	study	MB8	 JH111	 ∆sgrS,		λattB::lacIq-PN25tetR-specR,	kanR::Cp19'-'adiY	 This	study	MB9	 JH111	 ∆sgrS,	λattB::lacIq-PN25tetR-specR,	kanR::Cp19'-'folE	 This	study	MB12	 JH111	 rne131::kanR,	∆sgrS,	λattB::lacIq-PN25tetR-specR	 This	study	MB35	 PM1205	 PBAD-folE-short’-'lacZ	 This	study	MB39	 PM1205	 PBAD-folE-short26'-'lacZ	 This	study	MB40	 PM1205	 PBAD-purR-long'-'lacZ	 This	study	MB41	 PM1205	 PBAD-gpmA'-'lacZ	 This	study	MB42	 PM1205	 PBAD-gltA'-'lacZ	 This	study	MB43	 PM1205	 PBAD-cycA'-'lacZ	 This	study	MB44	 PM1205	 PBAD-icd'-'lacZ	 This	study	MB45	 PM1205	 PBAD-ydjN'-'lacZ	 This	study	MB46	 PM1205	 PBAD-nepI'-'lacZ	 This	study	MB47	 PM1205	 PBAD-fumA'-lacZ	 This	study	MB48	 PM1205	 PBAD-potD'-'lacZ	 This	study	MB49	 PM1205	 PBAD-mglB'-'lacZ	 This	study	MB51	 PM1205	 PBAD-marC''-lacZ	 This	study	MB52	 PM1205	 PBAD-bglA'-'lacZ	 This	study	MB53	 PM1205	 PBAD-rbsC'-'lacZ	 This	study	MB54	 PM1205	 PBAD-rbsK'-'lacZ	 This	study	MB55	 PM1205	 PBAD-pntB'-'lacZ	 This	study	MB56	 PM1205	 PBAD-ydhQ'-'lacZ	 This	study	
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Table	2.1	(cont.)		
Strain	 Background	 Genotype	 Source	or	Reference	MB57	 PM1205	 PBAD-yiiR'-'lacZ	 This	study	MB58	 PM1205	 PBAD-fruA'-'lacZ	 This	study	MB59	 PM1205	 PBAD-cheY'-'lacZ	 This	study	MB60	 PM1205	 PBAD-asd(I)'-'lacZ	 This	study	MB61	 PM1205	 PBAD-asd30(I)'-'lacZ	 This	study	MB63	 PM1205	 PBAD-asd32(I)'-'lacZ	 This	study	MB64	 PM1205	 PBAD-yeeE'-'lacZ	 This	study	MB65	 PM1205	 PBAD-pntA'-'lacZ	 This	study	MB66	 PM1205	 PBAD-purR-short'-'lacZ	 This	study	MB67	 PM1205	 PBAD-mipA'-'lacZ	 This	study	MB70	 DB166	 ∆ppsA::kan,	λattB::lacIq-PN25tetR-specR	 This	study	MB88	 PM1205	 PBAD-purR-medium'-'lacZ	 This	study	MB89	 PM1205	 PBAD-purR30-medium'-'lacZ	 This	study	MB90	 PM1205	 PBAD-purR31-medium'-'lacZ	 This	study	MB91	 PM1205	 PBAD-purR32-medium'-'lacZ	 This	study	MB96	 MB70	 ∆ppsA,			λattB::lacIq-PN25tetR-specR	 This	study	MB98	 MB96	 ∆ppsA	∆aspC::kan,	λattB::lacIq-PN25tetR-specR	 This	study	MB99	 MB96	 ∆ppsA	∆pck::kan,	λattB::lacIq-PN25tetR-specR	 This	study	MB100	 DB166	 ∆aspC::kan,		λattB::lacIq-PN25tetR-specR	 This	study	MB101	 DB166	 ∆pck::kan,	λattB::lacIq-PN25tetR-specR	 This	study	MB104	 NM200	 kanR::Cp19-purR	 This	study	MB105	 DB166	 λattB::lacIq-PN25tetR-specR,	kanR::Cp19'-'purR	 This	study	MB106	 JH111	 ∆sgrS,		λattB::lacIq-PN25tetR-specR,	kanR::Cp19'-'purR	 This	study	MB108	 PM1205	 PBAD-yeeD'-'lacZ	 This	study	MB109	 PM1205	 PBAD-ykgMO'-'lacZ	 This	study	MB110	 PM1205	 PBAD-znuA'-'lacZ	 This	study	MB111	 PM1205	 PBAD-znuC'-'lacZ	 This	study	MB113	 PM1205	 PBAD-cusF'-'lacZ	 This	study	MB114	 PM1205	 PBAD-lamB'-'lacZ	 This	study	MB117	 PM1205	 PBAD-pstS'-'lacZ	 This	study	MB118	 PM1205	 PBAD-asd(II)'-'lacZ	 This	study	MB119	 PM1205	 PBAD-asd(I-II)'-'lacZ	 This	study	MB122	 PM1205	 PBAD-zur'-'lacZ	 This	study	MB124	 PM1205	 PBAD-pliG'-'lacZ	 This	study	MB125	 PM1205	 PBAD-mepM'-'lacZ	 This	study	MB138	 NM200	 purR-3xFLAG::kanR	 This	study	MB158	 NM200	 ptsG-3xFLAG::kanR	 This	study	
	
	*NCI,	National	Cancer	Institute,	Frederick,	MD	**NCI,	National	Cancer	Institute,	Bethesda,	MD	
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Table	2.2	Plasmids		
Plasmid	 Vector	 Genotype	 Source	or	Reference	Plac-vector	 pBRplac		 vector	control	 [84]	Plac-SgrS	 pBRplac		 Plac-sgrS	 [157]	pBRCS12	 pHDB3	 vector	control	 [274]	pLCV1	 pHDB3	 Plac-sgrS	 [267]	pHDB3	 pBR322	derivative	 vector	control	 [274]	pSUB11	 pSU311	 3xFLAG::FRT-kanR-FRT	 [264]	pZAMB1	 pZA31R	 PLtet0-1-sgrSEc	 This	study	pZAMB4	 pZA31R	 PLtet0-1-sgrSYp	 This	study	pZAMB5	 pZA31R	 PLtet0-1-sgrSEa	 This	study	pZAMB6	 pZA31R	 PLtet0-1-sgrSKp	 This	study	pZAMB7	 pZA31R	 PLtet0-1-sgrSCk	 This	study	pZAMB1-33	 pZAMB1	 PLtet0-1-sgrS33	 This	study	pZEMB8	 pZE12S	 PLlac0-1-ptsG-gfpsf	 This	study	pZEMB10	 pZEMB8	 PLlac0-1-manX-gfpsf	 This	study	pZEMB15	 pZEMB8	 PLlac0-1-yigL-gfpsf	 This	study	pZEMB18	 pZEMB8	 PLlac0-1-adiY-gfpsf	 This	study	pZEMB18-1	 pZEMB8	 PLlac0-1-adiY1-gfpsf	 This	study	pZEMB18-33	 pZEMB8	 PLlac0-1-adiY33-gfpsf	 This	study	pZEMB22	 pZEMB8	 PLlac0-1-folE-gfpsf	 This	study	pZEMB25	 pZEMB8	 PLlac0-1-purR-gfpsf	 This	study	pZEMB26	 pZEMB8	 PLlac0-1-asdI-gfpsf	 This	study	pZEMB27	 pZEMB8	 PLlac0-1-asdI-II-gfpsf	 This	study	pBRMB38	 pBRCS12	 Plac-adiY	 This	study	pBRMB39	 pBRCS12	 Plac-folE	 This	study	pBRMB40	 pBRCS12	 Plac-purR	 This	study	Plac-SgrS30	 pBRplac		 Plac-sgrS30	 This	study	Plac-SgrS31	 pBRplac		 Plac-sgrS31	 This	study	Plac-SgrS32	 pBRplac		 Plac-sgrS32	 This	study		
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Table	2.3	Oligonucleotides	
	
Oligo	 Description	 Seqience	5'-3'	MBP1F	 Forward	primer	for	cloning	E.	coli	ptsG	to	pZE12S;	contains	EcoRI	site	 CCCCGAATTCATAAATAAAGGGCGCTTAGATGCCCTG	MBP1R10	 Reverse	primer	for	cloning	30	bp	E.	coli	
ptsG	region	to	pZE12S;	contains	KpnI	site	 CCCCGGTACCTTGCAGGTTAGCAAATGCATTCTT	MBP2F	 forward	primer	for	manX	cloning	to	make	pZEMB10	 CCCCGAATTCGCGAAACGCAGGGGTTTTTGGTTG	MBP2R34	 reverse	primer	for	manX	cloning	to	make	pZEMB10	 CCCCGGTACCGATCCAGCCGACGTTTTCCTGCTC		MBP4F	 Forward	primer	for	cloning	E.	coli	sgrS	into	pZA31R;	contains	NdeI	site	 GGGAATTCCATATGGATGAAGCAAGGGGGTGCCCCATG	MBP4R	 Reverse	primer	for	cloning	E.	coli	sgrS	into	pZA31R;	contains	BamHI	site	 CCCCGGATCCACGTTCCCTTTTTAGCGCGGCGAGAAT	MBP6F	 Forward	primer	for	cloning	K.	
pneumoniae	sgrS	to	pZA31R;	contains	NdeI	site	 GGGAATTCCATATGGATGAAGCGAGGAGGTGAATATGA	MBP6R	 Reverse	primer	for	cloning	K.	
pneumoniae	sgrS	to	pZA31R;	contains	BamHI	site	 CCCCGGATCCTCCTTAACACACGCGAAGAAAACG	MBP7F	 Forward	primer	for	cloning	E.	caratovora	
sgrS	to	pZA31R;	contains	NdeI	site	 GGGAATTCCATATGAAGGAAAGAGAGGAGGTGGCTCAT	MBP7R	 Reverse	primer	for	cloning	E.	caratovora	
sgrS	to	pZA31R;	contains	BamHI	site	 CCCCGGATCCACGCGGTAAGCAGATCTGCACCAT	MBP8F	 Forward	primer	for	cloning	Y.	pestis	sgrS	to	pZA31R;	contains	NdeI	site	 GGGAATTCCATATGAAGAAAAGCGGGTTATCGTGACAA	MBP8R	 Reverse	primer	for	cloning	Y.	pestis	sgrS	to	pZA31R;	contains	BamHI	site	 CCCCGGATCCGCGTCAAGGCCGAAGG	MBP10F	 Forward	primer	for	cloning	C.	koseri	sgrS	to	pZA31R;	contains	NdeI	site	 GGGAATTCCATATGGATGAAGCAATATGGAGAGGTCTTCGA	MBP10R	 Reverse	primer	for	cloning	C.	koseri	sgrS	to	pZA31R;	contains	BamHI	site	 CCCCGGATCCTTATGTCTAAACGCAGCCGAAACG	MBP16F2	 forward	primer	for	yigL	cloning	to	make	pZEMB15	 CCCCGAATTCGAACGCGTGGTGGATAACCGCATG	MBP16R41	 reverse	primer	for	yigL	cloning	to	make	pZEMB15	 CCCCGGTACCCGCAAACACAAAGTTGATGCCGCG		MBP21F	 asd	qPCR	forward	primer	 GCGCTAAAGGCCCTCGATATCATTGTG	MBP21R	 asd	qPCR	reverse	primer	 GGGGTCAAGAATGATGATGGCGTCATC	MBP23F	 Forward	primer	for	kanR::Cp19	amplification	and	cloning	upstream	of	
asd	 GATGTGTGCTGTATAAATGTGCCGGTCTCCTCTTGGCACATTAACTATTATATCAACCCGGATCCCTCC	MBP23R	 Reverse	primer	for	kanR::Cp19	amplification	and	cloning	upstream	of	
asd	 GCTAACAAAGCAGGATAAGTCGCATTACTGATGGCTTCGCGTGTAGGCTGGAGCTGCTTCG	MBP24F	 Forward	primer	for	kanR::Cp19	amplification	and	cloning	upstream	of	
adiY	 GGCCCCACCCCGCGCTTTTTTTTGCCTGTTATTTATCCTGGTGTAGGCTGGAGCTGCTTCG	MBP24R	 Reverse	primer	for	kanR::Cp19	amplification	and	cloning	upstream	of	
adiY	 TTGTATGATGAATATAAACATGCATAAAAATAACGAGTTTTAACTATTATATCAACCCGGATCCCTCC	MBP25F	 Forward	primer	for	kanR::Cp19	amplification	and	cloning	upstream	of	
folE	 GCTCTTCGAGCATTTCCATGCGTGGCTCCTTGTTGTGTTGGTGTAGGCTGGAGCTGCTTCG	MBP25R	 Reverse	primer	for	kanR::Cp19	amplification	and	cloning	upstream	of	
folE	 GTTAAAACATCGTTATGCAAATACGGAAGTGAAAGTTACTCTAACTATTATATCAACCCGGATCCCTCC	MBP29F2	 Forward	primer	to	amplify	adiY	for	cloning	into	pZEMB8;	contains	EcoRI	site	 CCCCGAATTCAAACTCGTTATTTTTATGCATGTTTATATTCATCATACAATTATATAACC	
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Table	2.3	(cont.)		
Oligo	 Description	 Seqience	5'-3'	MBP29R40	 Reverse	primer	to	amplify	adiY	for	cloning	into	pZEMB8;	contains	KpnI	site	 CCCCGGTACCACAATTTAATAACGCCATATGGTTAGCTTTAAGGC	MBP30F	 Forward	primer	to	amplify	folE	for	cloning	into	pZEMB8;	contains	EcoRI	site	 CCCCGAATTCGAGTAACTTTCACTTCCGTATTTGCATAACGATG	MBP30R40	 Reverse	primer	to	amplify	folE	for	cloning	into	pZEMB8;	contains	KpnI	site	 CCCCGGTACCAATAAGGCTTTTGCGCGTTTCGTTATCC	MBP36F	 Forward	primer	for	QuikChange	mutagenesis	of	adiY1	 CGCACTCAGGAGTAATAGTATGAGGATTTGCAGCGACCAACCTTG	MBP36R	 Reverse	primer	for	QuikChange	mutagenesis	of	adiY1	 CAAGGTTGGTCGCTGCAAATCCTCATACTATTACTCCTGAGTGCG	MBP38F	 Forward	primer	for	QuikChange	mutagenesis	of	adiY27	 CTGGTCTTTTATTCGCATATAGGAGTACATGTATGAGGATTTGCAGCG	MBP38R	 Reverse	primer	for	QuikChange	mutagenesis	of	adiY27	 CGCTGCAAATCCTCATACATGTACTCCTATATGCGAATAAAAGACCAG	MBP42F	 Forward	primer	for	amplification	of	
kanR	from	pKD13	 GCAACCTGTTGAGTAATAATTAGCTCAAAGTAATCAAGCCGTGTAGGCTGGAGCTGCTTC	MBP42R	 Reverse	primer	for	amplification	of	kanR	from	pKD13	 CTTCCAGCTCAGCAAATAATTTCGCTTTAAAACATATCATATTCCGGGGATCCGTCGACC	MBP43F	 Forward	confirmation	primer	for	FRT-kanR-FRT	casette	cloning	downstream	of	
rne131	 GCAACACATCATGCCTCTGCCGCTC	MBP43R	 Reverse	confirmation	primer	for	FRT-kanR-FRT	casette	cloning	downstream	of	
rne131	 GCAAACGGCATTGCAGGCATCGTATAAAGC	MBP47F	 Forward	primer	for	QuickChange	mutagenesis	of	sgrS27	 GTTGACTTGCCTGCATCATGTGTGACTATATATTGGTGTAAAATC	MBP47R	 Reverse	primer	for	QuickChange	mutagenesis	of	sgrS27		 GATTTTACACCAATATATAGTCACACATGATGCAGGCAAGTCAAC	MBP54F	 folE	qPCR	forward	primer	 CAGCTGCTGAATCTCGACCTGGC	MBP54R	 folE	qPCR	reverse	primer		 GATATCGCGCACGGTGACCATTTCATC	MBP55F	 purR	qPCR	forward	primer	 GTTACACCCTGATTCTGGGCAATGCG	MBP55R	 purR	qPCR	reverse	primer	 GATACTCTTCCAGCATCGCCAGCAAC	MBP56F	 Forward	primer	for	in	vitro	transcription	and	footprinting	of	asd;	contains	T7	promoter	 TAATACGACTCACTATAGGATGTGCCAAGAGGAGACCGG	MBP56F	 T7	forward	primer	for	in	vitro	transcription	asd	(+1)	 TAATACGACTCACTATAGGATGTGCCAAGAGGAGACCGG	MBP56R	 Reverse	primer	for	in	vitro	transcription	and	footprinting	of	asd		 GCTGAGAAGTAGAAAAGAAGACAGGGCG	MBP59F	 adiY	qPCR	forward	primer	 GATGTCTGGATAAGGGTGAATGGGAAAGAACC	MBP59R	 adiY	qPCR	reverse	primer	 TGCGAGAGATCTTTATTCAGAAACCGGAGG	MBP61F	 zinT	qPCR	forward	primer		 CAGTGACTGGGATGGAGTCTGGCAATC	MBP61R	 zinT	qPCR	reverse	primer		 GGAATTCAACAATGCCGTCCTCAATGCC	MBP62F	 znuA	qPCR	forward	primer		 CAGAACATGATTATTCACTGCGCCCATCGG	MBP62R	 znuA	qPCR	reverse	primer		 CAAGCTGCGCAATCGTTACCTGCTTC	MBP63F	 cusC	qPCR	forward	primer	 CAGGTGAAGACGCTGATTAGCGAGG	MBP63R	 cusC	qPCR	reverse	primer		 CCCTTTAAGATTACCGCTCCAGCTGC	MBP64F	 ykgMO	qPCR	forward	primer	 CTGGATGGCGTAACGTATCCATACGTGAC	MBP64R	 ykgMO	qPCR	reverse	primer		 CCAAAACGTTGGGTGAATCGTGCAACATTTC	MBP65F	 Forward	primer	for	in	vitro	transcription	of	purR;	contains	T7	promoter	 TAATACGACTCACTATAGGTACACTATTTGCGTACTGGCCATTGACC	
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Table	2.3	(cont.)		
Oligo	 Description	 Seqience	5'-3'	MBP65F	 T7	forward	primer	for	in	vitro	transcription	purR	(+1)	 TAATACGACTCACTATAGGTACACTATTTGCGTACTGGCCATTGACC	MBP65R	 Reverse	primer	for	in	vitro	transcription	of	purR-long	 GTGGTTAACCTTCAGGCTACGCG	MBP70F	 ydjN	qPCR	forward	primer	 CTGCTGCA	AATGATCGTT	ATGCCGTTAG	TC	MBP70R	 ydjN	qPCR	reverse	primer	 CGTGGTAAACAAAAGCGTACCGATGGTC	MBP71F	 yeeE	qPCR	forward	primer	 GTTAATTCAGGCGGGCCTACTGACTTACG	MBP71R	 yeeE	qPCR	reverse	primer		 GATCCAACTGCCGATCAATCCCTCAC	MBP72F	 yeeD	qPCR	forward	primer		 CAGGTCTGTCCGTTTCCACTCATAGAAGC	MBP72R	 yeeD	qPCR	reverse	primer		 GATAATCGGTGATGGCATGTCCTTCTTCTGC	MBP73F	 secG	qPCR	forward	primer		 GGCAATTGGCCTTGTTGGTCTGATCATG	MBP73R	 secG	qPCR	reverse	primer	 GCACCAGACTGATGATGAAGAATAACGTTGC	MBP74F	 nepI	qPCR	forward	primer	 CTCCTGCTTGCTGGTTTCCTTTGCTAAC	MBP74R	 nepI	qPCR	reverse	primer		 CGGCAATCACCAGCGCAATAGAAAC	MBP84F	 T7	forward	primer	for	in	vitro	transcription	ptsG	(+1)	 TAATACGACTCACTATAGGATAAATAAAGGGCGCTTAGATGCCCTG	MBP86F	 Forward	primer	for	in	vitro	transcription	and	footprinting	of	adiY;	contains	T7	promoter	 TAATACGACTCACTATAGGAATTTGTACTATTAGTAAAACTCGTTATTTTTATGCATGT	MBP86R	 Reverse	primer	for	in	vitro	transcription	and	footprinting	of	adiY		 GGTTAGCTTTAAGGCTAATAGGTTCTTTCC	MBP92F	 Forward	primer	for	cloning	asd	into	pZEMB8	 CCCCGAATTCATGTGCCAAGAGGAGACCGG	MBP92R1	 Reverse	primer	to	make		Plac-asdI-gfp	 CCCCGGTACCCTGAGAAGTAGAAAAGAAGACAGGGCG	MBP92R2	 Reverse	primer	to	make	Plac-asdI-II-gfp	 CCCCGGTACCCATACCGCGCCAGCCGATAAAAC	MBP94F	 Forward	primer	for	in	vitro	transcription	of	folE;	contains	T7	promoter	 TAATACGACTCACTATAGGCGCACAATAATCAGGCTGTAAATCAG	MBP94R	 Reverse	primer	for	in	vitro	transcription	of	folE			 GTTTCGTTATCCATTTCATGCACGG	MBP104R	 Reverse	primer	to	amplify	folE-short	(only	UTR	and	ATG	START	codon	fused	to	lacZ)	for	cloning	into	PM1205	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACCATTTATGATTTCTCCTGCAG	MBP105F	 Forward	primer	for	cloning	yeeE	into	PM1205	to	make	Para-yeeE-lacZ	 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATATTAACATTCATCTGGTTAA	MBP106F	 Forward	primer	for	cloning	nepI	into	PM1205	to	make	Para-nepI-lacZ	 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATCTTTTCCCCTGAAACATGCC	MBP107F	 Forward	primer	for	cloning	purR	into	PM1205	 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATTACACTATTTGCGTACTGGC	MBP107R	 Reverse	primer	for	cloning	purR-long	into	PM1205	to	make	Para-purR-long-
lacZ	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACGCTAGGGGAGTAGTGTAATT	MBP110F	 Forward	primer	for	cloning	gpmA	into	PM1205	to	make	Para-gpmA-lacZ	 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATAAGCATTGCTGTTGCTTCGT	MBP110R	 Reverse	primer	for	cloning	gpmA	into	PM1205	to	make	Para-gpmA-lacZ	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACCAGCAGCTTACCTGCTGCTT	MBP111F	 Forward	primer	for	cloning	pntA	into	PM1205	to	make	Para-pntA-lacZ		 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATCGTACATGAGCAGCTTGTGT	MBP112F	 Forward	primer	for	cloning	gltA	into	PM1205	to	make	Para-gltA-lacZ	 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATTGAAGTCGGTATTTCACCTA	MBP112R	 Reverse	primer	for	cloning	gltA	into	PM1205	to	make	Para-gltA-lacZ		 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACTGAACCGAGAGTACGGATAT	
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Table	2.3	(cont.)	
	
Oligo	 Description	 Seqience	5’-3’	MBP115F	 Forward	primer	for	cloning	cycA	into	PM1205	to	make	Para-cycA-lacZ	 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATGTCCCGATACAGATTCGTCG	MBP115R	 Reverse	primer	for	cloning	cycA	into	PM1205	to	make	Para-cycA-lacZ	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCAAGGCTAATCGTTTTGC	MBP116F	 Forward	primer	for	cloning	fumA	into	PM1205	to	make	Para-fumA-lacZ	 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATTTTAACAGGGCAACGGAACA	MBP117F	 Forward	primer	for	cloning	mipA	into	PM1205	to	make	Para-mipA-lacZ	 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATGCCCGCTAAACATTTGTTTA	MBP118F	 Forward	primer	for	cloning	icd	into	PM1205	to	make	Para-icd-lacZ	 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATATAACGCGCATCTTTCATGA	MBP118R	 Reverse	primer	for	cloning	icd	into	PM1205	to	make	Para-icd-lacZ	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACTTCAGGAACGTTGAGTTTGC	MBP122R	 Reverse	primer	to	amplify	folE26-short	mutant	for	cloning	into	PM1205	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACCATTTATGATTTCTCCTCGTGGTGTGACG	MBP125R	 Reverse	primer	for	cloning	yeeE	into	PM1205	to	make	Para-yeeE-lacZ	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACATACATATCGCGAAAACCA	MBP126R	 Reverse	primer	for	cloning	nepI	into	PM1205	to	make	Para-nepI-lacZ	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACCATTGGCGTCAACAAACTGA	MBP127F	 Forward	primer	2	for	cloning	ydjN	into	PM1205	to	make	Para-ydjN-lacZ	 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATCACCTTTCTGGAATAAGCAA	MBP127R	 Reverse	primer	2	for	cloning	ydjN	into	PM1205	to	make	Para-ydjN-lacZ	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACCGCCAGACTCCACTGTTTAT	MBP129R	 Reverse	primer	2	for	cloning	pntA	into	PM1205	to	make	Para-pntA-lacZ	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACGTCAAAACTTGCCAGTTGAC	MBP132R	 Reverse	primer	2	for	cloning	fumA	into	PM1205	to	make	Para-fumA-lacZ	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACGTGTTCGCTGGTTAGCAGG	MBP133R	 Reverse	primer	2	for	cloning	mipA	into	PM1205	to	make	Para-mipA-lacZ	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACGCCCAGGGAAAATTTACCTT	MBP135F	 Forward	QuikChange	primer	to	make	
sgrS24	mutant	 GTTGACTTGCCTGCATCATGTCACACTGAG	MBP135R	 Reverse	QuikChange	primer	to	make	
sgrS24	mutant	 TTTACACCAATACTCAGTGTGACATGATGC	MBP136F	 Forward	QuikChange	primer	to	make	
sgrS25	mutant		 GTTGACTTGCCTGCATCATCACTGACTGAG	MBP136R	 Reverse	QuikChange	primer	to	make	
sgrS25	mutant		 TTTACACCAATACTCAGTCAGTGATGATGC	MBP137F	 Forward	QuikChange	primer	to	make	
sgrS26	mutant		 CAATTCTGAAAGTTGACTTGCCTCGTTCATGTG	MBP137R	 Reverse	QuikChange	primer	to	make	
sgrS26	mutant	 CAATACTCAGTCACACATGAACGAGGCAAG	MBP138F	 Forward	primer	to	amplify	full	length	asd	and	introduce	BamHI	site	upstream	of	+1	 CCCCCCGGATCCATGTGCCAAGAGGAGACCGGC	MBP138R	 Reverse	primer	to	amplify	full	length	asd	and	introduce	HindIII	site	 CCCCCCAAGCTTCGCGCCCCAGATTTAATGAATAAAGA	MBP139R	 Reverse	primer	for	cloning	purR-short	into	PM1205	to	make	Para-purR-short-
lacZ	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACCATTCCATTTCACTCCAGAC	MBP140F	 Forward	primer	for	cloning	mglB	into	PM1205	to	make	Para-mglB-lacZ		 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATGTTTTAACGTTGTAACCCGT	MBP140R	 Reverse	primer	for	cloning	mglB	into	PM1205	to	make	Para-mglB-lacZ	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACTGTTACACCAATGCGAGTAT	MBP142F	 Forward	primer	for	cloning	marC	into	PM1205	to	make	Para-marC-lacZ		 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATTGATAACCCAGATACACAGG	MBP142R	 Reverse	primer	for	cloning	marC	into	PM1205	to	make	Para-marC-lacZ	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACAAGAAATAACGCGACAGTTG	
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Table	2.3	(cont.)		
Oligo	 Description	 Seqience	5'-3'	MBP143F	 Forward	primer	for	cloning	bglA	into	PM1205	to	make	Para-bglA-lacZ		 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATTTACGCCCAGCCAGAATGTC	MBP143R	 Reverse	primer	for	cloning	bglA	into	PM1205	to	make	Para-bglA-lacZ	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACGCCGCCTTCGACCTGATGAG	MBP144F	 Forward	primer	for	cloning	rbsC	into	PM1205	to	make	Para-rbsC-lacZ	 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATGCGGGGAATTTACTCGTGAG	MBP144R	 Reverse	primer	for	cloning	rbsC	into	PM1205	to	make	Para-rbsC-lacZ	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACCAGCAGAGCGATAAGCGATT	MBP145F	 Forward	primer	for	cloning	rbsK	into	PM1205	to	make	Para-rbsK-lacZ	 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATAGGTTGTATGACCTGATGGT	MBP145R	 Reverse	primer	for	cloning	rbsK	into	PM1205	to	make	Para-rbsK-lacZ	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACTACGGTTTCGCCTGGAGTAG	MBP146F	 Forward	primer	for	cloning	pntB	into	PM1205	to	make	Para-pntB-lacZ	 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATGTTGATGTCGGTCACCAACG	MBP146R	 Reverse	primer	for	cloning	pntB	into	PM1205	to	make	Para-pntB-lacZ	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACATGTTTCGAAAGACCGGCCA	MBP147F	 Forward	primer	for	cloning	ydhQ	into	PM1205	to	make	Para-ydhQ-lacZ	 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATGTCGTGGATAAATCCTCCGT	MBP147R	 Reverse	primer	for	cloning	ydhQ	into	PM1205	to	make	Para-ydhQ-lacZ		 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACGCCTTCAGTAAGTTGCGTCG	MBP148F	 Forward	primer	for	cloning	yiiR	into	PM1205	to	make	Para-yiiR-lacZ		 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATTGACAGTACCTTTTGTTATGACTGG	MBP148R	 Reverse	primer	for	cloning	yiiR	into	PM1205	to	make	Para-yiiR-lacZ	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACCGCCAGTGAGAAAAGCACCA	MBP149F	 Forward	primer	for	cloning	fruA	into	PM1205	to	make	Para-fruA-lacZ		 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATGTAAGTCAAAGCAATGTGGG	MBP149R	 Reverse	primer	for	cloning	fruA	into	PM1205	to	make	Para-fruA-lacZ	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACATTGTCGATGATTTCCAGTT	MBP150F	 Forward	primer	for	cloning	cheY	into	PM1205	to	make	Para-cheY-lacZ	 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATGTGGTGTCTGCGAAGTGGTC	MBP150R	 Reverse	primer	for	cloning	cheY	into	PM1205	to	make	Para-cheY-lacZ	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACCTCTTTCAGCAGGTTACGCA	MBP151F	 Forward	primer	for	cloning	asd(I)	into	PM1205	to	make	Para-asd-lacZ	 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATATGTGCCAAGAGGAGACCGG	MBP151F	 Forward	primer	for	cloning	asdI	into	PM1205	to	make	Para-asdI-lacZ	fusion	 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATATGTGCCAAGAGGAGACCGG	MBP151R	 Reverse	primer	for	cloning	asd	into	PM1205	to	make	Para-asd-lacZ	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACCATAAGCGTTTTTTTCCTGCAAAGATGTGTGCTG	MBP151R	 reverse	primer	for	cloning	asdI	into	PM1205	to	make	Para-asdI-lacZ	fusion	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACCATAAGCGTTTTTTTCCTGCAAAGATGTGTGCTG	MBP151R1	 reverse	primer	for	cloning	asd30-I	into	PM1205	to	make	Para-asd30-I-lacZ	fusion	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACCATAAGCGTTTTTTTCCTGCAAAGATGTCACCTGTA	MBP151R2	 reverse	primer	for	cloning	asd31-I	into	PM1205	to	make	Para-asd31-I-lacZ	fusion	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACCATAAGCGTTTTTTTCCTGCAAAGATCACTGCTG	MBP151R3	 reverse	primer	for	cloning	asd32-I	into	PM1205	to	make	Para-asd32-I-lacZ	fusion	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACCATAAGCGTTTTTTTCCTCGTAAGATGTGTGCTG	MBP152F	 Forward	primer	for	cloning	adiY	into	pBRCS12;	contains	BamHI	site	 CCCCCCGGATCCAAACTCGTTATTTTTATGCATGTTTATATT	MBP152R	 Reverse	primer	for	cloning	adiY	into	pBRCS12;	contains	HindIII	site	 CCCCCCAAGCTTGTTATTAATATAGCTCTTCGTTAAGGTT	MBP153F	 Forward	primer	for	cloning	folE	into	pBRCS12;	contains	BamHI	site	 CCCCCCGGATCCGAGTAACTTTCACTTCCGTATTTGCATAAC	
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Table	2.3	(cont.)		
Oligo	 Description	 Seqience	5'-3'	MBP153R	 Reverse	primer	for	cloning	folE	into	pBRCS12;	contains	HindIII	site	 CCCCCCAAGCTTCAAAATCGAGCGTGACGTTGC	MBP154F	 Forward	primer	for	cloning	purR	into	pBRCS12;	contains	BamHI	site	 CCCCCCGGATCCTACACTATTTGCGTACTGGCCATTGACCCC	MBP154R	 Reverse	primer	for	cloning	purR	into	pBRCS12;	contains	HindIII	site	 CCCCCCAAGCTTCGGAAGAGACTCCCGCAACGGG	MBP163F	 ppsA::kan	(KEIO)	mutant	confirmation	primer	forward	 GAAGCGTAGAACGTTATGTCTGGTT	MBP163R	 ppsA::kan	(KEIO)	mutant	confirmation	primer	reverse		 ACGCAGGATGTCTGTGAAGAGATTG		MBP164R	 Reverse	primer	for	cloning	purR-medium	into	PM1205	to	make	Para-purR-
medium-lacZ	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACTGTTTTGTTGATCACGTGTGACACAGTTGT	MBP165R	 Reverse	primer	to	amplify	purR24-
medium	mutant	for	cloning	into	PM1205		 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACTGTTTTGTTGATCACCACTGACACAGTTGT	MBP166R	 Reverse	primer	to	amplify	purR25-
medium	mutant	for	cloning	into	PM1205		 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACTGTTTTGTTGATCACGTCACACACAGTTGT	MBP167R	 Reverse	primer	to	amplify	purR26-
medium	mutant	for	cloning	into	PM1205		 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACTGTTTTGTCGTTCACGTGTGACACAGTTGT	MBP174R	 Reverse	primer	for	in	vitro	transcription	of	purR-medium	 TGTTTTGTTGATCACGTGTGACACAGTTGT	MBP174R		 reverse	primer	for	in	vitro	transcription	
purR	(+290)	 TGTTTTGTTGATCACGTGTGACACAGTTGT	MBP178R	 Reverse	primer	for	in	vitro	transcription	of	purR-short	 CATTCCATTTCACTCCAGACCCTAACTTCA	MBP181F	 Forward	primer	for	cloning	kanR::Cp19	in	purR	(kanR	sequence)		 GCATTTTTACACACTGTGATGAAAAAATCTCCCGTCATTTGTGTAGGCTGGAGCTGCTTCG	MBP181R	 Reverse	primer	for	cloning	kanR::Cp19	in	purR	(Cp19	sequence)	 GCGTCAGGAAGGGGTCAATGGCCAGTACGCAAATAGTGTATAACTATTATATCAACCCGGATCCCTCC	MBP182F	 Forward	confirmation	primer	within	kanR	gene	 GTGTAGGCTGGAGCTGCTTCG	MBP182R	 Reverse	confirmation	primer	within	
purR		 CCAGACCCTAACTTCAGCTCCTGC	MBP183F	 Forward	primer	for	cloning	yeeD	into	PM1205	to	make	Para-yeeD-lacZ	fusion		 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATGTAAGGCGCGACTGGCAAC	MBP183R	 Reverse	primer	for	cloning	yeeD	into	PM1205	to	make	Para-yeeD-lacZ	fusion		 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCTTTTTGAACGGTGATGCT	MBP184F	 Forward	primer	for	cloning	yeiB	(downstream	of	folE)	into	PM1205	to	make	Para-yeiB-lacZ	fusion	 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATATTAAAAGGCAGGAACCatgGAGCG	MBP185F	 Forward	primer	for	cloning	ykgMO	into	PM1205	to	make	Para-ykgMO-lacZ	fusion	 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATTTATGTTATAACATAACAGGTAAAAATGATGAAGC	MBP185R	 Reverse	primer	for	cloning	ykgMO	into	PM1205	to	make	Para-ykgMO-lacZ	fusion	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACACGTTTTTTCTTACGACCCTGAAC	MBP186F	 Forward	primer	for	cloning	pliG	into	PM1205	to	make	Para-pliG-lacZ	fusion	 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATGTTGAGTCCATGCCCCCTTT	MBP186R	 Reverse	primer	for	cloning	pliG	into	PM1205	to	make	Para-pliG-lacZ	fusion	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACCTTAATTTGAATATCGACGTTATATTTTTTAGTTTTG	MBP187F	 Forward	primer	for	cloning	cusC	into	PM1205	to	make	Para-cusC-lacZ	fusion	 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATCATAAAATCACCAGAAATTATGAGCCTatg	MBP187R	 Reverse	primer	for	cloning	cusC	into	PM1205	to	make	Para-cusC-lacZ	fusion	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACAAGATTACCGCTCCAGCTG	MBP188F	 Forward	primer	for	cloning	cusF	into	PM1205	to	make	Para-cusF-lacZ	fusion	 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATACAGCAATATACTCGTCATACTTCAAG	
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Table	2.3	(cont.)		
Oligo	 Description	 Seqience	5'-3'	MBP188R	 Reverse	primer	for	cloning	cusF	into	PM1205	to	make	Para-cusF-lacZ	fusion	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACCTGGCTGACTTTAATATCCTGTAATAAAG	MBP189F	 Forward	primer	for	cloning	znuA	into	PM1205	to	make	Para-znuA-lacZ	fusion	 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATGTTAATTTTAGTCTTGCAGTAGTCATG	MBP189R	 Reverse	primer	for	cloning	znuA	into	PM1205	to	make	Para-znuA-lacZ	fusion	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACTAAGTCCGCGTTCTGTAAGC	MBP190F	 Forward	primer	for	cloning	znuC	into	PM1205	to	make	Para-znuC-lacZ	fusion	 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATTCATGACTACTGCAAGACTAAAATTAACatg	MBP190R	 Reverse	primer	for	cloning	znuC	into	PM1205	to	make	Para-znuC-lacZ	fusion	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACATGTGTACCAGGGCGTAAGC	MBP191F	 Forward	primer	for	cloning	mepM	(yebA)	into	PM1205	to	make	Para-mepM-lacZ	fusion	 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATGAATATCAAACTGGGTAAAACAAGCTATTC	MBP191R	 Reverse	primer	for	cloning	mepM	(yebA)	into	PM1205	to	make	Para-mepM-lacZ	fusion	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACAGCTTGATCAATCGGCTCAC	MBP192F	 Forward	primer	for	cloning	lamB	into	PM1205	to	make	Para-lamB-lacZ	fusion	 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATGAGCGTTGCCATCTGTTCCG	MBP192R	 Reverse	primer	for	cloning	lamB	into	PM1205	to	make	Para-lamB-lacZ	fusion	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACACATTCGTTGCCAAGACGGTA	MBP193F	 Forward	primer	for	cloning	asdII	into	PM1205	to	make	Para-asdII-lacZ	fusion	 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATCTTTGCAGGAAAAAAACGCT	MBP193R	 reverse	primer	for	cloning	asdI-II	into	PM1205	to	make	Para-asdI-II-lacZ	fusion	 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCGTCGAAGTCGCGCTC	MBP204F2	 Forward	primer	to	amplify	3xFLAG::kan	for	purR	cloning	 GGTGATGTGTTCTGAGTACCCAGAGCCGTTGCTGGCGATGGACTACAAAGACCATGACGGTGATTATAAAG	MBP204R2	 Reverse	primer	to	amplify	3xFLAG::kan	for	purR	cloning	 CGGCAAGGCGGCCTGCGCCGGTGTTACGTTCCAGCGGGCCATGGTCCATATGAATATCCTCCTTAG	MBP211F	 Forward	primer	to	amplify	3xFLAG::kan	for	ptsG	cloning		 CTCCGGTGCGATCGCAGCGTACATGTTTAACCGTTTCTACGACTACAAAGACCATGACGGTGATTATAAAG	MBP211R	 Reverse	primer	to	amplify	3xFLAG::kan	for	ptsG	cloning	 ACCGTAAATGCCAAACGCAACTACCGGGTTCTGGTAAGCAATGGTCCATATGAATATCCTCCTTAG	MBP213R		 reverse	primer	for	in	vitro	transcription	
ptsG	(+240)	 TGCGATACAACGGCGGGC		MBP214R	 reverse	primer	for	in	vitro	transcription	
manX	(+240)	 GCATTTTCACCTGGAACGAAATCGATCC	MBP215R		 reverse	primer	for	in	vitro	transcription	
asdI-II	(+240)	 AGATCAAAGGCATCCTGAAGTGTGC	MBP216R		 reverse	primer	for	in	vitro	transcription	
yigL	(+50	relative	to	yigL	start	codon)	 TCGGGAGAAAGTAACGTGCCATC	MBP222R		 reverse	primer	for	in	vitro	transcription	
asdI	(+110)	 GAACGGAGCCGACCATACCG	MBP225F		 T7	forward	primer	for	in	vitro	transcription	yigL	(-250	relative	to	yigL	start	codon)	 TAATACGACTCACTATAGGCCAACGCTTCTCTTGCAGGC	MBP226F	 T7	forward	primer	for	in	vitro	transcription	asdII	(+51)	 TAATACGACTCACTATAGGGTTGGTTTTATCGGCTGGCGCG	MBP226R	 reverse	primer	for	in	vitro	transcription	
asdII	(+310)	 TGGATAGATTTCGTTGGTATAATCGCCGCC	MBP234F	 T7	forward	primer	for	in	vitro	transcription	gfp	(+1	to	+240)	 TAATACGACTCACTATAGGATGAGCAAAGGAGAAGAACTTTTCACTGG	MBP234R	 reverse	primer	for	in	vitro	transcription	
gfp	(+1	to	+240)	 CCGTTTCATATGATCCGGATAACGGG	MBP-SgrSFor	 pZAMB1	forward	primers	to	amplify	SgrS	for	sequencing	 CATATGGATGAAGCAAGGGGGTGCCCCATG	MBP-SgrSRev	 pZAMB1	reverse	primers	to	amplify	SgrS	for	sequencing	 GGATCCACGTTCCCTTTTTAGCGCGGCGAGAAT	
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Table	2.3	(cont.)		
Oligo	 Description	 Seqience	5'-3'	MBP-adiY-bio	 adiY-specific	5'-biotinylated	probe	for		Northern	blot	detection	 CAGTTTCTGCGGGCATCATGCTGTGTTGCG	MBP-asd-bio	 asd-specific	5'-biotinylated	probe	for	Northern	blot	detection	 GGAAGCGGCCTGGTAGGTTGCAACGGACAC	MBP-folE-bio	 folE-specific	5'-biotinylated	probe	for	Northern	blot	detection	 GCGGCGTTTCCATCAAACTGTCATCAGC	MBP-purR-bio2	 purR-specific	5'-biotinylated	probe	for	Northern	blot	detection	 GCCCAGAATCAGGGTGTAACCTTTCTGGAA	ssrA-bio	 ssrA-specific	5'-biotinylated	probe	for	Northern	blot	detection	 CGCCACTAACAAACTAGCCTGACGCCACTAACAAA	confirm-For	 Confirmation	of	cloning	into	PM1205,	flanking	the	inserted	fragment	 AGCATTCTGTAACAAAGCGGGACCAAAGCC	confirm-Rev	 Confirmation	of	cloning	into	PM1205,	flanking	the	inserted	fragment	 GCATCTGCCAGTTTGAGGGGACGACGACAG	folE-For	 Forward	primer	to	amplify	folE	starting	at	+1	for	cloning	into	PM1205		 ACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCTCCATGAGTAACTTTCACTTCCGTA	folE-Rev2	 Reverse	primer	to	amplify	folE-long	for	cloning	into	PM1205		 TAACGCCAGGTTTTCCCAGTCACGACGTTGTAAAACGACGTTATCCATTTCATGCACGG	gfpsf-F		 Linker+superfolder	gfp	forward	amplification	primer	for	pZE12S	cloning;	contains	KpnI	site	 CCCCGGTACCGGATCCGCTGGCTCCGCTG	gfpsf-R			 Linker+superfolder	gfp	reverse	amplification	primer	for	pZE12S	cloning;	contains	XbaI	site	 GATGCCTCTAGATTATTTGTAGAGCTCATCCATGCC	O-JH218		 T7	forward	primer	for	in	vitro	transcription	manX	(+1)	 TAATACGACTCACTATAGGGGATGAAGCAAGGGGGTGCCCCATG	O-SA070	 Forward	primer	for	in	vitro	transcription	of	full	length	gfp;	contains	T7	promoter	 TAATACGACTCACTATAGGGACGTAAAGGAGGAATTCATGAGCAAAGGAGAAGAACTTTTCACTG	O-SA071	 Reverse	primer	for	in	vitro	transcription	of	full	length	gfp	 TACGTTTATTTGTAGAGCTCATCCATGCCATGTG	
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CHAPTER	3		
IDENTIFICATION	AND	CHARACTERIZATION	OF	NOVEL	SGRS	TARGETS2		
3.1	Introduction	SgrS	is	crucial	for	the	response	to	glucose-phosphate	stress	and	is	highly	expressed	under	this	stress	condition	[267].	SgrS	represses	translation	of	two	mRNA	targets,	ptsG	and	manXYZ	[114,	206,	207,	267]	that	encoding	transporters	of	the	phosphoenolpyruvate	phosphotransferase	system	(PEP-PTS),	EIICBglc	(PtsG)	and	EIIABCDman	(ManXYZ),	respectively	[199,	212].	SgrS	activates	a	third	mRNA	target,	yigL,	which	encodes	haloacid	dehalogenase	(HAD)-like	phosphatase	that	dephosphorylates	sugars	prior	to	their	efflux	[196].	SgrS	base	pairing	with	yigL	mRNA	protects	it	from	RNase	E-mediated	degradation	[196].	Together,	SgrS	regulation	of	these	three	mRNA	targets	reduces	accumulation	of	sugar-phosphates	by	inhibiting	synthesis	of	sugar	transporters,	and	enhances	dephosphorylation	and	efflux	of	sugars.		We	have	shown	that	while	SgrS	regulation	of	ptsG,	manXYZ	and	yigL	is	necessary,	it	is	not	sufficient	for	full	recovery	from	glucose-phosphate	stress	under	certain	circumstances	[252].	We	hypothesized	that	SgrS	regulation	of	other	as	yet	undefined	mRNA	targets	might	be	important	for	cell	physiology	during	stress.		Therefore,	in	order	to	better	understand	how	bacteria	restore	metabolic	homeostasis	during	glucose-phosphate	stress	and	the	role	of	SgrS	in	mediating	this	response	we	performed	global	transcriptomic	analyses	to	identify	genes	differentially	regulated	directly	by	SgrS.	With	this	work,	we	more	than	double	the	number	of	genes	in	the	SgrS	regulon	by	characterizing	regulation	of	four	new	targets:	asd,	adiY,	folE	and	purR	mRNAs.	While	the	specific	function	of	these	genes	in	glucose-phosphate	stress	remains	to	be	uncovered,	we	present	evidence	that	dysregulation	of	these	genes	specifically	under	stress	conditions	is	deleterious	to	cell	growth.	This	study	suggests	that	SgrS	regulation	of	target	mRNAs	not	only	modulates	sugar	uptake	and	efflux,	but	also	modifies	metabolism	in	order	to	promote	homeostasis	and	growth	recovery.																																																									2	Chapter	contains	material	from	the	following	publications:	Bobrovskyy	M.	and	Vanderpool	C.K.,	Molecular	Microbiology,	2016	
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3.2	Results	
3.2.1	Genes	differentially	regulated	by	ectopically	expressed	SgrS			 Glucose-phosphate	stress	caused	by	αMG	results	in	growth	inhibition	(particularly	of	sgrS	mutants)	and	we	expect	that	expression	of	many	genes	changes	due	to	secondary	effects	from	growth	inhibition	(data	not	shown).	To	reduce	these	secondary	effects,	SgrS	was	expressed	ectopically	in	E.	coli	for	10	minutes	in	the	absence	of	stress	and	RNA-Seq	analyses	were	performed.	There	is	no	discernible	difference	in	growth	of	SgrS-expressing	cells	compared	to	vector	control	cells	under	these	conditions	(data	not	shown).	The	gene	expression	profile	of	cells	expressing	SgrS	(from	a	Plac-sgrS	plasmid)	was	compared	to	that	of	the	vector	control	strain	(data	not	shown).	For	this	experiment,	genes	were	considered	differentially	expressed	if	they	met	the	following	criteria:	>1.5-fold	change	in	expression	between	samples	with	statistical	significance	of	<1x10-2	(qValue	as	determined	by	Rockhopper)	[161].	Only	23	genes	fell	within	these	thresholds	and	were	selected	for	further	analysis	(Table	3.1).		 Among	the	genes	that	were	differentially	expressed	after	the	10-minute	pulse	of	SgrS,	ptsG,	manX	and	yigL	were	already	known	to	be	direct	SgrS	targets	[196,	207,	267].	Other	characterized	SgrS-regulated	genes	manY	and	manZ	(in	an	operon	with	manX)	were	affected,	but	missed	the	fold-change	cutoff	(they	were	downregulated	1.45-fold	(qValue	of	4.2x10-4)	and	1.41-fold	(qValue	of	1.37x10-7),	respectively	(data	not	shown).	This	was	expected	as	maximal	reduction	of	manXYZ	mRNA	levels	occurs	at	a	later	time,	more	than	10	minutes	after	SgrS	induction	[207].	In	addition	to	these	known	targets,	a	number	of	genes	encoding	diverse	(or	unknown)	functions	were	differentially	regulated	in	response	to	SgrS	expression.	These	include	genes	involved	in	aspartate	metabolism,	purine	biosynthesis,	folate	production	and	metal	homeostasis	(Table	3.1).			 RT-qPCR	was	used	to	confirm	expression	changes	for	some	of	the	candidate	targets	identified	in	RNA-Seq	experiments	(Table	3.1,	Figure	3.1A).	Results	of	RT-qPCR	analysis	were	consistent	with	RNA-Seq	for	10	out	of	12	genes	tested	(Figure	3.1A).	Levels	of	candidate	mRNA	targets	asd,	folE,	yeeD,	yeeE	and	purR	were	
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decreased	by	~2-fold	in	response	to	SgrS	induction	while	levels	of	cusC	mRNA	decreased	>10-fold	(Figure	3.1A).	SgrS	induction	resulted	in	increased	levels	of	
ykgM	and	znuA	mRNAs	(Figure	3.1A),	which	was	consistent	with	RNA-seq	results	(Table	3.1).	The	nepI	mRNA	(encoding	a	purine	ribonucleoside	efflux	transporter)	showed	~3-fold	reduced	levels	in	response	to	SgrS	induction	via	RT-qPCR,	whereas	very	little	difference	was	observed	in	RNA-Seq	(Figure	3.1A,	data	not	shown).	Regulation	of	ydjN	was	inconsistent	with	RNA-Seq,	while	zinT	did	not	show	differential	regulation	(Figure	3.1A,	Table	3.1),	so	both	of	these	genes	were	excluded	from	further	analyses.		 One	additional	target	candidate,	adiY,	was	analyzed	based	on	microarray	analyses	of	RNA	from	strains	grown	under	the	same	conditions	as	for	RNA-Seq	experiments	(J.	B.	Rice	and	C.	K.	Vanderpool,	unpublished).	The	adiY	gene	encodes	a	transcription	factor	regulating	arginine	decarboxylase	genes.	Expression	of	adiY	is	highest	under	anaerobic	and	low	pH	conditions	[246].	While	strains	for	microarray	and	RNA-Seq	analyses	were	grown	aerobically,	perhaps	slight	differences	in	growth	conditions	led	to	detection	of	adiY	mRNA	in	microarrays,	but	not	RNA-Seq.	Regardless,	to	further	test	whether	adiY	mRNA	is	regulated	by	SgrS,	cultures	were	grown	without	aeration	to	allow	for	sufficient	adiY	expression	for	detection	by	qRT-PCR.	In	cultures	where	SgrS	was	induced,	adiY	mRNA	levels	were	reduced	~5-fold	compared	to	vector	control	cultures	(Figure	3.1B).		
3.2.2	Identifying	genes	post-transcriptionally	regulated	by	SgrS	in	E.	coli	
	 To	further	narrow	the	search	for	direct	targets	of	SgrS,	we	took	advantage	of	computational	base	pairing	prediction	programs	such	as	CopraRNA	[286],	IntaRNA	[30,	211]	and	RNAhybrid	[125,	205]	to	identify	potential	SgrS-mRNA	interactions.	Several	mRNAs	that	were	differentially	regulated	in	RNA-Seq	experiments	(Table	3.1,	data	not	shown)	as	well	as	others	that	were	not	differentially	regulated	but	were	predicted	by	algorithms	(data	not	shown)	were	selected	for	further	characterization.		 To	determine	if	putative	targets	were	post-transcriptionally	regulated	by	SgrS,	we	constructed	lacZ	translational	reporter	fusions	under	control	of	the	PBAD	
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(arabinose-inducible)	promoter	(as	described	in	[156]	in	hosts	carrying	the	vector	control	or	Plac-sgrS	plasmid.	We	tested	reporter	fusions	to	36	candidate	genes	for	regulation	by	SgrS	(Figure	3.2A).	While	the	majority	of	the	candidates	showed	mild	(<1.5-fold)	or	no	regulation	by	SgrS,	translation	of	three	genes:	asd,	folE	and	purR	was	repressed	>2-fold	by	SgrS	(Figure	3.2A).	Translational	fusions	to	gfp	confirmed	post-transcriptional	repression	by	SgrS	for	asd,	folE,	purR	and	adiY	(Figure	3.2B).	Together,	these	results	suggest	that	many	of	the	changes	observed	in	RNA-Seq	were	due	to	indirect	effects	of	SgrS	on	transcription	and	not	to	post-transcriptional	targeting	of	mRNAs	by	SgrS.	It	is	worth	noting	that	many	genes	that	were	not	differentially	regulated	in	RNA-Seq,	but	predicted	computationally	(data	not	shown),	were	not	regulated	post-transcriptionally	upon	ectopic	production	of	SgrS	(Figure	3.2A).		
3.2.3	Post-transcriptional	regulation	of	asd	by	SgrS		 To	investigate	SgrS	regulation	of	asd,	we	constructed	a	strain	where	the	native	asd	promoter	was	replaced	by	a	constitutive	Cp19	promoter	[103]	in	wild-type	and	ΔsgrS	strains.	The	asd	mRNA	was	detected	by	Northern	blot	in	RNA	samples	harvested	from	cells	at	0,	10	and	20	min.	after	exposure	to	αMG.	For	wild-type	E.	coli,	αMG	exposure	resulted	in	reduced	levels	of	asd	mRNA	(Figure	3.3),	whereas	in	the	ΔsgrS	background	asd	mRNA	levels	remained	unperturbed	(Figure	3.3).	Ectopic	production	of	SgrS	(in	the	absence	of	αMG)	also	promoted	a	reduction	in	asd	mRNA	levels	(Figure	3.3).	Since	transcription	of	asd	in	these	experiments	was	controlled	by	a	constitutive	promoter,	we	conclude	that	SgrS	promotes	degradation	of	asd	mRNA,	consistent	with	asd	being	a	direct	target	of	SgrS.	To	test	for	direct	interactions	between	SgrS	and	asd	mRNA,	in	vitro	transcribed	asd	(+1	to	+179	nt)	and	SgrS	(full-length)	were	subjected	to	electrophoretic	mobility	shift	assays	(EMSAs)	and	footprinting.		These	experiments	confirmed	that	SgrS	base	pairs	with	the	5’	region	of	the	asd	transcript	(Figures	3.4,	and	3.5A-C).	When	unlabeled	asd	mRNA	is	annealed	with	labeled	SgrS,	structural	changes	indicated	by	protection	and	hypersensitivity	are	evident	(Figure	3.5A).		The	
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most	obvious	region	of	asd	mRNA-dependent	protection	covers	SgrS	nts	+158	to	+176	(Figure	3.5A).	This	same	region	is	important	for	SgrS	regulation	of	previously	characterized	targets	including	ptsG	[207,	267],	manX	[207],	manY	[206]	and	yigL	[196].	Interestingly,	SgrS	protected	two	different	regions	of	asd	mRNA	(Figure	3.5B,	C).	One	region	of	protection	overlaps	the	asd	RBS	(nts	+32	to	+49,	“Site	I”	Figure	3.5B).	The	second	region	of	SgrS-dependent	protection	is	within	the	asd	coding	sequence	at	positions	+109	to	+130	relative	to	the	transcription	start	(“Site	II”	Figure	3.5C).	The	fact	that	only	one	region	of	asd-dependent	protection	was	observed	on	SgrS,	suggests	that	same	SgrS	sequence	can	bind	at	two	distinct	sites	on	
asd	mRNA	(Figure	3.5D,E).	To	elucidate	the	role	of	the	two	different	SgrS	binding	sites	on	asd	mRNA,	we	constructed	translational	fusions	with	different	asd	fragments	containing	both	pairing	sites	(asdI-II,	Figure	3.6A)	or	each	site	individually	(asdI,	asdII,	Figure	3.6A).	The	results	indicate	that	site	I	is	absolutely	required	for	SgrS	to	regulate	asd	translation.	While	site	II	is	not	sufficient	for	asd	repression,	when	it	is	present	with	site	I,	it	appears	to	allow	tighter	repression	by	SgrS	(Figure	3.6B,	compare	~7.3-fold	repression	of	asdI-II	versus	~2.6-fold	repression	of	asdI).	When	we	introduced	mutations	in	the	asdI	construct	(asd30-I	and	asd32-I,	Figure	3.5D)	that	disrupt	pairing	at	site	I,	the	mutant	fusions	were	no	longer	regulated	by	wild-type	SgrS	(Figure	3.6B).	Compensatory	mutations	in	SgrS	(SgrS30	and	SgrS32,	Figure	3.5D)	were	defective	in	regulation	of	wild-type	asdI	(Figure	3.6B),	but	restored	regulation	of	the	corresponding	asdI	mutant	fusions	(Figure	3.6B).	These	results	indicate	that	SgrS	regulates	asd	translation	by	direct	base	pairing.	In	addition	to	translation	inhibition,	SgrS	results	in	destabilization	of	the	target	transcript	by	recruiting	RNase	E.	We	tested	whether	degradation	is	necessary	for	asd	repression	by	examining	SgrS	regulation	of	asdI	and	asdI-II	constructs	in	wild-type	and	the	rne131	mutant	strain	deficient	in	degradosome	assembly	[142].	This	mutation	abrogates	SgrS-dependent	mRNA	degradation	of	other	targets	[176,	207].	SgrS	repressed	asdI	and	asdI-II	to	the	same	extent	in	wild-type	and	rne131	hosts	(Figure	3.6B),	demonstrating	that	RNase	E	is	not	required	for	SgrS-dependent	translational	repression	of	asd	reporter	fusions.	To	summarize,	direct	base	pairing	of	SgrS	at	the	RBS	within	the	5’	UTR	is	
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necessary	and	sufficient	to	inhibit	translation	of	asd	mRNA,	however	an	additional	SgrS	binding	site	within	the	asd	coding	sequence	might	be	important	for	optimal	asd	repression.	
	
3.2.4	Post-transcriptional	regulation	of	adiY	by	SgrS	
	 In	a	Cp19-adiY	strain,	levels	of	adiY	mRNA	decreased	significantly	at	10	minutes	and	were	undetectable	at	15	minutes	after	αMG	exposure	in	a	wild-type	host,	but	remained	unchanged	in	the	ΔsgrS	background	(Figure	3.7A).	When	SgrS	was	produced	ectopically	in	unstressed	cultures,	adiY	mRNA	abundance	dropped	rapidly	(Figure	3.7A).	Since	transcription	of	adiY	in	these	experiments	is	controlled	by	a	heterologous	promoter,	these	results	support	the	idea	that	SgrS	modulates	adiY	mRNA	stability.		
	 SgrS	regulates	an	adiY	translational	fusion	containing	only	the	adiY	113-nt	5'	UTR	and	120	nt	of	coding	sequence	(Figure	3.2B),	suggesting	that	the	SgrS	binding	site	is	within	these	limits.		EMSAs	confirmed	that	SgrS	forms	a	duplex	with	the	5'	region	of	adiY	mRNA	(nts	+1	to	+233,	Figure	3.8).	Footprinting	revealed	that	SgrS	protects	adiY	mRNA	in	the	translation	initiation	region,	from	nts	+98	to	+112	(Figure	3.7B).	The	predicted	SgrS-adiY	mRNA	base	pairing	interaction	(Figure	3.7C)	was	further	tested	genetically.	Two	mutations,	adiY1	and	adiY33	(Figure	3.7C),	that	disrupt	the	interaction	rendered	the	adiY	reporter	insensitive	to	wild-type	SgrS	(Figure	3.7D).	A	compensatory	mutation	in	SgrS	(SgrS33)	that	restores	pairing	with	
adiY33	also	restored	regulation	(Figure	3.7D).	To	test	whether	degradation	of	adiY	mRNA	was	required	for	SgrS-mediated	repression,	adiY	regulation	was	monitored	in	an	rne131	mutant	host	[142].	In	this	host,	SgrS	still	repressed	adiY	translation,	albeit	less	stringently	than	in	the	rne+	host	(Figure	3.7D).		This	result	suggests	that	degradation	plays	a	role	but	is	not	absolutely	required	for	SgrS-mediated	regulation	of	adiY	mRNA.	Together,	these	results	are	consistent	with	SgrS	pairing	directly	at	the	adiY	RBS	to	inhibit	ribosome	binding,	repress	translation	and	promote	degradation	of	adiY	mRNA.	
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3.2.5	Post-transcriptional	regulation	of	folE	by	SgrS	
	 Levels	of	folE	mRNA	(from	Cp19-folE)	in	wild-type	E.	coli	decreased	after	
αMG	addition.	Under	the	same	conditions,	folE	transcript	levels	remained	stable	in	the	ΔsgrS	strain	(Figure	3.9A).	These	results	are	consistent	with	observations	from	RNA-Seq	and	RT-qPCR,	both	showing	reduced	folE	mRNA	levels	in	SgrS-expressing	cells	(Table	3.1,	Figure	3.1A).	SgrS	binds	folE	mRNA	in	vitro	(Figure	3.8).	Further,	translational	reporter	fusions	folE-long	and	folE-short	(Figure	3.9B)	were	both	regulated	by	SgrS,	demonstrating	that	sequences	required	for	SgrS-dependent	regulation	of	folE	reside	in	the	5'	UTR	(Figure	3.9C).	IntaRNA	[30,	211]	predicted	that	SgrS	nts	+158	to	+174	base	pair	with	folE	nts	+172	to	+185	(Figure	3.9D),	which	encompass	the	RBS	and	a	CA-rich	sequence	that	resembles	previously	described	translation	enhancer	elements	[226,	288].	Mutations	introduced	into	SgrS,	in	SgrS30	and	SgrS32	(Figure	3.9D)	fully	or	partially	disrupt	regulation	of	wild-type	folE,	respectively	(Figure	3.9C).		The	compensatory	mutation	in	folE	(folE32)	prevented	regulation	by	wild-type	SgrS,	but	restored	regulation	by	SgrS32	(Figure	3.9C).	As	observed	for	adiY,	SgrS	repressed	folE	translation	more	weakly	in	the	rne131	host,	deficient	in	degradosome	assembly	(Figure	3.9E).	Together,	these	results	are	consistent	with	SgrS	pairing	with	and	occluding	the	folE	RBS,	which	leads	to	translation	inhibition	and	degradation	of	folE	mRNA.			
3.2.6	Post-transcriptional	regulation	of	purR	by	SgrS		 To	elucidate	the	region	of	purR	mRNA	targeted	by	SgrS,	we	made	truncated	
purR	mRNAs	of	different	lengths	(Figure	3.10A)	by	in	vitro	transcription	and	performed	EMSAs	to	define	the	region	containing	the	SgrS	binding	site.	Radiolabeled	full-length	SgrS	formed	higher	molecular	weight	complexes	with	purR-
long	and	purR-medium,	while	no	shift	was	observed	for	purR-short	(Figure	3.10B).	Translational	reporter	fusions	using	the	same	fragments,	purR-long,	purR-medium	and	purR-short	revealed	SgrS-dependent	translational	repression	for	purR-long	and	
purR-medium	but	not	purR-short	(Figure	3.10C).	Together,	these	results	indicated	that	SgrS	must	pair	within	the	purR	coding	sequence	between	nucleotides	+158	and	
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+230	(encompassing	the	first	25	codons).	IntaRNA	predicted	SgrS	pairing	at	nts	+204	to	+222	of	purR	mRNA,	which	corresponds	to	codons	17-23	of	purR,	a	region	contained	within	purR-medium.	SgrS	bases	+160	to	+179,	predicted	to	interact	with	
purR	(Figure	3.10D),	overlap	the	SgrS	region	that	interacts	with	all	characterized	targets,	including	asd,	adiY	and	folE	mRNAs	described	in	this	study.		
	 We	tested	regulation	of	purR-medium	by	SgrS30	and	SgrS31,	which	contain	mutations	that	disrupt	the	predicted	base	pairing	(Figure	3.10D).	Mutants	SgrS30	and	SgrS31	were	unable	to	regulate	wild-type	purR-medium	(Figure	3.10C).	Compensatory	mutations	in	purR-medium	(purR30	and	purR31,	Figure	3.10D)	were	no	longer	regulated	by	wild-type	SgrS,	but	regulation	by	SgrS30	and	SgrS31,	respectively,	was	restored	(Figure	3.10C).	In	the	rne131	background,	purR-medium	and	purR-long	were	still	regulated	by	SgrS,	suggesting	that	RNase	E-mediated	degradation	is	not	necessary	for	regulation	(Figure	3.10C).	This	conclusion	is	also	supported	by	the	finding	that	purR	mRNA	levels	did	not	change	when	SgrS	was	expressed	ectopically	(Figure	3.11,	last	panel).		We	note	that αMG	affects	purR	mRNA	levels	in	an	SgrS-independent	fashion	(Figure	3.11,	first	two	panels).	SgrS	pairs	49	to	67	nts	downstream	of	the	start	codon,	outside	the	region	occupied	by	the	ribosome.	A	previous	study	demonstrated	that	sRNA	binding	sites	within	a	5-codon	window	could	directly	interfere	with	ribosome	binding	and	inhibit	translation	[23].	Since	the	SgrS	binding	site	on	purR	is	well	outside	this	window,	we	hypothesized	that	SgrS	does	not	interfere	directly	with	translation	initiation	but	perhaps	inhibits	translation	via	an	intermediate	such	as	Hfq.	The	sRNA	Spot	42,	which	pairs	far	upstream	of	the	start	codon	of	its	target	sdhC,	was	recently	demonstrated	to	repress	
sdhC	translation	indirectly	via	recruiting	Hfq	to	bind	at	a	site	that	directly	occludes	ribosome	binding	[57].	To	test	whether	SgrS-dependent	regulation	of	purR	requires	Hfq,	we	performed	in	vitro	translation.	While	purR	translation	was	strongly	repressed	in	the	presence	of	both	SgrS	and	Hfq	(produced	at	only	7.6%	of	control	levels,	Figure	3.12),	SgrS	alone	could	not	efficiently	block	translation	(57%	of	control	levels,	Figure	3.12).	In	contrast,	Hfq	alone	inhibited	purR	translation	as	well	as	the	combination	of	SgrS	and	Hfq	(8.5%	of	control,	Figure	3.12).	These	results	are	
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consistent	with	the	model	that	Hfq	itself	plays	the	major	role	in	inhibiting	translation	of	purR,	whereas	SgrS	alone	cannot	efficiently	block	translation.	The	requirement	for	Hfq	for	translational	repression	of	purR	contrasts	with	the	direct	SgrS-dependent	repression	of	ptsG	mRNA.	For	ptsG,	the	SgrS	binding	site	directly	overlaps	the	RBS	[267],	allowing	direct	competition	with	ribosomes.	Consistent	with	this	canonical	mechanism	for	sRNA-dependent	repression,	SgrS	alone	repressed	
ptsG	translation	in	vitro	almost	as	efficiently	as	the	combination	of	SgrS	plus	Hfq	(11.3%	versus	2.8%,	respectively,	compared	to	control)	whilst	Hfq	alone	had	only	a	modest	effect	(60%	of	control	levels,	Figure	3.12).	The	control	gfp	mRNA	was	translated	independently	of	SgrS	or	Hfq	(Figure	3.12).	In	summary,	these	data	are	consistent	with	a	model	in	which	SgrS	base	pairs	within	the	coding	sequence	of	purR	mRNA	and	represses	translation	through	a	mechanism	requiring	the	RNA	chaperone	Hfq.		
3.2.7	Regulation	of	asd,	adiY,	folE	and	purR	by	SgrS	orthologs	
	 Orthologs	of	SgrS	are	found	in	numerous	γ-proteobacteria	such	as	
Salmonella,	Erwinia	amylovora,	Klebsiella	pneumoniae,	Citrobacter	koseri	and	
Yersinia	pestis	[94].	While	the	ability	to	regulate	some	targets,	especially	ptsG,	appears	to	be	widely	conserved	among	SgrS	orthologs	[94,	197],	regulation	of	other	targets	is	more	variable	[207,	274].	To	gain	insight	into	whether	the	new	targets	are	conserved	in	SgrS	regulons	of	diverse	organisms,	we	investigated	whether	SgrS	orthologs	could	complement	an	E.	coli	ΔsgrS	mutant	for	regulation	of	E.	coli	targets.		SgrS	orthologs	from	E.	amylovora,	K.	pneumoniae,	C.	koseri	and	Y.	pestis	were	expressed	in	E.	coli	reporter	strains.		The	asdI	reporter	was	not	regulated	by	SgrS	orthologs	from	any	species	other	than	E.	coli	(Figure	3.13A),	likely	due	to	the	fact	that	the	base	pairing	interaction	at	asd	site	I	is	not	well	conserved	(Figure	3.13B).	Predicted	native	SgrS-asd	interactions	from	enteric	species	show	limited	and	partially	disrupted	conservation	of	base	pairing	(Figure	3.13C)	suggesting	that	asd	regulation	by	SgrS	might	be	specifically	limited	to	E.	coli.		
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All	four	SgrS	orthologs	regulated	E.	coli	adiY	translation	to	varying	degrees	(Figure	3.14A).	The	native	E.	coli	SgrS-adiY	mRNA	interaction	involves	two	stretches	of	complementarity	(Figure	3.14B).	The	first	stretch	(SgrS	nucleotides	+174	to	+179)	is	highly	conserved	[94,	207,	274]	while	the	second	(nts	+165	to	+171)	is	less	conserved	(Figure	3.14B).	Although	adiY	orthologs	are	absent	from	K.	pneumoniae,	
C.	koseri,	Y.	pestis	and	E.	amylovora.	Salmonella	SgrS	does	not	show	conserved	complementarity	with	its	cognate	adiY	mRNA	(Figure	3.14C).	
	 For	folE,	Y.	pestis	and	C.	koseri	SgrS	partially	repressed	while	E.	amylovora	and	K.	pneumoniae	SgrS	failed	to	repress	translation	(Figure	3.15A),	consistent	with	patterns	of	conservation	of	interacting	regions	(Figure	3.15B).	Predicted	interactions	of	SgrS	orthologs	with	cognate	folE	mRNAs	from	Salmonella,	K.	
pneumoniae,	C.	koseri,	Y.	pestis	and	E.	amylovora	show	only	partial	conservation	of	cognate	base	pairing	interactions	(Figure	3.15C).			 The	purR	coding	sequence	is	highly	conserved	and	alignment	of	cognate	SgrS	and	purR	pairs	from	different	species	shows	similar	predicted	base	pairing	interactions	in	E.	coli,	Salmonella,	E.	amylovora,	K.	pneumoniae	and	C.	koseri	(Figure	3.16).	While	SgrS	and	purR	sequences	of	Y.	pestis	were	very	divergent,	a	potential	region	of	complementarity	was	identified	(Figure	3.16).		Collectively,	these	data	suggest	that	SgrS	regulation	of	asd,	adiY	and	folE	may	be	limited	to	E.	coli,	whereas	
purR	is	a	more	conserved	member	of	the	SgrS	regulon.		
	
3.2.8	Overexpression	of	the	new	SgrS	targets	exacerbates	glucose-phosphate	
stress	in	a	ΔppsA	mutant		 Since	SgrS	represses	each	of	the	newly	identified	targets,	we	hypothesized	that	activities	of	the	products	encoded	by	asd,	adiY,	folE	or	purR	are	detrimental	to	growth	under	glucose-phosphate	stress	conditions.		We	tested	this	hypothesis	by	ectopic	overexpression	of	adiY,	folE	and	purR	from	an	inducible	promoter	in	wild-type	and	sgrS	mutant	strains	grown	under	stress	conditions,	but	did	not	identify	any	overt	phenotypic	differences	compared	to	control	strains	(Figure	3.17A,	wild-type).	Previous	work	from	our	laboratory	implicated	depletion	of	glycolytic	intermediates	
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as	an	important	cause	of	growth	inhibition	of	sgrS	mutants	exposed	to	glucose-phosphate	stress	conditions.		Supplementation	of	glycolytic	intermediates	rescued	the	growth	defect	of	an	sgrS	mutant	exposed	to	αMG	[208].		Overproduction	of	PEP	synthase	(encoded	by	ppsA)	likewise	ameliorated	growth	inhibition	of	an	sgrS	mutant	during	αMG-induced	stress	[208],	specifically	implicating	PEP	as	being	limiting	for	growth	under	stress	conditions.	Therefore,	we	reasoned	that	ppsA	mutants	might	be	more	vulnerable	to	depletion	of	PEP	under	stress	conditions.	It	follows	that	if	SgrS	regulation	of	the	newly	identified	targets	modulates	metabolism	in	a	way	that	alleviates	PEP	depletion,	we	might	see	phenotypes	associated	with	these	targets	specifically	in	a	ppsA	mutant	background.	Thus,	we	ectopically	expressed	adiY,	folE	and	purR	in	wild-type	and	ΔppsA	strains	and	monitored	growth	on	glycerol	minimal	plates	supplemented	with	glucose	analogs	αMG	or	2DG	to	induce	glucose-phosphate	stress.	Ectopic	expression	of	any	of	the	three	genes	in	the	absence	of	stressors	did	not	affect	growth	and	was	similar	to	uninduced	controls	(Figure	3.17A).	The	ΔppsA	mutant	strain	carrying	the	vector	control	was	more	sensitive	to	stress	caused	by	αMG	at	an	early	time	point	(Figure	3.17A,	40	hr),	but	after	72	hours	of	growth,	the	ΔppsA	strain	with	vector	had	grown	to	levels	similar	to	the	wild-type	strain.		Notably,	the	ΔppsA	strain	overexpressing	folE	was	strongly	growth	inhibited	compared	to	the	ppsA	mutant	carrying	the	vector	control	when	growing	in	the	presence	of	either	αMG	or	2DG	(Figure	3.17A).	The	ΔppsA	strain	overexpressing	adiY	or	purR	grew	similarly	to	the	control	on	plates	with	αMG	(Figure	3.17A),	but	in	the	presence	of	2DG,	particularly	at	40	hours,	adiY-	and	purR-overexpressing	cells	were	strongly	growth	inhibited	compared	to	the	control	(Figure	3.17A).		Similarly,	we	ectopically	expressed	asd	in	wild-type	and	ΔppsA	strains	growing	in	minimal	fructose	medium	supplemented	with	αMG	to	induce	glucose-phosphate	stress.	(We	used	fructose	as	the	sole	carbon	source	because	strains	were	sensitive	to	ectopically	expressed	asd	when	cultured	in	minimal	glycerol	medium	even	without	induction	of	stress.)	In	the	absence	of	stress,	strains	overexpressing	
asd	had	a	slightly	slower	growth	rate	compared	to	vector	control	strains,	but	
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reached	a	similar	final	density	(Figure	3.17B).	When	cells	were	stressed	by	addition	of	αMG,	the	growth	of	the	ΔppsA	mutant	expressing	asd	was	strongly	inhibited	for	several	hours,	in	contrast	with	other	strains	that	all	grew	similarly	well	(Figure	3.17C).	To	summarize,	asd,	adiY,	folE	and	purR	overexpression	renders	a	ΔppsA	mutant	more	sensitive	to	glucose-phosphate	stress.		These	observations	are	consistent	with	our	hypothesis	that	SgrS-mediated	repression	of	these	genes	modulates	metabolism	in	a	way	that	improves	growth	during	stress	conditions.		 		
3.3	Discussion		 Bacterial	sRNAs	have	been	shown	to	regulate	numerous	genes	via	short	discontinuous	stretches	of	base	pairing.		SgrS	has	served	as	a	valuable	model	system	to	study	target	regulation	by	sRNAs	in	enteric	bacteria	such	as	E.	coli	and	
Salmonella.	Prior	to	our	study,	E.	coli	SgrS	was	known	to	directly	regulate	three	mRNAs:	ptsG,	manXYZ	and	yigL	[196,	207,	267].	In	addition	to	these	targets,	in	
Salmonella,	SgrS	negatively	regulates	the	Salmonella-specific	sopD	mRNA,	encoding	a	secreted	virulence	effector	protein	[195].	Here,	we	substantially	expand	the	SgrS	regulon	by	defining	asd,	adiY,	folE	and	purR	as	direct	targets	of	E.	coli	SgrS	(Figures	3.3-3.12).	
	 In	this	study,	we	show	that	pulse	expression	of	SgrS	(in	the	absence	of	stress)	yields	a	narrow	spectrum	of	changes	in	gene	expression.		In	addition	to	affecting	known	targets	(ptsG,	manXYZ	and	yigL)	and	newly	identified	targets	(asd,	adiY,	folE	and	purR),	SgrS	pulse	expression	also	altered	levels	of	mRNAs	encoding	functions	involved	in	metal	homeostasis	(zinc-related	genes	zinT	and	znuABC	and	copper	homeostasis	genes	cusF	and	cusC),	predicted	transporters	(nepI,	ydjN)	and	poorly	characterized	genes	(yeeD,	pliG,	yeiB,	yebA,	ykgM)	(Table	3.1).	Though	RT-qPCR	confirmed	the	SgrS-dependent	changes	in	mRNA	levels	for	the	majority	of	these	genes,	further	analysis	indicated	that	the	effects	were	not	post-transcriptional	(Figure	3.2A),	suggesting	that	these	mRNAs	are	not	direct	targets	of	SgrS.	To	facilitate	efforts	to	better	predict	direct	SgrS	targets	in	future	searches,	we	elucidated	an	SgrS-recognition	motif	based	on	the	known	SgrS	base	pairing	sites.	
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The	multiple	Em	for	motif	elicitation	tool	(MEME)	[7]	was	used	to	align	ptsG,	manX,	
manY,	yigL,	asd	(sites	I	and	II),	adiY,	folE	and	purR	SgrS	binding	sites	(Figure	3.18A).	The	consensus	SgrS	binding	site	based	on	these	targets	is	G/C-rich	and	contains	a	prominent	5'-ACRCA-3'	motif	(Figure	3.18B),	which	is	complementary	with	two	sites	on	SgrS.	The	first	SgrS	site	comprises	a	5'-UGAGU-3'	sequence	at	positions	+175	to	+179,	and	includes	two	nucleotides	(G176	and	G178)	shown	to	be	crucial	for	regulation	of	ptsG	mRNA	[114,	275].	The	second	SgrS	site	contains	the	5'-UGUGU-3'	sequence	responsible	for	interaction	with	manX	mRNA,	where	G168	and	G170	are	crucial	for	regulation	of	this	target	[207].	Identifying	the	5'-ACRCA-3'	motif	in	other	mRNAs	that	are	differentially	expressed	in	response	to	SgrS	production	might	improve	prediction	of	additional	members	of	the	SgrS	regulon.		 Our	analyses	of	the	new	SgrS	targets	revealed	diversity	in	the	mechanisms	SgrS	employs	to	post-transcriptionally	regulate	asd,	adiY,	folE	and	purR.	In	the	common	mode	of	sRNA-mediated	repression,	SgrS	base	pairs	within	the	5’	UTR	of	
asd,	adiY	and	folE,	occluding	the	RBS,	which	interferes	with	translation	initiation.	Optimal	repression	of	asd,	however,	involves	an	additional	SgrS	interaction	with	a	binding	site	in	the	coding	sequence	of	asd.	We	note	that	SgrS	pairs	at	two	distinct	sites	on	another	target,	manXYZ	mRNA,	and	that	pairing	at	both	sites	is	required	to	promote	degradation	of	manXYZ	mRNA	and	increase	the	stringency	of	regulation	[206].	It	remains	possible	that	the	two	SgrS	binding	sites	on	asd	play	a	similar	role	in	promoting	asd	mRNA	degradation,	or	that	another	step	of	regulation	is	affected	by	the	involvement	of	two	binding	sites.	In	both	cases,	manXYZ	and	asd,	further	work	will	be	required	to	elucidate	the	molecular	mechanism	of	SgrS-mediated	regulation	via	binding	at	two	sites.		The	SgrS	binding	site	within	the	purR	coding	sequence	is	too	far	downstream	of	the	translation	initiation	region	to	directly	occlude	ribosome	binding.	Instead,	we	hypothesize	that	SgrS	indirectly	represses	translation	of	purR	by	a	‘role	reversal’	with	Hfq,	similar	to	the	mechanism	defined	for	Spot	42-dependent	regulation	of	
sdhC	mRNA	[57].	Spot	42	pairs	upstream	of	the	sdhC	RBS	and	cannot	directly	interfere	with	the	ribosome	binding,	while	recruiting	Hfq	effectively	blocks	translation	initiation.	Unlike	canonical	mechanisms	where	the	sRNA	directly	inhibits	
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translation,	it	can	also	play	a	chaperone	role	of	providing	target	specificity	for	Hfq	[57].	Our	in	vitro	translation	analyses	show	that	SgrS	is	sufficient	for	repression	of	a	target	known	to	be	regulated	by	direct	ribosome	occlusion	(Figure	3.12,	PtsG-FLAG),	whereas	for	purR,	Hfq	alone	can	repress	translation	while	SgrS	alone	has	a	very	modest	effect	(Figure	3.12,	PurR-FLAG).	Our	data	are	consistent	with	a	model	where	SgrS,	purR	mRNA	and	Hfq	form	a	nucleoprotein	complex,	and	that	SgrS	promotes	binding	of	Hfq	in	the	translation	initiation	region	where	it	can	directly	interfere	with	ribosome	binding.	Combined	with	published	work	[114,	195,	196,	206,	207,	267],	our	results	add	to	the	already	impressive	variety	of	mechanisms	SgrS	employs	to	regulate	target	genes.				 Although	it	is	clear	that	SgrS	represses	translation	of	each	of	the	newly	identified	targets	by	base	pairing-dependent	mechanisms,	the	underlying	physiological	roles	for	these	repression	events	is	not	precisely	clear.		The	four	new	targets	encode	enzymes	(asd,	folE)	or	regulators	(adiY,	purR)	of	diverse	metabolic	pathways.	We	show	that	aberrant	overexpression	of	each	of	them	yields	stress-dependent	growth	defects	of	varying	severity,	specifically	in	a	host	compromised	for	PEP	synthesis	from	pyruvate	(ppsA	mutant,	Figure	3.17).		Since	our	previous	work	implicates	depletion	of	glycolytic	intermediates	(particularly	PEP)	as	an	important	cause	of	growth	inhibition	during	stress	[208],	we	posit	that	SgrS-mediated	regulation	of	these	new	targets	modifies	metabolism	to	promote	replenishment	of	one	or	more	limiting	metabolites,	possibly	PEP	or	other	glycolytic	intermediates	that	can	be	synthesized	from	PEP.		 One	way	to	replenish	the	pool	of	PEP	is	through	PpsA,	which	uses	pyruvate	as	a	substrate	(Figure	3.19).	Mutants	lacking	ppsA	are	indeed	more	susceptible	to	growth	inhibition	due	to	accumulation	of	non-metabolizable	glucose	analogs	[124].	Alternative	to	the	PpsA	pathway,	PEP	carboxykinase	(Pck)	can	produce	PEP	from	oxaloacetate	(OAA),	a	TCA	cycle	intermediate	(Figure	3.19).	Aspartate	can	be	converted	to	OAA	by	the	enzyme	aspartate	transaminase	(AspC),	linking	aspartate	metabolism	to	glycolysis	(Figure	3.19).	Moreover,	supplementing	aspartate	in	the	growth	medium	can	partially	relieve	the	glucose-phosphate	stress-related	growth	defect	of	a	ppsA	mutant	strain	[124].	Previous	analysis	of	carbon	metabolism	in	E.	
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coli	indicates	that	OAA	to	PEP	conversion	is	important	in	the	strain	defective	in	PTS-mediated	sugar	transport.	Specifically,	carbon	flux	through	Pck	was	shown	to	respond	to	changes	in	PEP	availability	in	the	cell	[69].	Pck	was	also	suggested	to	stimulate	glycolytic	flux	under	the	conditions	of	reduced	carbon	flux	due	to	defects	in	PTS	[165].	We	hypothesize	that	SgrS	regulation	of	asd	expression	might	increase	the	pool	of	available	aspartate	that	can	be	converted	by	AspC	to	OAA,	which	is	then	used	by	Pck	to	replenish	PEP	(Figure	3.19).	Accordingly,	our	results	demonstrate	that	ectopic	expression	of	asd	in	glucose-phosphate	stress-sensitive	strain	(ΔppsA	mutant	strain)	is	growth	inhibitory	(Figure	3.17B,	C).				 The	adiY	gene	encodes	a	regulator	that	activates	transcription	of	adiA,	encoding	an	arginine	decarboxylase	involved	in	arginine-dependent	acid	resistance.	AdiA	converts	arginine	to	agmatine	and	in	the	process	consumes	intracellular	protons,	which	helps	to	raise	cytosolic	pH.	Agmatine	is	then	exchanged	for	an	additional	arginine	from	the	environment	by	a	symporter	AdiC	[36].	Interestingly,	AdiY	is	only	active	under	anaerobic	conditions	[246].	The	arginine	decarboxylase	used	for	biosynthesis	under	aerobic	conditions	is	encoded	by	speA,	and	we	note	that	SgrS	had	no	effect	on	speA	mRNA	levels	in	pulse	expression	experiments	(Table	3.1).		This	suggests	that	perhaps	the	role	of	SgrS	in	modulating	the	arginine	decarboxylase	pathway	(through	adiY	regulation	and	indirect	effects	on	adiA)	may	not	be	physiologically	relevant	under	our	particular	(aerobic)	stress	conditions.		We	have	not	explored	the	nature	of	glucose-phosphate	stress	or	SgrS-dependent	phenotypes	under	anaerobic	conditions,	thus	we	cannot	speculate	further	on	a	possible	rationale	for	SgrS-mediated	regulation	of	adiY	under	these	conditions.				 On	the	whole,	members	of	the	SgrS	target	regulon	are	functionally	quite	diverse.		Our	previous	studies	clearly	demonstrate	that	the	physiological	importance	of	regulation	of	particular	SgrS	targets	is	variable	and	depends	on	the	specific	growth	conditions.	Regulation	of	ptsG	alone	is	sufficient	to	rescue	growth	in	the	presence	of	αMG	when	cells	are	growing	in	rich	medium	(LB),	but	in	minimal	media,	stress	results	in	more	pronounced	growth	inhibition	that	cannot	be	rescued	by	regulation	of	ptsG	alone.	Instead,	when	cells	are	growing	in	nutrient-poor	minimal	media	and	stressed	by	exposure	to	αMG,	SgrS-mediated	repression	of	ptsG	and	
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activation	of	yigL	is	necessary,	but	not	sufficient	for	full	growth	rescue	[252].	In	contrast,	regulation	of	ptsG	and	yigL	is	dispensable	when	cells	are	stressed	by	another	glucose	analog,	2DG	(2-deoxy	glucose).	SgrS-mediated	regulation	of	
manXYZ	is	required	for	growth	rescue	in	the	presence	of	2DG	[207].	We	postulate	that	SgrS-mediated	regulation	of	newly	characterized	targets	asd,	adiY,	folE	and	
purR	may	be	required	only	under	specific	conditions	that	we	have	not	yet	defined.	Based	on	the	observations	that	overexpression	of	these	targets	is	detrimental	specifically	in	stressed	cells	in	a	host	background	with	compromised	PEP	metabolism,	we	predict	that	modulation	of	these	targets	by	SgrS	will	be	most	important	under	stress	conditions	that	put	a	severe	strain	on	metabolic	flux.	Regulation	of	asd,	adiY,	folE	and	purR	under	such	conditions	could	help	restore	metabolic	homeostasis.		 Although	SgrS	is	conserved	among	enteric	bacteria,	the	diversity	of	its	target	regulon	is	evident.	In	Salmonella,	in	addition	to	ptsG,	manXYZ	and	yigL,	the	sopD	mRNA	is	repressed	by	SgrS	[195].		The	sopD	gene	is	encoded	on	a	Salmonella	pathogenicity	island,	so	this	target	is	only	part	of	the	Salmonella	SgrS	regulon.	Species-specific	regulation	by	SgrS	is	also	highlighted	by	the	finding	that	Erwinia	and	Yersinia	SgrS	orthologs	do	not	regulate	their	cognate	manXYZ	orthologs	[207].	Current	evidence	suggests	that	SgrS	and	other	base	pairing-dependent	sRNA	regulators	evolved	as	a	result	of	establishing	a	regulatory	interaction	with	one	primary	target	mRNA,	while	additional	targets	in	the	regulon	adopted	sequences	complementary	to	the	sRNA	allowing	their	regulation	[197].	Considering	SgrS	conservation	and	distribution	among	γ-proteobacteria	suggest	a	fairly	ancient	origin	of	this	sRNA	[94,	234],	it	is	conceivable	that	different	sets	of	genes	in	different	organisms,	sometimes	including	horizontally	acquired	genes	like	Salmonella	sopD	[195],	evolved	binding	sites	and	established	regulatory	relationships	with	SgrS.	The	present	study	shows	that	E.	coli	SgrS	regulates	adiY,	which	is	not	conserved	among	other	enteric	species	(Figure	3.14C),	and	thus	represents	an	E.	coli-specific	target	of	SgrS.		Regulation	of	asd,	folE	and	purR	also	appears	to	be	narrowly	distributed	phylogenetically,	as	SgrS	orthologs	have	only	partially	conserved	base	pairing	interactions	with	their	cognate	asd,	folE	and	purR	mRNAs	(Figures	3.13C,	3.15C,	
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3.16).	Full	elucidation	of	SgrS	regulons	in	diverse	organisms	will	help	us	understand	how	target	regulons	evolve	along	with	their	sRNA	regulator,	and	shed	light	on	roles	played	by	SgrS	in	helping	enteric	bacteria	cope	with	stresses	that	they	experience	in	their	specific	environmental	niches.		 It	is	evident	that	glucose-phosphate	stress	alters	cellular	metabolic	balance,	which	results	in	a	plethora	of	changes	in	the	gene	expression.	Glycolysis	is	a	central	metabolic	pathway	that	provides	intermediates	for	biosynthesis	of	numerous	cellular	macromolecules	and	also	generates	energy	by	substrate-level	phosphorylation.	Imbalanced	glycolytic	metabolism	thus	has	potentially	very	broad	impacts	not	only	locally,	but	also	systemically.	Our	previous	work	demonstrates	that	SgrS	plays	a	central	role	in	recovery	from	glucose-phosphate	stress	by	reducing	uptake	of	non-metabolizable	sugars	through	repression	of	genes	encoding	sugar	transporters	[207,	267]	and	enhancing	efflux	of	sugars	via	activating	a	phosphatase	whose	activity	is	a	prerequisite	for	efflux	of	sugars	[196].	Our	current	work	demonstrates	that	the	effects	of	SgrS	extend	beyond	regulation	of	sugar	uptake	and	efflux	and	imply	that	SgrS	regulation	of	diverse	metabolic	pathways	may	contribute	to	the	stress	response	under	some	circumstances.	We	hypothesize	that	SgrS-dependent	regulation	of	the	newly	described	targets	asd,	adiY,	folE	and	purR	mRNAs	helps	restore	metabolic	homeostasis	in	order	to	promote	recovery	from	glucose-phosphate	stress.		
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3.4	Tables	and	Figures	
	
Gene	
Name	 Product	Description	
Fold-change	
Plac-
sgrS/vector	
qValue	
Post-
transcriptional	
Regulation	
sgrT	 inhibitor	of	glucose	uptake	 215.00	 0	 	
sgrS	 sRNA	regulator	of	glucose-phosphate	stress	response	 191.68	 0	 	
zinT	 zinc	and	cadmium	binding	protein,	periplasmic	 15.88	 0	 NR	
cusF	 periplasmic	copper-	and	silver-binding	protein	 0.08	 0	 NR	
ptsG	 fused	glucose-specific	PTS	enzymes:	IIB	component/IIC	component	 0.07	 0	 Rep	
cusC	 copper/silver	efflux	system,	outer	membrane	component	 0.01	 0	 	
ykgM	 rpmE	(L31)	paralog	 4.58	 9.77E-163	 NR	
ykgO	 rpmJ	(L36)	paralog	 3.90	 2.37E-113	 NR	
znuA	 zinc	transporter	subunit:	periplasmic-binding	component	of	ABC	superfamily	 3.80	 1.10E-70	 NR	
yebA	 predicted	peptidase	 2.47	 1.17E-27	 NR	
yeiB	 predicted	inner	membrane	protein	(in	operon	with	folE)	0.51	 3.78E-17	 	
pliG	 predicted	protein	 2.25	 1.85E-16	 NR	
asd	 aspartate-semialdehyde	dehydrogenase,	NAD(P)-binding	 0.51	 2.54E-15	 Rep	
purR	 DNA-binding	transcriptional	repressor,	hypoxanthine-binding	 0.54	 2.77E-12	 Rep	
yeeD	 conserved	protein	(in	operon	with	yeeE)	 0.58	 2.97E-11	 NR	
manX	 fused	mannose-specific	PTS	enzymes:	IIA	component/IIB	component	 0.60	 9.89E-10	 Rep	
znuB	 zinc	transporter	subunit:	membrane	component	of	ABC	superfamily	 2.05	 1.43E-09	 	
yigL	 sugar	phosphatase	 1.77	 9.19E-09	 Act	
znuC	 zinc	transporter	subunit:	ATP-binding	component	of	ABC	superfamily	 1.86	 1.47E-07	 NR	
folE	 GTP	cyclohydrolase	I	 0.54	 7.25E-07	 Rep	
ydjN	 predicted	transporter	 0.56	 2.25E-06	 NR	
malK	 fused	maltose	transport	subunit,	ATP-binding	component	of	ABC	superfamily	 1.57	 1.41E-04	 NR	
mglB	 methyl-galactoside	transporter	subunit	 1.62	 2.48E-03	 NR	
	
Table	3.1	Differential	gene	expression	after	SgrS	pulse	expression.	E.	coli	CV104	(ΔsgrS)	carrying	vector	or	Plac-sgrS	plasmid	was	grown	in	defined	MOPS	rich	medium	with	0.2%	glucose	to	OD600~0.5.	Total	RNA	was	extracted	10	minutes	after	addition	of	0.1	mM	IPTG.	RNA-Seq	was	performed	and	data	analyzed	using	Rockhopper	[161].	Genes	with	≥1.5-fold	change	in	expression	(Plac-sgrS/vector)	and	statistical	significance	of	<1x10-2	(qValue)	are	shown.	Increase	in	expression	is	indicated	by	fold-change	>1	and	decrease	in	expression	is	indicated	by	fold-change	<1.	Post-transcriptional	regulation	is	characterized	as	translationally	activated	(Act),	translationally	repressed	(Rep),	not	regulated	(NR).					
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Figure	3.1	Abundance	of	putative	mRNA	targets	of	SgrS.	E.	coli	strain	CV104	(ΔsgrS)	carrying	vector	or	Plac-sgrS	plasmid	was	grown	(A)	with	and	(B)	without	shaking	in	defined	MOPS	rich	medium	with	0.2%	glucose	to	OD600~0.5.	Total	RNA	was	extracted	10	minutes	after	addition	of	0.1	mM	IPTG	to	induce	SgrS	expression.	Gene	specific	primers	were	used	to	determine	relative	transcript	abundance	with	RT-qPCR.	Levels	of	mRNA	were	normalized	to	a	housekeeping	gene	rrsA	encoding	16S	rRNA	in	E.	coli.	Error	bars	represent	standard	error	for	at	least	three	biological	replicates.																
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Figure	3.2	Post-transcriptional	regulation	of	putative	SgrS	targets.	A)	Translational	fusions	to	lacZ	(controlled	by	PBAD	promoter)	were	constructed	for	the	indicated	genes.	Reporter	strains	carrying	vector	or	Plac-sgrS	plasmid	were	grown	in	TB	medium	with	0.002%	L-arabinose	to	early	exponential	phase	and	0.1	mM	IPTG	added	to	induce	SgrS	expression.	β-galactosidase	activity	of	the	reporter	fusion	assayed	at	OD600~0.5-0.6.	The	vertical	dotted	line	indicates	2-fold	change	in	expression.	Error	bars	represent	standard	error	for	at	least	three	independent	biological	replicates.	B)	E.	coli	carrying	plasmids	with	Ptet-sgrS	and	target	translational	fusions	to	gfp	reporter	under	the	control	of	the	Plac	promoter	were	cultured	in	MOPS	rich	medium	with	0.2%	fructose	to	mid-log	phase.	Relative	fluorescence	units	(RFU)	of	GFP	and	optical	density	(OD600)	were	measured.		Activity	in	SgrS-expressing	strains	was	normalized	to	activity	in	control	strains.	Error	bars	represent	standard	error	for	at	least	three	biological	replicates.			
	
Figure	3.3	SgrS-dependent	destabilization	of	asd	mRNA	during	glucose	
phosphate	stress	response.	E.	coli	strains	Cp19-asd	(MB4),	Cp19-asd	ΔsgrS	(MB7)	and	Cp19-asd	ΔsgrS	with	Plac-sgrS	plasmid	(MB7	pLCV1)	were	grown	in	LB	medium	to	OD~0.4.	Total	RNA	was	extracted	at	t=0,	10,	20	min.	after	addition	of	0.5%	αMG	or	0.1	mM	IPTG.	Levels	of	asd	mRNA	were	detected	by	northern	blot.		
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Figure	3.4	Interaction	of	SgrS	with	asd	mRNA	in	vitro.	Full	length	SgrS	(+1	to	+227	nt),	and	partial	asd	(+1	to	+179	nt)	transcripts	were	synthesized	by	in	vitro	transcription.	Labeled	SgrS	(0.1	pmol)	(or	labeled	asd	(0.1	pmol)	in	the	first	gel	of	panel)	and	unlabeled	asd	mRNA	(20	or	100	pmol)	were	denatured	at	95°C	and	hybridized	on	ice	for	5	min,	than	placed	in	hybridization	buffer	for	30	min	at	37°C.	Hybridized	samples	were	mixed	with	non-denaturing	loading	buffer	and	resolved	with	native	5.6%	PAGE.		
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Figure	3.5	SgrS	interacts	with	two	distinct	sites	on	asd	mRNA.	In	vitro	transcribed	full	length	SgrS	and	asd	mRNA	fragments	were	generated	using	T7	RNA	polymerase	and	labeled	at	the	5’	end	with	32P	radioisotope	(asd*	and	SgrS*).	Labeled	RNA	was	hybridized	with	unlabeled	SgrS	or	asd	as	indicated,	treated	with	RNase	T1,	alkaline	hydrolysis	(OH)	or	lead	acetate	(PbAc),	and	resolved	on	denaturing	SDS	PAGE.	Positions	of	G	residues	are	labeled.	Footprint	analysis	indicates	A)	asd-specific	protection	(lighter	banding	pattern)	of	SgrS,	B)	SgrS-specific	protection	in	the	asd	mRNA	leader	(Site	I)	and	C)	SgrS-specific	protection	in	the	asd	mRNA	coding	sequence	(Site	II).	Representation	of	SgrS	base	pairing	at	two	sites:	D)	asd	mRNA	leader	(Site	I)	and	E)	asd	mRNA	coding	sequence	(Site	II).	Sequences	highlighted	in	blue,	green	and	red	respectively	correspond	to	Site	I,	Site	II	and	asd	protection	observed	in	the	footprinting	experiments	(A-C).		
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Figure	3.6	Characterization	of	SgrS	base	pairing	with	asd	mRNA.	A)	Diagram	of	
asdI-II,	asdI	and	asdII	with	locations	of	SgrS	binding	Sites	I	and	II	B)	β-galactosidase	activity	of	translational	asdI-II-lacZ,	asdI-lacZ	and	asdII-lacZ	reporter	fusions	was	tested	in	the	presence	and	absence	of	SgrS	in	wild-type	and	rne131	hosts	as	indicated.	Mutations	in	asd	(asd30-I,	asd32-I)	disrupt	complementarity	with	SgrS.	Compensatory	mutations	in	SgrS	(SgrS30,	SgrS32)	restore	complementarity.													
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Figure	3.7	Characterization	of	post-transcriptional	regulation	of	adiY	by	SgrS.	A)	E.	coli	strains	Cp19-adiY,	Cp19-adiY	ΔsgrS	and	Cp19-adiY	ΔsgrS/Plac-sgrS	(Table	S2)	were	grown	in	LB	to	OD~0.4.	RNA	was	extracted	at	0,	5	and	15	minutes	after	addition	of	0.5%	αMG	or	0.1	mM	IPTG.	adiY	mRNA	was	detected	by	Northern	blot.	B)	In	vitro	transcribed	full	length	SgrS	and	adiY	mRNA	fragments	were	generated.	5´	end-labeled	adiY	mRNA	(adiY*)	was	hybridized	with	unlabeled	SgrS	where	noted	and	treated	with	RNase	T1,	alkaline	hydrolysis	(OH)	or	lead	acetate	(Pb	(II)),	and	resolved	on	denaturing	SDS	PAGE.	The	positions	of	G	residues	are	indicated.	C)	Predicted	base	pairing	of	SgrS	with	adiY	mRNA;	adiY1	and	adiY33	alleles	contain	mutations	indicated	in	red;	SgrS33	contains	the	indicated	(red)	compensatory	mutation	that	restores	complementarity	to	adiY33.	Vertical	lines	represent	predicted	Watson-Crick	(G:C,	A:U)	base-pairing	and	two	dots	represent	non-canonical	(G:U)	interactions.	D)	E.	coli	ΔsgrS	and	ΔsgrS	rne131	strains	carrying	plasmids	with	Plac-adiY´-´gfp,	Plac-adiY1´-´gfp	or	Plac-adiY33´-´gfp	and	Ptet-sgrS	or	Ptet-
sgrS33	were	grown	in	rich	MOPS	medium	with	0.2%	fructose	to	exponential	phase	in	the	presence	of	the	appropriate	inducers.	Relative	fluorescence	units	(RFU)	of	GFP	and	optical	density	(OD600)	were	measured.	Activity	in	SgrS	expressing	strain	was	normalized	to	activity	of	the	vector	control	strain.		
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Figure	3.8	Interaction	of	SgrS	with	asd,	adiY	and	folE	mRNAs	in	vitro.	Full	length	SgrS	(+1	to	+227	nt),	and	partial	adiY	(+1	to	+233	nt)	or	folE	(+112	to	+300)	transcripts	were	synthesized	by	in	vitro	transcription.	Labeled	SgrS	(0.1	pmol)	and	unlabeled	adiY	or	folE	mRNAs	(20	or	100	pmol)	were	denatured	at	95°C	and	hybridized	on	ice	for	5	min,	than	placed	in	hybridization	buffer	for	30	min	at	37°C.	Hybridized	samples	were	mixed	with	non-denaturing	loading	buffer	and	resolved	with	native	5.6%	PAGE.				
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Figure	3.9	Characterization	of	post-transcriptional	regulation	of	folE	by	SgrS.	A)	E.	coli	strains	Cp19-folE	and	Cp19-folE	ΔsgrS	were	cultured	to	OD600~0.4	in	LB	medium.	Total	RNA	was	extracted	0,	10,	or	20	min.	after	addition	of	0.5%	αMG	and	
folE	mRNA	detected	by	Northern	blot.	B)	Truncated	folE	of	different	length	used	to	construct	folE-long´-´lacZ	and	folE-short´-´lacZ	reporter	fusions.	C)	β-galactosidase	activity	of	translational	folE-long´-´lacZ	and	folE-short´-´lacZ	reporter	fusions	in	the	presence	or	absence	of	SgrS	alleles.	Fusion	folE32-short	contains	mutations	that	restore	complementarity	with	SgrS32	(shown	in	D).	Error	bars	represent	standard	error	for	at	least	three	biological	replicates.	D)	Predicted	SgrS-folE	mRNA	base	pairing.	Mutations	corresponding	to	folE32,	SgrS30	and	SgrS32	are	marked	in	red.	The	folE	RBS	is	underlined.	Vertical	lines	represent	predicted	Watson-Crick	(G:C,	A:U)	base-pairing.	E)	E.	coli	ΔsgrS	and	ΔsgrS	rne131	with	folE´-´gfp	and	vector	control	or	Ptet-sgrS	plasmids	were	grown	in	rich	MOPS	medium	with	0.2%	fructose	to	exponential	phase	in	the	presence	of	appropriate	inducers.	Relative	fluorescence	units	(RFU)	of	GFP	and	optical	density	(OD600)	were	measured.	Activity	in	strains	expressing	SgrS	was	normalized	to	activity	of	the	corresponding	vector	control	strain.	Error	bars	represent	standard	error	for	at	least	three	biological	replicates.		
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Figure	3.10	Characterization	of	post-transcriptional	regulation	of	purR	by	
SgrS.	A)	Limits	of	purR	fragments	that	were	used	for	gel	shift	assays	(B)	and	translational	fusions	(C).	B)	Full	length	SgrS	and	truncated	purR	transcripts	were	synthesized	in	vitro.	5´-end	labeled	SgrS	(SgrS*)	and	increasing	concentrations	of	unlabeled	purR-short,	purR-medium	and	purR-long	RNAs	were	hybridized	and	resolved	on	native	PAGE.	C)	β-galactosidase	activity	of	indicated	purR	translational	reporter	fusions	was	tested	in	the	absence	or	presence	of	SgrS	alleles.	The	sequences	of	wild-type	and	mutant	SgrS	and	purR	are	indicated	in	D.	Compensatory	mutations	purR30	and	purR31	restore	base	pairing	with	SgrS30	and	SgrS31	mutants,	respectively.	Error	bars	represent	standard	error	for	at	least	three	biological	replicates.	D)	Predicted	SgrS-purR	mRNA	base	pairing	interactions.	Mutations	corresponding	to	purR30,	purR31	and	SgrS30,	SgrS31	are	indicated	in	red.	Vertical	lines	represent	predicted	Watson-Crick	(G:C,	A:U)	base	pairing	and	two	dots	represent	noncanonical	(G:U)	interactions.							
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Figure	3.11	Characterization	of	purR	stability	in	response	to	glucose-
phosphate	stress.	E.	coli	strains	Cp19-purR	(MB105),	Cp19-purR	ΔsgrS	(MB106),	Cp19-purR	ΔsgrS/Vector	(MB106/pHDB3)	and	Cp19-purR	ΔsgrS/Plac-sgrS	(MB106/pLCV1)	were	grown	in	LB	to	OD~0.4.	RNA	was	extracted	at	0,	10	and	20	min.	after	addition	of	0.5%	αMG	or	0.1	mM	IPTG.	purR,	ssrA	(loading	control)	mRNAs	and	SgrS	sRNA	were	detected	by	Northern	blot.																			
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Figure	3.12	Inhibition	of	purR	translation	by	SgrS.	In	vitro	transcription	generated	purR-3xFLAG,	ptsG-3xFLAG,	gfp	and	SgrS	RNAs.	purR	and	ptsG	RNAs	were	mixed	with	SgrS	in	the	presence	or	absence	of	Hfq	and	in	vitro	translation	was	performed.	Control	gfp	RNA	was	supplemented	in	each	reaction.	Products	of	translation	were	detected	by	western	blot	with	anti-FLAG	or	anti-GFP	antibodies.	Bend	densities	were	measured	using	ImageJ	and	normalized	to	GFP	controls.																									
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Figure	3.13	
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Figure	3.13	Characterization	of	post-transcriptional	regulation	of	asd	by	SgrS	
orthologs	from	enteric	bacteria.	A)	ΔsgrS	E.	coli	strain	(JH111)	harboring	asdI´-
´gfp	(pZEMB26)	and	plasmids	with	SgrS	from:	E.	coli	(Ec;	pZAMB1),	Y.	pestis	(Yp;	pZAMB4),	E.	amylovora	(Ea;	pZAMB5),	K.	pneumoniae	(Kp;	pZAMB6)	and	C.	koseri	(Ck;	pZAMB7)	were	grown	in	rich	MOPS	medium	with	0.2%	fructose.	GFP	fluorescence	(RFU)	and	optical	density	(OD600)	were	measured	and	normalized	to	controls.	B)	Predicted	base	pairing	of	E.	coli	asd	with	SgrS	orthologs	from	E.	coli	(Ec),	
Y.	pestis	(Yp),	E.	karotovora	(Ek),	K.	pneumoniae	(Kp),	C.	koseri	(Ck).	C)	Predicted	base	pairing	between	SgrS	orthologs	and	cognate	asd	mRNA	from	enteric	bacteria.	
E.	coli	asd	RBS	is	underlined	and	highly	conserved	SgrS	sequence	is	highlighted	in	blue.	Vertical	lines	represent	predicted	Watson-Crick	(G:C,	A:U)	base	pairing	and	two	dots	represent	non-canonical	(G:U)	interactions.		
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Figure	3.14	Characterization	of	post-transcriptional	regulation	of	adiY	by	SgrS	
orthologs	from	enteric	bacteria.	A)	ΔsgrS	E.	coli	strain	(JH111)	harboring	adiY´-
´gfp	(pZEMB18)	and	plasmids	with	SgrS	from:	E.	coli	(Ec;	pZAMB1),	Y.	pestis	(Yp;	pZAMB4),	E.	amylovora	(Ea;	pZAMB5),	K.	pneumoniae	(Kp;	pZAMB6)	and	C.	koseri	(Ck;	pZAMB7)	were	grown	in	rich	MOPS	medium	with	0.2%	fructose.	Activity	is	reported	as	GFP	fluorescence	(RFU)	normalized	to	optical	density	(OD600);	activities	in	strains	carrying	SgrS	were	normalized	to	the	vector	control.	B)	Predicted	base	pairing	between	SgrS	orthologs	and	E.	coli	adiY	mRNA.	Species	names	are	shown	as	subscripts	and	abbreviated	as	in	(A).	C)	Predicted	base	pairing	between	SgrS	orthologs	and	cognate	adiY	mRNA	from	enteric	bacteria.	Vertical	lines	represent	predicted	Watson-Crick	(G:C,	A:U)	base-pairing	and	two	dots	represent	non-canonical	(G:U)	interactions.	The	highly	conserved	region	of	SgrS	is	highlighted	in	blue.	The	underlined	adiY	sequences	correspond	to	the	predicted	RBS	and	the	AUG	start	codon	is	indicated	in	green.																				
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Figure	3.15	Characterization	of	post-transcriptional	regulation	of	folE	by	SgrS	
orthologs	from	enteric	bacteria.	A)	E.	coli	ΔsgrS	(JH111)	strain	harboring	folE´-
´gfp	(pZEMB22)	and	plasmids	with	SgrS	from:	E.	coli	(Ec;	pZAMB1),	Y.	pestis	(Yp;	pZAMB4),	E.	amylovora	(Ea;	pZAMB5),	K.	pneumoniae	(Kp;	pZAMB6)	and	C.	koseri	(Ck;	pZAMB7)	were	grown	in	MOPS	rich	medium	with	0.2%	fructose.	Activity	is	reported	as	GFP	fluorescence	(RFU)	normalized	to	optical	density	(OD600);	activities	in	strains	carrying	SgrS	were	normalized	to	the	vector	control.		B)	Predicted	base	pairing	between	SgrS	orthologs	and	E.	coli	folE	mRNA.		C)	Predicted	base	pairing	between	SgrS	orthologs	and	cognate	folE	mRNA	from	enteric	bacteria.	Species	names	are	shown	as	subscripts	and	abbreviated	as	in	(A).	Vertical	lines	represent	predicted	Watson-Crick	(G:C,	A:U)	base-pairing	and	two	dots	represent	non-canonical	(G:U)	interactions.	The	highly	conserved	region	of	SgrS	is	highlighted	in	blue.	Underlined	folE	sequences	correspond	to	the	predicted	RBS.	
	
	
	
	
	
C
:  :    |||||||    |||||| :|  
5’-…GGCGGAGGCGUCACACC___UGCAGGAGAAA…-3’!
SgrSEc!
folEEc!
3’-…GUUAUGAGUCAGUGUGUACUACGUCCGUUCA…-5’!
:  :    | |||||    ||   | :| 
5’-…GGCAGAGGCGCCACACC___UGCAGGAGAAC…-3’!
SgrSSt!
folESt!
3’-…GUUAUGAGUCAGUGUGUACUACAGACGUUAA…-5’!
  |:  : | :|||  ||||    ||  |      
5’-…AUCAUUUCGCUCUCAAUUAGAGUGAGAGCGA…-3’!
SgrSYp!
folEYp!
3’-…UGUGGUAAUGAGUCUUAAAAAAACCAUGAAC…-5’!
|:    ||||| |:|  : :| : 
5’-…CCAGCAGCCCCCACCACUGCCGGAGAAGAAA…-3’!
SgrSEa!
folEEa!
3’-…ACCACUUUAUAGUGGUAAUGAGUCUUAUGAA…-5’!
| |    | |||||    ||   | :| 
5’-…GCAAAGAGCGCCACACC___UGCAGGAGAAA…-3’!
SgrSKp!
folEKp!
3’-…GUUAUGAGUCAGUGUGUACUACAGACGUUCA…-5’!
:  :    | ||||||   ||   | :| 
5’-…GGCAGAGGCGCCACACC___UGCAGGAGAAG…-3’!
SgrSCk!
folECk!
3’-…GUUAUGAGUCAGUGUGUACUACAGACGUUAA…-5’!
170!180! 160!
Segment	I	 Segment	II	
	 89	
	
	
Figure	3.16	Predicted	base	pairing	interactions	between	SgrS	orthologs	and	
cognate	targets.	Predicted	base	pairing	between	SgrS	orthologs	and	cognate	purR	mRNA	from	enteric	bacteria.	Subscripts	indicate	abbreviated	species	names	as	described	in	Figure	3.13.	Vertical	lines	represent	predicted	Watson-Crick	(G:C,	A:U)	base-pairing	and	two	dots	represent	non-canonical	(G:U)	interactions.		
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Figure	3.17	Target	overexpression	phenotypes	in	stressed	E.	coli	cells.	A)	E.	coli	wild-type	and	ΔppsA	mutant	strains	harboring	Plac-adiY,	Plac-folE,	Plac-purR	plasmids	or	vector	control	were	cultured	on	M63	minimal	plates	with	0.4%	glycerol	and	combinations	of	IPTG,	αMG	or	2DG	as	indicated.	Growth	was	observed	after	40	and	72	hours	of	incubation.	B,C)	E.	coli	wild-type	and	ΔppsA::kan	strains	ectopically	expressing	asd	(or	with	vector	control)	were	grown	in	minimal	fructose	medium	in	the	C)	presence	of	0.5%	αMG	and	B)	absence	of	the	stressor.							
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Figure	3.18	SgrS	recognition	motif.	A)	Target	mRNA	sequences	containing	characterized	SgrS	binding	sites	used	to	generate	the	predicted	motif.	B)	LOGO	of	a	conserved	SgrS	binding	motif	predicted	by	MEME	[7]	based	on	the	sequences	of	known	targets	of	SgrS.			
B
A
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Figure	3.19	Relevant	pathways	of	carbon	utilization	in	E.	coli.	Glucose	and	its	analogs	are	taken	up	by	the	cell	through	the	phosphotranferase	system	(PTS)	that	relays	a	phosphate	group	from	phosphoenolpyruvate	(PEP)	to	the	incoming	sugar	during	translocation.	Glucose-phosphate	then	enters	glycolysis	to	replenish	the	pool	of	PEP	that	was	diminished	during	the	uptake	process.	Block	in	glycolysis	or	uptake	of	non-metabolizable	glucose	analogs	results	in	accumulation	of	these	phosphosugars	in	the	cytoplasm	and	inability	to	replenish	PEP	through	glycolytic	flux.	Under	such	conditions,	PEP	can	be	produced	from	pyruvate	or	oxaloacetate	(OAA)	through	the	action	of	enzymes	encoded	by	ppsA	(in	blue)	and	pck	genes	respectively.	While	aspartate	can	be	utilized	to	produce	OAA,	aspartate	semialdehyde	dehydrogenase	encoded	by	asd	(in	red)	is	essential	in	aspartate	utilization	pathway	producing	other	amino	acids.		
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CHAPTER	4	
DETERMINANTS	OF	TARGET	PRIORITIZATION	AND	REGULATORY	HIERARCHY	
FOR	THE	SMALL	RNA	SGRS3	
	
4.1	Introduction		 Bacteria	live	in	diverse	niches,	often	encountering	rapidly	changing	and	stressful	conditions.	Bacterial	stress	responses	can	mitigate	the	negative	effects	of	stress	on	cell	structure	and	function.	Usually	stress	responses	are	coordinated	by	molecules—	either	RNAs	or	proteins,	that	alter	expression	of	a	regulon	comprised	of	multiple	genes.	Coordinated	regulation	of	the	regulon	prepares	the	cell	to	survive	or	adapt	to	the	stress	[65,	248].	Whereas	most	proteins	control	expression	of	target	regulons	by	binding	to	DNA	sequences	and	modulating	the	frequency	of	transcription	initiation,	RNAs	often	modulate	gene	expression	post-transcriptionally.	A	major	class	of	RNA	regulators	in	bacteria	is	referred	to	simply	as	small	RNAs	(sRNAs).	These	sRNA	regulators	are	very	often	produced	in	response	to	a	particular	stress,	and	once	synthesized,	regulate	a	target	mRNA	regulon	through	sRNA-mRNA	base	pairing	interactions	that	modify	mRNA	translation	or	stability	[79,	249].	In	diverse	bacteria,	dozens	to	hundreds	of	sRNAs	have	been	identified	[35,	122,	294].	While	the	majority	of	sRNAs	have	not	been	characterized,	many	studies	support	the	current	concept	that	sRNA	regulatory	networks	are	just	as	extensive	and	complex	as	networks	controlled	by	protein	transcription	factors	[220,	227].			 A	large	body	of	work	illuminating	different	base	pairing-dependent	molecular	mechanisms	of	post-transcriptional	regulation	by	sRNAs	has	accumulated	[20,	21].	The	sRNA	SgrS	(sugar-phosphate	stress	sRNA)	has	served	as	an	outstanding	model	for	discovery	of	both	negative	and	positive	mechanisms	of	target	mRNA	regulation.	SgrS	is	induced	in	response	to	metabolic	stress	associated	with	disruption	of	glycolytic	flux	and	subsequent	intracellular	accumulation	of	sugar	phosphates	(also	referred	to	as	glucose-phosphate	stress)	[267,	268].	SgrS	regulates	at	least	8	mRNAs	in	order	to	promote	recovery	from	glucose-phosphate	stress.	SgrS-																																																								3	Chapter	contains	data	produced	in	collaboration	with	Jane	Frandsen	and	Tina	M.	Henkin	from	the	Department	of	Microbiology	and	Center	for	RNA	Biology,	at	the	Ohio	State	University	
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dependent	repression	of	mRNAs	encoding	sugar	transporters	(ptsG,	manXYZ)	reduces	uptake	of	sugars	to	prevent	further	sugar-phosphate	accumulation	(Figure	4.1)	[206,	207,	267].	Activation	of	a	sugar	phosphatase	(yigL)	mRNA	allows	the	cell	to	dephosphorylate	and	pump	out	accumulated	sugars	[196],	and	repression	of	other	mRNAs	encoding	a	variety	of	metabolic	functions	is	believed	to	reroute	metabolism	to	promote	recovery	from	stress	(Figure	4.1)	[19].	Each	target	of	SgrS	is	regulated	by	a	distinct	molecular	mechanism.	How	different	mechanisms	of	regulation	lead	to	specific	patterns	of	control	of	mRNA	stability	and	translation	is	an	open	question.	 		 Temporally	ordered	and	hierarchical	patterns	of	gene	regulation	carried	out	by	protein	transcription	factors	have	been	characterized	in	a	number	of	systems	[40,	254,	259,	291].	These	regulatory	patterns	allow	cells	to	efficiently	respond	to	environmental	signals	by	prioritizing	induction	or	repression	of	functions	needed	to	respond	to	those	signals.	Many	protein	regulators	establish	a	hierarchy	of	regulation	based	on	their	affinity	for	binding	sites	in	the	operator	regions	of	target	genes.	As	concentrations	of	active	regulator	increase,	genes	are	sequentially	regulated	beginning	with	genes	with	the	highest	affinity	binding	sites	in	their	operators	and	proceeding	to	genes	controlled	by	increasingly	lower-affinity	binding	sites	[76].	There	is	growing	evidence	that	sRNAs	also	regulate	their	target	genes	hierarchically	[68,	138].	However,	the	mechanisms	involved	in	establishing	and	maintaining	prioritized	regulation	of	sRNA	targets	are	not	known.			 We	hypothesize	that	the	temporal	progression	of	target	regulation	by	SgrS	is	specifically	optimized	to	promote	efficient	recovery	from	glucose-phosphate	stress	(Figure	4.1).	To	test	this	hypothesis,	we	began	this	study	by	defining	the	efficiency	of	SgrS	regulation	of	each	target.	We	determined	that	SgrS	indeed	prioritizes	regulation	of	some	targets	over	others.	We	went	on	to	examine	the	factors	that	determine	regulatory	efficiency,	including	the	roles	of	the	RNA	chaperone	Hfq	and	the	arrangement	and	strength	of	SgrS	target	binding	sites.	This	work	led	to	the	discovery	of	a	novel	attenuation	mechanism	for	sRNA	regulation	that	requires	two	sRNA	binding	sites	on	a	single	mRNA	target.	Collectively,	our	results	upheld	the	hypothesis	that	sRNAs	regulate	expression	of	genes	in	their	target	regulons	
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hierarchically.	Moreover,	we	establish	that	distinct	features	of	each	sRNA-mRNA	pair	and	differing	molecular	mechanisms	of	regulation	determine	the	regulatory	priority	for	each	target.		
4.2	Results	
4.2.1	SgrS	differentially	regulates	targets	at	the	level	of	translation	
	 Previous	studies	suggested	the	possibility	of	a	hierarchy	of	regulatory	effects	carried	out	by	the	small	RNA	SgrS,	which	controls	translation	of	a	diverse	set	of	mRNA	targets	[19,	196,	206,	207,	267].	To	study	this	issue	we	devised	a	two-plasmid	system	to	control	expression	of	SgrS	and	target	translational	fusions	(Figure	4.2).	All	target	transcript	fragments	fused	to	gfp	contain	experimentally	confirmed	SgrS	binding	sites.	Regulation	of	target	translation	by	SgrS	was	measured	as	described	previously	[138].			 To	quantify	translational	regulation	by	SgrS	and	facilitate	comparisons	of	regulatory	efficiency	among	targets,	we	analyzed	the	data	as	described	by	Levine,	et	al.	[138].	Activity	of	reporter	fusions	was	measured	by	monitoring	GFP	fluorescence	over	time.	By	plotting	the	GFP	fluorescence	(RFU)	as	a	function	of	growth	(OD600)	for	target-gfp	fusions	in	the	absence	of	SgrS,	we	defined	“basal	fusion	activity”	at	different	concentrations	of	the	inducer	IPTG	(example	in	Figure	4.3A).	This	method	of	quantifying	the	activity	of	translational	fusions	at	different	levels	of	induction	was	necessary,	as	the	increase	in	fluorescence	is	not	directly	proportional	to	the	increase	in	IPTG	concentrations	([138]	and	Figure	4.3A).	However,	the	slopes	of	the	fusion	activity	curves	reveal	clear	dose-dependence.	Further,	while	the	absolute	values	for	basal	fusion	activity	differ	among	different	target	fusions,	all	fusions	responded	to	induction	in	a	dose-dependent	manner	(Figure	4.4A).	Similar	plots	(RFU/OD600)	were	generated	for	each	of	the	target-gfp	fusions	induced	at	different	IPTG	concentrations	in	the	presence	of	SgrS	(example	in	Figure	4.3B-F).	We	define	“regulated	fusion	activity”	as	the	slope	of	the	curve	(RFU/OD600)	under	conditions	where	both	the	fusion	and	SgrS	are	induced	(example	in	Figure	4.3B).	As	levels	of	SgrS	are	increased,	clear	patterns	of	repression	or	induction	are	seen	for	all	target	fusions	(Figures	4.3B-F	and	4.4B-F).		
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	 To	define	the	efficiency	of	regulation	of	each	target	we	plotted	regulated	fusion	activity	as	a	function	of	basal	fusion	activity	for	ptsG,	manX,	asd,	purR,	and	
yigL.	When	there	is	no	SgrS-mediated	regulation	we	obtain	a	line	with	a	slope	of	1	for	all	targets	(Figure	4.5A-E).	The	curves	with	slopes	<1,	indicate	that	the	fusion	is	being	repressed	by	SgrS.	This	is	true	for	ptsG,	manX,	asd	and	purR	reporter	fusions	(Figure	4.5A-D).	The	curves	with	the	slopes	>1	are	indicative	of	activation	by	SgrS,	which	is	true	only	for	yigL	(Figure	4.5E).	Importantly,	the	magnitude	of	regulation	or	regulatory	efficiency	was	responsive	to	SgrS	levels.	As	concentrations	of	SgrS	inducer	(aTc)	increased,	slopes	of	lines	for	repressed	targets	were	correspondingly	reduced	(Figure	4.5A-D).	Interestingly,	this	was	not	the	case	for	yigL,	the	only	positively	regulated	target	of	SgrS	(Figure	4.5E).	The	magnitude	of	activation	did	not	increase	beyond	a	maximal	level	obtained	at	20	ng/mL	of	inducer.	While	the	basis	of	this	difference	between	repressed	and	activated	targets	is	unclear,	it	likely	reflects	the	inherently	different	molecular	mechanisms	of	regulation:	mRNA	stabilization	for	
yigL	and	translational	repression	for	all	other	targets.				 We	then	compared	regulatory	efficiency	among	different	targets	for	each	level	of	SgrS	induction.	At	the	two	lowest	levels	of	SgrS	induction	(10ng/mL	and	20	ng/mL	aTc),	only	ptsG	and	yigL	showed	substantial	repression	and	activation,	respectively	(Figure	4.6A,	B).		In	contrast,	manX,	asd	and	purR	fusions	yielded	curves	whose	slopes	remained	at	~1,	indicating	no	regulation	at	these	lower	levels	of	SgrS	(Figure	4.6A,	B).	Our	interpretation	of	these	results	is	that	ptsG	and	yigL	are	the	highest	priority	or	“strongest”	targets	of	SgrS,	since	they	are	regulated	preferentially	when	SgrS	levels	are	low.	With	increasing	levels	of	SgrS	induction	(20-50	ng/ml	aTc),	regulation	of	the	“weaker”	targets	manX,	asd	and	purR	became	apparent	(Figure	4.6C,	D,	E).		As	SgrS	levels	increased,	ptsG	repression	became	more	efficient	until	reaching	maximal	repression	at	40	ng/mL	of	aTc,	and	it	remained	the	most	strongly	repressed	target	at	all	levels	of	SgrS	(Figure	4.6A-E).	Collectively,	our	data	suggest	that	SgrS	targets	are	preferentially	regulated	in	the	following	order:	1/2)	
ptsG	and	yigL,	3)	manX,	4)	asd,	and	5)	purR	(Figure	4.6A-E).	We	hypothesize	that	the	position	of	each	target	within	the	regulatory	hierarchy	is	determined	by	
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characteristics	of	SgrS-target	mRNA	interactions	and	the	mechanism	of	SgrS-dependent	regulation.			
4.2.2	Target	mRNAs	have	different	SgrS	binding	strength	
	 One	of	the	initial	steps	in	sRNA-mediated	regulation	is	the	formation	of	the	base-pairing	interactions	with	the	target	mRNA.	Binding	of	the	sRNA	with	its	target	mRNA	is	dependent	on	sequence	complementarity	and	RNA	secondary	structure.	We	examined	the	characteristics	of	SgrS-target	mRNA	binding	in	vitro	to	determine	whether	the	strength	of	binding	is	correlated	with	the	target	hierarchy	observed	at	the	level	of	translation	(Figure	4.6A-E).		Electromobility	shift	assays	(EMSAs)	were	performed	to	determine	the	strength	of	the	interactions	between	SgrS	and	its	target	RNAs	ptsG,	manX,	purR,	yigL	and	asd.	Binding	of	SgrS	with	ptsG	had	a	Kd	of	0.11±0.01	µM	(Figure	4.7B),	which	was	lower	than	those	for	SgrS	binding	to	most	of	the	other	targets	(Figure	4.7A).	SgrS-manX	mRNA	binding	had	a	Kd	of	19.7±2.78	µM	(Figure	4.7C)	which	is	weaker	than	interaction	with	ptsG	(Figure	4.7B),	but	stronger	compared	to	purR	and	yigL	(Figure	4.7A).	Surprisingly,	while	asdI	(containing	only	the	upstream	SgrS	binding	site)	regulation	is	less	efficient	compared	to	manX	(Figure	4.6A-E),	it	binds	SgrS	more	strongly	(Figure	4.7A)	with	a	Kd	of	0.15±0.04	µM	(Figure	4.7D),	which	is	comparable	to	SgrS	binding	with	ptsG	(Figure	4.7A,B).	Our	previous	work	demonstrated	that	SgrS	also	binds	at	a	site	referred	to	as	asdII,	located	within	the	coding	sequence	of	asd	mRNA;	EMSAs	show	weak	SgrS	interaction	with	asdII	alone	(Figure	4.7A).	We	could	not	determine	Kd	values	for	SgrS	interaction	with	asdII,	
purR	and	yigL,	due	to	limitations	in	obtaining	high	enough	concentrations	of	RNA,	but	it	is	apparent	that	SgrS	binding	to	these	targets	is	much	weaker	compared	to	
ptsG,	manX	and	asdI	(Figure	4.7A).			 Results	of	EMSAs	with	SgrS	and	asdI-II	(containing	both	SgrS	binding	sites)	revealed	apparent	cooperativity	between	the	binding	events.	SgrS	binding	to	asdI-II	has	a	Kd	of	0.07±0.01	mM	(Figure	4.7E),	slightly	lower	even	than	that	of	SgrS-ptsG	mRNA	binding.	Moreover,	we	observed	two	shifted	species,	that	correspond	to	one	or	two	SgrS	sRNAs	pairing	with	a	single	asdI-II	transcript	(Figure	4.8A).	The	Kds	for	
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SgrS	binding	to	asdI	and	asdI-II	are	comparable	(Figure	4.7D,E),	but	SgrS	binding	to	site	asdII	was	almost	undetectable	(Figure	4.7A)	unless	it	was	present	in	the	combination	with	site	I	in	the	context	of	asdI-II	(Figure	4.8A).		This	strongly	suggests	cooperative	binding	where	SgrS	occupancy	of	site	II	within	the	asd	CDS	is	dependent	on	initial	SgrS	binding	at	site	I	within	the	asd	5'	UTR.			 	
4.2.3	Structural	analyses	of	asd	mRNA	
	 Our	data	thus	far	indicate	that	SgrS	regulates	mRNA	targets	in	a	hierarchical	fashion	(Figure	4.1).	SgrS-mRNA	binding	affinities	alone	do	not	explain	the	target	hierarchy,	as	SgrS-ptsG	mRNA	and	SgrS-asd	mRNA	interactions	have	very	similar	Kds,	but	ptsG	is	clearly	much	more	efficiently	regulated	at	all	concentrations	of	SgrS	compared	with	asd	(Figure	4.6).	To	further	understand	the	features	that	influence	the	efficiency	of	target	regulation,	we	performed	more	detailed	analyses	of	SgrS-asd	mRNA	interactions.			 We	used	the	IntaRNA	program	[30,	285]	to	predict	the	free	energy	(ΔG)	for	SgrS	interactions	with	asd	(Figure	4.8B).	IntaRNA	accounts	for	the	energy	necessary	to	open	double-stranded	regions	of	RNA	secondary	structure,	to	make	them	accessible	(single-stranded)	for	pairing.	To	take	into	the	account	secondary	structure	of	asd	mRNA,	we	first	analyzed	SgrS	interactions	with	sites	I	and	II	within	
asdI-II	(+1	to	+240),	which	we	denote	as	“structured”	(Figure	4.8B,	structured).	Interaction	of	SgrS	with	site	I	is	predicted	to	have	ΔG	of	-10.5	kcal/mol,	while	SgrS	pairing	with	site	II	has	ΔG	of	-1.1	kcal/mol	(Figure	4.8B,	structured).	When	analyzing	only	the	base-pairing	sequences	(denoted	“unstructured”),	which	eliminates	formation	of	extended	secondary	structures,	SgrS	pairing	at	site	I	has	ΔG	of	-18	kcal/mol	and	pairing	at	site	II	has	ΔG	of	-7.4	kcal/mol	(Figure	4.8B,	unstructured).	We	conclude	that	SgrS	interaction	with	site	II	is	less	favorable,	requiring	~10-times	more	energy	to	form	compared	to	site	I	when	both	sites	are	considered	in	the	context	of	the	asdI-II	secondary	structure.	When	site	II	is	accessible	(i.e.,	single	stranded),	occupancy	by	SgrS	is	more	favorable.	These	data	suggest	that	binding	of	SgrS	at	site	I	might	enhance	binding	at	site	II	by	altering	the	secondary	structure	of	the	mRNA	to	make	site	II	more	accessible.	
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	 We	investigated	asdI-II	structure	with	selective	2'-hydroxyl	acylation	analyzed	by	primer	extension	(SHAPE),	where	exposed	single-stranded	RNA	is	modified	by	N-methylisotoic	anhydride	(NMIA),	while	double-stranded	RNA	is	protected	and	not	reactive.	The	sequence	encompassing	the	asd	RBS	(+44	to	+50)	is	located	within	a	partial	single-stranded	loop	(+34	to	+58,	site	I)	on	top	of	mostly	unreactive	double-stranded	stem	structure	(+2	to	+92)	(Figure	4.8C).	Although	nts	+40-43	are	predicted	to	pair	with	nts	+47-50,	this	short	four	base-pair	stem	is	likely	to	be	dynamic,	considering	mild	NMIA	reactivity	at	nts	+44	and	+48	(Figure	4.8C).	Downstream	of	the	first	stem-loop	structure,	separated	by	five	unpaired	nucleotides,	is	the	highly	structured	second	stem	(+98	to	+139)	(Figure	4.8C)	followed	by	a	single-stranded	unstructured	region	(+140-175)	(Figure	4.8C).			 SgrS	pairs	at	nts	+31	to	+49	(site	I),	which	mostly	exhibit	NMIA	reactivity,	indicative	of	single-stranded	conformation	of	site	I	(Figures	4.8C).	Moreover,	nts	+37	and	+38	are	very	reactive,	and	therefore	highly	accessible	for	pairing	with	the	“seed”	sequence	of	SgrS	(Figure	4.8C).	The	seed	interaction	of	SgrS	within	this	single-stranded	loop	might	promote	the	opening	of	the	adjacent	paired	nucleotides,	especially	the	short	four-nt	stem	at	nts	+40	to	+50.	SgrS	also	interacts	with	the	tip	of	the	downstream	stem	(site	II,	nucleotides	+110	to	+129),	which	is	mostly	double-stranded	and	would	not	be	accessible	to	base	pair	with	SgrS	(Figure	4.8C).	In	light	of	binding	cooperativity	observed	in	Figure	4.8A,	we	speculate	that	SgrS	pairing	with	site	I	might	induce	rearrangement	of	asd	secondary	structure	to	facilitate	interaction	with	site	II.			 We	used	SHAPE	to	probe	asdI-II	structure	in	the	presence	of	SgrS	(Figure	4.9A,B).	At	higher	(20x)	concentration	SgrS	remodeled	asdI-II	structure	into	two	stem-loops	(+14	to	+78	and	+83	to	+160)	separated	by	four	unpaired	nucleotides	and	followed	by	a	U-rich	sequence	(+161	to	+175)	(Figure	4.9A).	Importantly,	SgrS	binding	sites	I	and	II	are	located	within	the	single-stranded	loops	of	the	two	stem-loop	structures	(Figure	4.9A).	At	lower	(10x)	concentration	of	SgrS,	higher	reactivity	was	observed	throughout	the	asdI-II	RNA	(Figure	4.9B).	Structural	changes	lead	to	unfolding	of	some	double-stranded	regions	and	make	them	more	reactive	with	NMIA.	We	think	that	at	equilibrium	SgrS	(at	10x	concentration)	does	not	occupy	
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both	binding	sites	on	asdI-II	RNA.	Partial	occupancy	of	only	site	I,	which	is	more	accessible	(single-stranded)	and	has	higher	affinity	for	SgrS	could	results	in	structural	changes	making	previously	occluded	regions	of	asdI-II	more	dynamic,	and	therefore	more	reactive	to	NMIA	(Figure	4.9B).			
4.2.4	Optimal	repression	by	SgrS	involves	both	pairing	sites	within	asd	mRNA	
	 We	next	examined	the	roles	of	the	two	SgrS	binding	sites	in	the	efficiency	of	translational	regulation.	SgrS	regulation	of	an	asdI-II	translational	fusion	was	compared	to	regulation	of	an	asdI	fusion	(Figure	4.10A).	By	plotting	regulated	activity	as	a	function	of	basal	activity	as	described	above	we	determined	that	SgrS	repression	of	asdI-II	was	more	efficient	than	repression	of	asdI	across	the	entire	range	of	SgrS	expression	levels	(Figure	4.10B).	This	is	also	in	line	with	our	previous	findings	using	asdI-,	asdII-,	and	asdI-II-lacZ	translational	fusions,	which	showed	that	SgrS	repressed	asdI,	but	failed	to	repress	asdII,	with	repression	of	asdI-II	being	optimal	[19].	Comparison	to	other	targets	indicates	that	asdI-II	is	regulated	more	efficiently	than	manX,	asdI	and	purR,	at	all	concentrations	of	SgrS	(Figure	4.10C).	These	results	indicate	that	the	second	binding	site	on	asd	mRNA	both	enhances	the	stringency	of	SgrS-mediated	translational	repression	and	mRNA	turnover.	Moreover,	addition	of	the	second	binding	site	on	asd	changes	its	regulatory	priority	relative	to	other	targets	in	the	SgrS	regulon.		
	
4.3	Discussion		 sRNAs	are	ubiquitous	regulators	of	bacterial	stress	responses	and	metabolic	adaptation	[21],	many	of	which,	e.	g.	RyhB,	simultaneously	control	expression	of	multiple	genes	[220].		Previously,	we	identified	four	additional	targets	that	significantly	expanded	SgrS	regulon	(Chapter	3),	which	now	consists	of	nine	genes	[19,	196,	206,	207,	267].	The	majority	of	SgrS	targets,	i.e.	ptsG,	manX,	asd	and	purR,	are	repressed	via	distinct	mechanisms	at	the	translational	level	[19,	207,	267],	with	one	target,	yigL,	being	activated	through	mRNA	stabilization	[196].	The	current	study	determines	that	SgrS	regulates	ptsG,	manX,	asd,	purR	and	yigL	with	different	efficiency	(Figure4.5A).	We	further	identified	a	hierarchy	of	targets	being	regulated	
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by	SgrS	in	the	following	order:	1/2)	ptsG	and	yigL,	3)	manX,	4)	asd,	and	5)	purR	(Figure	4.6A-E).	Indeed,	ptsG	and	yigL	are	known	to	be	important,	because	their	regulation	is	necessary	for	full	recovery	from	αMG-induced	glucose-phosphate	stress	[252].	Regulation	of	manX	was	specifically	important	when	stress	was	induced	by	2DG	because	the	product	of	manXYZ	operon,	EIICDman	transporter,	is	responsible	for	the	uptake	of	this	glucose	analog,	but	not	αMG	[207,	252].	Therefore,	blocking	the	uptake	of	deleterious	sugars	(repression	of	ptsG	and	manX),	and	promoting	dephosphorylation	and	efflux	(activation	of	yigL)	are	the	first	line	of	defense.	Initial	stress,	however,	might	cause	perturbations	in	the	metabolic	flux	(Chapter	5),	so	SgrS	regulation	of	asd	and	purR	might	help	the	cell	restore	homeostasis	once	the	stress-causing	agent	(i.e.	αMG	or	2DG)	is	blocked.		Because	target	prioritization	might	be	tailored	for	effective	stress	recovery,	we	decided	to	probe	the	underlining	principles	that	define	this	order	of	regulation.	Differences	in	Hfq	binding	to	the	target	mRNAs	within	SgrS	regulon	could	affect	their	regulatory	priority.	EMSAs	were	performed	to	determine	Hfq	binding	affinity	for	ptsG,	manX,	purR,	yigL,	asdI,	asdII	and	asdI-II	(Figure	4.11A).	We	did	not	observe	any	significant	difference	in	the	Kd	values	between	the	targets	(Figure	4.11B).	We	also	tested	SgrS	affinity	for	target	mRNAs	in	the	presence	of	Hfq,	however	we	did	not	observe	facilitation	of	SgrS-target	duplex	formation	by	Hfq	(data	not	shown),	as	was	previously	described	by	Morita	et	al.	[177].	We	think	that	Hfq	might	not	extensively	participate	in	target	prioritization.	However,	given	that	sRNA	base	complementarity	with	target	transcript	is	the	basic	specificity-defining	feature	of	these	regulators,	we	probed	the	strength	of	binding	between	SgrS	and	its	target	mRNAs	(Figure	4.7).	Interesting	enough,	target	binding	in	vitro	(Figure	4.7A),	did	not	correlate	well	with	the	target	hierarchy	at	the	translational	level	(Figure	4.6A-E).	Specifically,	both	ptsG	and	asdI	showed	comparable	affinity	(Kd	of	0.11±0.01	µM	and	0.15±0.04	µM	respectively),	and	were	stronger	binding	partners	of	SgrS	compared	to	manX	(Kd	of	19.7±2.78	µM)	(Figure	4.7).	This	was	unexpected	because	
manX	translational	fusion	is	repressed	more	efficiently	compared	to	asdI.	From	previous	work,	we	knew	that	SgrS	regulation	occurs	via	pairing	at	two	sites,	within	the	leader	(site	I)	and	the	CDS	(site	II)	of	asd	mRNA	(Chapter	3).	Taking	this	into	
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consideration,	we	tested	SgrS	pairing	with	site	II,	which	is	very	weak	unless	it’s	present	in	the	context	of	site	I	(Figures	4.7A	and	4.8A).	This	indicates	that	two	molecules	of	SgrS	bind	cooperatively	to	sites	I	and	II	on	asd	mRNA.	We	think	that	SgrS	binding	at	site	I	could	induce	structural	rearrangement	that	makes,	otherwise	occluded	within	the	double-stranded	stem	(Figures	4.7A	and	4.8A),	site	II	more	accessible	for	binding.		 Analysis	of	asd	secondary	structure	predicts	two	stems,	with	SgrS	binding	sites	at	the	tips	(Figures	4.8C).	The	leader	sequence	of	asd	is	not	well	conserved	between	enteric	bacteria(Figure	4.12)	making	it	hard	to	predict	structural	conservation	of	the	first	stem-loop.	Coding	sequence	of	asd	is	conserved	however	(Figure	4.12),	suggesting	that	second	stem	structure	(+98	to	+139)	and	the	downstream	U-rich	sequence	(+161	to	+175)	could	be	present	in	some	species	of	enteric	bacteria.	Structure	of	asdI-II	modified	by	SgrS	contains	two	stem-loops	that	immediately	precede	the	U-rich	sequence	(Figure	4.9A).	Similar	U-rich	sequences	are	commonly	found	within	transcriptional	attenuators	and	facilitate	dissociation	of	RNA	Polymerase	after	stalling	at	the	preceeding	stem	loop	structures	[182,	183].		 Transcriptional	and	translational	fusions	of	asd	containing	both	stem	structures	had	significantly	higher	activity	compared	to	shorter	asd	fusions	missing	the	second	stem	structure	(data	not	shown).	This	increase	in	activity	of	longer	translational	asd	fusion	was	also	observed	in	the	degradosome	mutant	strain	(data	not	shown),	consistent	with	interference	in	transcription	or	translation,	rather	than	changes	in	stability	of	asd.	Taken	together	with	the	preliminary	results,	we	hypothesize	that	the	secondary	structure	(Figures	4.8C	and	4.9A)	might	be	important	for	asd	transcription.	Attenuation	mechanisms	commonly	involve	mutually	exclusive	secondary	structures	that	either	promote	(antiterminator	structure)	or	block	(terminator	structure)	transcription	[77,	183].	SgrS	regulation	may	alter	the	secondary	structure	of	asd	mRNA,	which	not	only	represses	translation	of	asd,	but	also	affects	its	transcription.	Recent	publication	described	a	mechanism	by	which	sRNA	affects	termination	by	interfering	with	the	Rho	binding	sites	at	the	5’end	of	the	mRNA	[223].	sRNA-mediated	transcriptional	attenuation	
	 103	
has	been	previously	described	for	cis-encoded	sRNAs	[80,	247],	but	limited	such	examples	exist	for	trans-encoded	sRNAs.		 Although	we	do	not	completely	understand	the	mechanism,	which	will	be	investigated	in	more	detail	at	a	later	time,	we	demonstrate	that	both	binding	sites	I	and	II	are	required	for	optimal	asd	repression	by	SgrS	(Figure	4.10B).	SgrS	binding	cooperativity	not	only	improves	the	efficiency	of	regulation,	but	also	changes	asd	priority	within	the	hierarchy	(Figure	4.10C).	sRNAs	evolve	by	gaining	base	complementarity	with	one	primary	target.	This	prime	relationship	places	enough	selective	pressure	for	the	sRNA	to	be	maintained.	Additional	targets	probably	evolve	later	by	developing	binding	sites	for	the	sRNA	[197].	SgrS	evolved	around	the	same	time	as	ptsG,	which	is	probably	its	primary	partner	[197].	How	did	the	two	SgrS	binding	sites	of	asd	evolved	remains	to	be	answered?	Nontheless	we	entertain	a	possibility	of	one	binding	site	arising	before	the	other,	with	the	more	recent	site	appearing	because	of	some	selective	pressures	for	tighter	asd	regulation.		 To	summarize,	we	elucidated	a	regulatory	hierarchy	of	SgrS	targets	and	determined	that	cooperative	binding	of	SgrS	to	two	sites	on	asd	mRNA	can	influence	its	prioritization	by	SgrS.	We	also	determined	the	secondary	structure	of	the	5’end	of	asd	mRNA,	which	might	play	a	role	in	asd	regulation.	Further	study	of	SgrS	regulation	of	target	mRNAs	is	necessary	to	understand	the	mechanisms	governing	target	prioritization	by	sRNAs	in	bacteria.																	
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Figure	4.1	Diagram	of	the	proposed	target	prioritization	during	glucose-
phosphate	stress	response.	Glucose	(or	its	analogs	αMG	and	2DG)	is	phosphorylated	upon	entry	through	the	phosphotransferase	system	(PTS)	transporters	EIICBglc	(PtsG)	or	EIICDman	(ManYZ).	If	sugar-phosphates	are	not	metabolized,	the	glucose-phosphate	stress	response	can	be	triggered,	and	the	transcription	factor	SgrR	becomes	active	and	promotes	SgrS	transcription.	SgrS,	assisted	by	Hfq,	represses	translation	of	ptsG	and	manXYZ	mRNAs	[206,	207,	267],	reducing	synthesis	of	sugar	transporters	and	accumulation	of	sugar-phosphates.	SgrS	stabilizes	yigL	mRNA,	promoting	sugar	phosphatase	(YigL)	synthesis,	which	allows	dephosphorylation	and	efflux	of	accumulated	sugars	[196].	SgrS-mediated	repression	of	four	additional	genes	asd,	purR,	folE	and	adiY	likely	reroutes	metabolism	to	restore	homeostasis	during	stress	recovery	[19].	The	triangle	at	the	bottom	of	the	cell	represents	timecourse	following	stress	induction	and	time-dependent	accumulation	of	SgrS	(from	left	to	right).	During	the	initial	induction	of	stress	response,	SgrS	concentration	is	low	and	only	the	highest	priority	targets	are	regulated.	When	stress	persists	and	concentrations	of	SgrS	increase,	lower	priority	targets	become	regulated.		
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Figure	4.2	Graphical	representation	of	genetic	constructs	in	two	compatible	
plasmids	used	to	study	target	regulation	by	SgrS.	One	plasmid	contains	full	length	SgrS	under	the	control	of	the	Ptet	promoter.		A	second	plasmid	contains	a	Plac	promoter	and	the	relevant	region	encoding	each	SgrS	target	(including	the	SgrS	binding	site)	translationally	fused	to	a	superfolder	gfp	(sfgfp)	reporter	gene.	
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Figure	4.3	Regulation	of	ptsG-gfp	fusion	by	SgrS.	Example	plots	of	ptsG-gfp	translational	fusion	activity	(RFU)	over	growth	(OD600)	at	various	IPTG	inducer	concentrations	at	(A)	basal	or	(B-F)	increasing	SgrS	expression	levels.	Slopes	of	the	linear	regression	plots	for	each	IPTG	concentration	were	calculated	to	obtain	(A)	basal	activity	and	(B-F)	regulated	activity	values.	
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Figure	4.4	Inducer	concentration-dependent	activity	of	target-gfp	fusions.	(A)	Basal	activity	(0	ng/ml	aTc)	or	(B-F)	regulated	activity	(10-50	ng/ml	aTc)	of	ptsG,	
manX,	purR,	asdI,	asdI-II	and	yigL	fusions	at	varying	IPTG	concentrations	(0-1.5	mM	IPTG).		
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Figure	4.5	Efficiency	of	target	regulation	by	SgrS.	Regulated	activity	was	plotted	as	a	function	of	basal	activity	(see	text	for	description)	for	(A)	ptsG,	(B)	manX,	(C)	
purR,	(D)	asdI,	and	(E)	yigL	fused	to	sfgfp	reporter	gene	(see	Figure	4.2).	Without	SgrS-mediated	regulation	we	obtained	a	line	with	a	slope	=1.	The	plots	with	slopes	<1,	indicate	repression	of	(A)	ptsG,	(B)	manX,	(C)	purR	and	(D)	asdI	by	SgrS.	The	plots	with	the	slopes	>1	are	indicative	of	activation	of	(E)	yigL.	
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Figure	4.6	Regulatory	hierarchy	established	by	SgrS.	Regulated	activity	was	plotted	as	a	function	of	basal	activity	for	ptsG,	manX,	purR,	asdI,	and	yigL	fusions.	Lack	of	SgrS	regulation	is	indicated	by	a	line	with	a	slope	=1.	The	plots	with	slopes	<1,	indicate	repression		(ptsG,	manX,	purR	and	asdI)	by	SgrS.	The	plots	with	slopes	>1	indicate	activation	(yigL).	Target	fusion	activity	was	monitored	at	different	levels	of	SgrS	induction	by	aTc:	(A)	10	ng/ml,	(B)	20	ng/ml,	(C)	30	ng/ml,	(D)	40	ng/ml,	(E)	50	ng/ml.			
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Figure	4.7	SgrS	binding	with	target	mRNAs	in	vitro.	A)	SgrS	was	labeled	with	32P	and	incubated	with	0µM	-	16	µM	dilutions	of	unlabeled	target	transcripts.	Electromobility	shift	assays	(EMSAs)	were	performed	after	incubating	full-length	SgrS	(+1	to	+227)	with	its	target	transcripts	ptsG	(+1	to	+240),	manX	(+1	to	+240),	
purR	(+1	to	+230),	yigL	(-191	to	+50	relative	to	ATG	translation	start	of	yigL)	,	asdI	(+1	to	+110)	and	asdII	(+71	to	+310).	B-E)	Targets	transcripts	ptsG	(+1	to	+240),	
manX	(+1	to	+240),	asdI	(+1	to	+110)	and	asdI-II	(+1	to	+240)	were	labeled	with	32P	and	incubated	with	appropriate	concentrations	of	unlabeled	SgrS.	EMSAs	were	performed	to	resolve	complex	formation.	Band	densities	were	measured	for	biological	replicates	(n,	top	left)	and	plotted	to	determine	dissociation	constant	(Kd,	bottom	right)	values	for	(B)	ptsG,	(C)	manX,	(D)	asdI	and	(E)	asdI-II.	
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Figure	4.8	Cooperative	SgrS	binding	with	asd.	A)	EMSA	of	radiolabeled	SgrS	in	the	presence	of	increasing	concentrations	of	asdI-II	transcript.	Shift	in	electromobility	corresponding	to	one	or	two	SgrS	bound	to	asdI-II	is	denoted	as	Site	I-SgrS*	and	Sites	I-II-SgrS*	respectively.	B)	Energy	of	interaction	predicted	by	IntaRNA.	“Short”	indicates	SgrS	(+158	to	+176)	pairing	with	asdI	(+31	to	+49)	and	SgrS	(+158	to	+178)	pairing	with	asdII	(+110	to	+129).	“Long”	indicates	full	length	SgrS	(+1	to	+227)	pairing	with	asdI-II	(+1	to	+180)	and	plotting	energy	for	interactions	at	either	site	I	(asdI)	or	site	II	(asdII).	C)	Performed	in	collaboration	with	Jane	Frandsen	and	Tina	M.	Henkin.	Relative	SHAPE	reactivity	of	asdI-II	RNA	with	NMIA.	Reactions	were	performed	with	0.15	µM	RNA	and	2	mM	NMIA.	Data	are	the	average	of	six	repeats	analyzed	using	QuSHAPE	with	statistical	outliers	removed	and	normalized	to	the	average	of	the	2%	highest	reactivities,	excluding	outliers		
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Figure	4.8	(cont.)		(C38).	Insert	shows	relative	reactivity	mapped	to	the	predicted	secondary	structure.	Red	nucleotides,	highly	reactive	(≥	0.6);	gold,	reactive	(0.3-0.6);	green,	moderately	reactive	(0.15-0.3);	blue,	minimally	reactive	(0.07-0.15);	grey,	unreactive	(<	0.07);	black,	unresolved	and	primer	binding	site.	Nucleotides	that	are	predicted	to	base	pair	with	SgrS	are	outlined.	Lines	represent	SgrS	binding	site	I	(blue)	and	site	II	(green)	and	translational	Start	codon	outlined	in	black.	
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Figure	4.9	SgrS	remodeling	of	asd	secondary	structure.	Performed	in	collaboration	with	Jane	Frandsen	and	Tina	M.	Henkin.	Relative	SHAPE	reactivity	of	
asdI-II	RNA	with	NMIA	in	the	presence	of	(A)	20x	or	(B)	10x	SgrS.	Inserts	show	relative	reactivity	mapped	to	the	predicted	secondary	structures.	Red	nucleotides,	highly	reactive	(≥	0.6);	gold,	reactive	(0.3-0.6);	green,	moderately	reactive	(0.15-0.3);	blue,	minimally	reactive	(0.07-0.15);	grey,	unreactive	(<	0.07);	black,	unresolved	and	primer	binding	site.	Nucleotides	that	are	predicted	to	base	pair	with	SgrS	are	outlined.	Lines	represent	SgrS	binding	site	I	(blue)	and	site	II	(green).	
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Figure	4.10	SgrS	binding	cooperativity	allows	for	improved	repression	of	asd	
translation.	A)	Illustration	of	asdI	and	asdI-II	constructs	with	SgrS	binding	sites	marked.	B)	Comparison	of	SgrS	regulation	of	asdI	and	asdI-II	fused	to	gfp	reporter	by	plotting	“regulated	activity”	over	“basal	activity”.	At	any	SgrS	expression	level	(i.e.	any	aTc	concentration)	repression	of	asdI-II	is	more	efficient	compared	to	asdI.	C)	Comparison	to	other	targets	demonstrates	that	asdI-II	is	regulated	stronger	than	
manX,	asdI	and	purR,	at	a	given	concentration	of	SgrS.	In	such	a	way,	presence	of	both	sites	for	SgrS	pairing	might	change	the	priority	of	asd	regulation	compared	to	other	targets	in	the	regulon.		
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Figure	4.11	Hfq	binding	with	target	mRNAs	in	vitro.	A)	Target	transcripts	ptsG	(+1	to	+240),	manX	(+1	to	+240),	purR	(+1	to	+230),	yigL	(-191	to	+50	relative	to	ATG	translation	start	of	yigL)	,	asdI	(+1	to	+110),	asdII	(+71	to	+310)	and	asdI-II	(+1	to	+240)	were	labeled	with	32P	and	incubated	with	appropriate	concentrations	of		
0.1 1 10 100 1000
0.0
0.2
0.4
0.6
0.8
1.0
1.2
Kd=34.68±6.57
n=2
0.1 1 10 100 1000
0.0
0.2
0.4
0.6
0.8
1.0
1.2 n=3
Kd=13.50±4.83
0.1 1 10 100 1000
0.0
0.2
0.4
0.6
0.8
1.0
1.2
Kd=10.79±1.21
n=3
0.1 1 10 100 1000
0.0
0.2
0.4
0.6
0.8
1.0
1.2 n=3
Kd=2.67±1.22
0.1 1 10 100 1000
0.0
0.2
0.4
0.6
0.8
1.0
1.2
Kd=12.17±2.16
n=2
0.1 1 10 100 1000
0.0
0.2
0.4
0.6
0.8
1.0
1.2 n=3
Kd=22.10±6.42
Hfq (nM)
0.1 1 10 100 1000
0.0
0.2
0.4
0.6
0.8
1.0
1.2
Kd=7.34±1.11 
n=2
Fr
ac
tio
n 
bo
un
d
0																																																										125	Hfq	[nM]	
I	
ptsG*	
II	
III	
IV	
ptsG*-Hfq	
I	
manX*	
II	
III	
IV	
manX*-Hfq	
I	
purR*	
II	
III	
purR*-Hfq	
I	
yigL*	
II	
III	
IV	
yigL*-Hfq	
I	
asdI*	
II	
III	
asdI*-Hfq	
I	
asdII*	
II	
III	
asdII*-Hfq	
I	
asdI-II*	
II	
III	
IV	
asdI-II*-Hfq	
	 116	
Figure	4.11	(cont.)		Hfq	protein.	EMSAs	were	performed	to	resolve	complex	formation.	B)	Band	densities	were	measured	for	biological	replicates	(n,	top	left)	and	plotted	to	determine	dissociation	constant	(Kd,	bottom	right)	values.	
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Figure	4.12	Alignment	of	5’end	of	asd	orthologs.	Leader	and	part	of	the	coding	sequence	(+1	to	+240)	of	E.	coli	K-12	(Escherichia)	asd	mRNA	was	aligned	with	asd	ortholog	mRNA	sequences	from	Klebsiella	pneumoniae	342	(Klebsiella),	
Pectobacterium	carotovorum	PC1	(Pectobacterium)	Salmonella	enterica	serovar	Typhimurium	LT2	(Salmonella)	and	Yersinia	pestis	KIM10	(Yersinia).	Sequence	alignment	generated	with	T-Coffee.	Translation	start	of	E.	coli	asd	is	marked.	
SCORE=73
*
 BAD AVG GOOD
*
Escherichia      :  76
Klebsiella       :  74
Pectobacterium   :  71
Salmonella       :  74
Yersinia         :  69
cons             :  73
Escherichia      --A---UGU---GC--C---AAG-----AG--------GA--------------GAC-----CGGCAC----
Klebsiella       GCAGGAUAAGUUGCUUUUCUGAUUGUUCAGCAAUCAUUGAUUAAUUUCACUUGCGACUUUAGCUGCAUUU-U
Pectobacterium   A-AGGUUGAACGACAC----GAUAAUUUACAGGUUUACGAC--AGGACGCGCGCGACCUCUUCGGCAGCU-C
Salmonella       --AGGAUAAGUCGCAUUACUGAUGGCUUCGCUAUCAUUGAUUAAUUUCACUUGCGACUUUGGCUGCUUUU-U
Yersinia         A-CCACUGAGCUGAAUCAG----CGUAUUGGGAUUUGUGCGUUUGCAACCUUGCCGCAACCCCCAC--UUAC
cons                   *                               *                 *     *  *      
Escherichia      ------------------------------------------AUUUAUACAG----CACACAUCUUUGCAGG
Klebsiella       GUAAGGUGAGGGAUAAU------CCAGUUGGAAACUGGCCAGGCACAAACAG----CACAC-ACCUCGCAGG
Pectobacterium   ACUGAGUCAGUACUCACCAAGCGCUA-U-CGACGUUAGCCAG-AAUUCUUU-UUGUUACC-CCCAAAGCAGG
Salmonella       GUAUGGUGAAGGAUGCG------CCA-CAGGAUACUGGC-GCGCAUACACAG----CACAUCUCUUUGCAGG
Yersinia         AUUGGGUAA-CCGCGCG-CA--GUUA-UACAAGACAGG-UAUCCAUAAAUCGGUGUCACCUUCCAAGGCAGG
cons                                                                      **    *   *****
Escherichia      AAAAAAACGCUUAUGAAAAAUGUUGGUUUUAUCGGCUGGCGCGGUAUGGUCGGCUCCGUUCUCAUGCAACGC
Klebsiella       AA---UACG-UUAUGAAAAAUGUUGGUUUUAUCGGCUGGCGCGGAAUGGUCGGCUCUGUUCUCAUGCAACGC
Pectobacterium   ACAGU--UA-CCAUGAAAAAUGUUGGUUUUAUUGGCUGGCGCGGUAUGGUCGGCUCGGUUCUCAUGCAGCGC
Salmonella       AAAAAAACG-CUAUGAAAAAUGUUGGUUUUAUCGGCUGGCGCGGAAUGGUCGGCUCUGUUCUCAUGCAACGC
Yersinia         GCAGU--AA-ACAUGAAAAACGUUGGUUUUAUCGGCUGGCGCGGUAUGGUCGGCUCAGUGCUCAUGCAACGC
cons                         ******** *********** *********** *********** ** ******** ***
Escherichia      AUGGUUGAAGAGCGCGACUUCGACGCCAUUCGCCCUGUCUUCUUUUCUACUUCUCAGCUUGGCCAGGCUGCG
Klebsiella       AUGGUUGAAGAGCGCGAUUUCGACGCCAUUCGCCCGGUGUUCUUCUCUACCUCCCAGCUGGGACAGCCAGCG
Pectobacterium   AUGGUGGAAGAACGCGACUUUGAUGUGAUUCACCCGGUAUUCUUUUCAACGUCUCAGCACGGCGAAGCGGCU
Salmonella       AUGGUAGAGGAGCGCGAUUUCGACGCUAUUCGCCCUGUUUUCUUUUCUACCUCCCAGUUUGGACAGGCGGCG
Yersinia         AUGAUUGAAGAACGCGACUUUGACGGUAUCCGCCCAGUCUUUUUCUCUACCUCUCAACAUGGCCAGGCUGCA
cons             *** * ** ** ***** ** ** *  ** * *** ** ** ** ** ** ** **    **  *  * ** 
Escherichia      CCGUCUUUUGGCGGAACCACUGGCACACUUCAGGAUGCCUUUGAUCU
Klebsiella       CCGUCAUUCGGCGGUAGCAC----------C--GGUG-------GCA
Pectobacterium   CCGGCGUUAGGUGGU--CAU----------CAAGGCG-------UGU
Salmonella       CCCACCUUCGGCGACACCUC----------C--ACCG-------GCA
Yersinia         CCGGCUUUCGCGGGC--CAC----------CAAGGUA-------CGU
cons             **  * ** *  *    *            *                
Start 
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CHAPTER	5	
GROWTH	PHENOTYPES	ASSOCIATED	WITH	GLUCOSE	ANALOGS	
	
5.1	Introduction		 Bacteria	rely	on	metabolism	of	sugars	as	the	primary	sources	of	carbon	and	energy	for	cell	growth	and	function.	Glucose	is	the	favored	sugar	for	E.	coli	and	gets	utilized	in	preference	to	other	sugars	(i.	e.	mannose,	arabinose).	Since	the	1960’s	it	has	been	known	that	perturbations	in	glycolysis	and	excessive	accumulation	of	phosphorylated	sugars	can	result	in	growth	inhibition	[63]	or	death	[98,	289].		Such	condition	in	E.	coli,	caused	by	perturbations	in	the	glycolytic	flux	or	uptake	of	nonmetabolizable	sugar	analogs	α-methyl	glucoside	(αMG)	and	2-deoxyglucose	(2DG),	has	been	termed	glucose-phosphate	stress	[267].	To	counteract	glucose-phosphate	stress,	expression	of	sRNA	SgrS	is	activated	allowing	for	relief	of	growth	inhibition,	which	otherwise	occurs	when	sgrS	is	deleted	[267].	While	regulation	of	genes	by	SgrS	in	response	to	glucose-phosphate	stress	is	well	described	[19,	207,	267],	the	underlying	factors	that	cause	growth	inhibition	and	the	signal	for	activation	of	SgrS	expression	remain	largely	unknown.			 Previous	studies	suggested	that	depletion	of	glycolytic	intermediates	is	the	primary	cause	of	growth	inhibition,	particularly	depletion	of	PEP	[208].	Glucose	and	its	analogs,	αMG	and	2DG,	are	taken	up	via	phosphoenolpyruvate-dependent	phosphotransferase	system	(PEP-PTS)	[199,	212],	which	involves	group	translocation	from	PEP	to	the	incoming	sugar.	We	hypothesize	that	PEP,	as	well	as	other	glycolytic	intermediates,	are	used	up	in	the	process,	but	are	not	replenished	correctly	due	to	non-metabolizable	nature	of	αMG	and	2DG.	This	is	consistent	with	the	previous	findings	that	E.	coli	lacking	PEP	synthetase	(ΔppsA	mutant),	which	cannot	catalyze	conversion	of	pyruvate	to	PEP,	exhibit	higher	sensitivity	to	2DG	[124].	In	Chapters	3	and	4,	we	discussed	SgrS	regulation	of	aspartate	semialdehyde	dehydrogenase	(encoded	by	asd),	implicating	aspartate	metabolism	in	stress	recovery	[19].	PEP	can	also	be	generated	by	PEP	carboxykinase	(encoded	by	pck)	from	oxaloacetate	(OAA),	which	in	turn	can	be	synthesised	from	aspartate	by	aspartate	aminotransferase	(encoded	by	aspC)	(Figure	3.19).		To	further	understand	
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the	role	of	PEP	and	aspartate	in	the	glucose-phosphate	stress	we	constructed	mutants	that	perturb	pathways	for	PEP	production	from	pyruvate	(ppsA)	or	aspartate	(aspC	and	pck),	and	tested	their	sensitivity	to	glucose	analogs	αMG	and	2DG.		
	
5.2	Results	
5.2.1	E.	coli	mutant’s	sensitivity	to	glucose	analogs	αMG	and	2DG		 Growth	of	wild-type	(WT)	E.	coli	and	strains	with	single	delitions	in	ΔppsA,	ΔaspC,	Δpck	or	double	deletions	in	ΔppsA	ΔaspC	and	ΔppsA	Δpck,	was	tested	on	agar	plates	containing	minimal	medium	supplemented	with	D-fructose	or	glycerol.	As	expected,	all	the	strains	tested	grew	well	on	fructose	or	glycerol	as	sole	carbon	sources	when	observed	after	24	and	48	hours	of	incubation	(Figure	5.1,	control).		In	the	presence	of	αMG,	no	growth	defects	were	observed	for	any	of	the	strains	growing	on	fructose	supplemented	media	(Figure	5.1A).		On	the	contrary,	when	growing	on	glycerol	with	added	0.5	%	αMG,	ΔaspC	and	ΔppsA	ΔaspC	were	growth	inhibited,	with	visible	suppressor	mutants	arising	(Figure	5.1B).	ΔppsA	ΔaspC	double	mutant	was	more	sensitive	to	0.25	%	αMG	compared	to	ΔaspC,	this	difference	was	not	observed	at	0.5%	αMG	(Figure	5.1B).	A	strain	with	ΔppsA	mutation	alone	was	not	inhibited,	but	showed	a	slight	growth	lag	on	0.5%	αMG	compared	to	WT	(Figure	5.1B).	Growth	of	mutants	with	0.1%	αMG	did	not	cause	any	dramatic	phenotypes,	but	ΔaspC	and	ΔppsA	ΔaspC	growth	was	slower	compared	to	other	strains	and	was	noticeable	at	24	h	of	growth	(Figure	5.1B).			 Same	strains	of	E.	coli	were	also	tested	for	sensitivity	to	another	glucose	analog,	2DG.		WT	strain	growing	on	fructose	plates	supplemented	with	0.5%	2DG	showed	slight	growth	defect	after	24	h,	but	fully	recovered	by	48	h	of	incubation	(Figure	5.2A,	WT).	ΔppsA	mutants	were	inhibited	at	0.5%	2DG,	but	growth	was	improved	at	a	lower	(0.25%)	2DG	concentration,	and	fully	restored	at	0.1%	2DG	(Figure	5.2A,	ΔppsA).	Mutation	of	aspC	resulted	in	growth	inhibition	at	all	three	concentrations	of	2DG,	with	0.5%	being	most	inhibitory.	The	double	mutant	ΔppsA	ΔaspC,	was	as	growth	inhibited	as	ΔaspC	at	0.25%	and	0.5%	2DG,	but	appeared	more	sick	at	0.1%	(Figure	5.2A,		ΔaspC	and	ΔppsA	ΔaspC).	The	Δpck	mutation	did	not	
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affect	growth	at	any	2DG	concentration,	but	the	ΔppsA	Δpck	strain	showed	similar	inhibitory	phenotype	as	ΔppsA,	and	is	likely	attributed	to	this	mutation	(Figure	5.2A,		Δpck	and	ΔppsA	Δpck).		To	our	surprise,	2DG	had	a	dramatic	inhibitory	effect	on	WT	and	all	the	mutants	when	growing	on	glycerol	as	the	sole	source	of	carbon	(Figure	5.2B).			 To	summarize,	αMG	did	not	affect	growth	of	any	of	the	tested	strains	utilizing	fructose,	but	caused	severe	growth	defect	of	ΔaspC	and	mild	stagnation	of	ΔppsA	strains	growing	on	glycerol	(Figure	5.1).	On	the	other	hand,	2DG	affected	growth	of	ΔaspC	and	ΔppsA	mutants	utilizing	fructose,	while	all	the	strains	(including	WT)	were	inhibited	when	glycerol	was	used	as	the	carbon	source	(Figure	5.2).	
	
5.2.2	Synthetic	phenotype	associated	with	growth	on	αMG	and	2DG	
	 Growth	of	WT	E.	coli	and	mutants	ΔppsA,	ΔaspC,	Δpck,	ΔppsA	ΔaspC	and	ΔppsA	Δpck	was	tested	on	agar	plates	containing	minimal	medium	supplemented	with	D-fructose	or	glycerol	in	the	presence	of	both	αMG	and	2DG	simultaneously.	We	observed	no	growth	on	fructose	medium	when	glucose	analogs	were	present	at	either	0.1%	or	0.25%	each	(Figure	5.3A).	This	was	unexpected	because	WT	strain	did	not	show	any	significant	growth	defect	on	fructose	media	with	αMG	(Figure	5.1A)	or	2DG	(Figure	5.2A),	when	they	were	added	individually.	This	synthetic	lethal	phenotype	suggests	that	αMG	and	2DG	might	function	through	distinct	mechanisms.	Lack	of	growth	on	glycerol	plates	with	αMG	and	2DG	(Figure	5.3B)	was	expected	because	we	previously	observed	that	2DG	alone	had	a	similar	effect	(Figure	5.2B).			 We	further	tested	the	same	strains,	with	the	addition	of	a	ΔsgrS	mutant,	for	growth	on	fructose	media	with	0.1%	αMG	and	0.1%	2DG	(Figure	5.4).	In	line	with	the	result	described	above,	all	the	strains,	except	ΔsgrS	grew	well	on	0.1%	αMG.	Strains	with	mutation	of	aspC	experienced	some	stagnation	and	ΔsgrS	showed	no	growth	in	the	presence	of	0.1%	2DG.	Supplementation	of	both	glucose	analogs	at	0.1%	resulted	in	growth	inhibition	of	all	the	strains,	including	WT.	Presence	of	Casamino	acids	(CAA)	in	the	media	however,	allowed	for	growth	of	WT	and	ΔppsA,	ΔaspC,	Δpck,	and	ΔppsA	ΔaspC	mutants,	except	ΔppsA	Δpck	and	ΔsgrS	that	showed	no	growth	(Figure	5.4).	In	other	words,	amino	acid	supplementation	was	not	
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sufficient	to	restore	growth	when	two	pathways	(i.e.	ppsA	and	pck	mutations)	for	PEP	synthesis	are	blocked,	and	in	the	absence	of	SgrS,	the	master	regulator	of	glucose	phosphate	stress.			
	 In	order	to	gain	a	better	insight	of	which	amino	acids	are	more	important	for	growth	with	glucose	analogs,	we	made	ten	amino	acid	solutions	called	AA1-10.	The	composition	of	each	is	presented	in	Table	5.1.	Solutions	AA3,	4,	8	and	9	restored	growth	of	WT	strain	on	glucose	analogs	(Figure	5.4).	WT	growth	was	also	partially	visible	in	the	presence	of	AA1,	6	and	10,	while	AA2,	5	and	7	did	not	have	any	effect	(Figure	5.4).	Together	this	shows	that	not	all	amino	acids	contribute	equally	to	growth	with	glucose	analogs.		Moreover,	AA4	and	9	that	successfully	allowed	growth	of	WT	(Figure	5.4),	both	contain	aspartate,	which	was	previously	shown	to	facilitate	recovery	from	2DG	stress	[124].		It’s	worth	noting	that	growth	recovery	of	the	mutant	strains	varied,	depending	on	the	AA	solution	used,	but	AA3,	4	and	9	were	most	successful	in	allowing	growth	of	ΔaspC	mutant,	while	growth	remained	inhibited	with	the	addition	of	AA8	(Figure	5.4).	Overall,	four	amino	acids	tryptophan,	threonine,	uracil	and	aspartate	are	in	common	between	AA3,	4,	8	and	9	solutions	(Table	5.1),	and	might	be	important	during	stress	produced	by	0.1%	αMG	and	0.1%	2DG.	Additional	experiments	testing	individual	amino	acid	contributions	to	stress	recovery	could	shed	more	light	on	the	mechanism	of	αMG	and	2DG	toxicity.	
	 In	summary,	inclusion	of	both	αMG	and	2DG	in	addition	to	fructose,	results	in	synthetic	inhibitory	phenotype,	potentially	due	to	distinct	modes	of	action	of	the	two	glucose	analogs.	Supplementation	with	amino	acids	can	alleviate	the	synthetic	phenotype,	with	various	groups	of	amino	acids	having	different	effect	on	growth	in	the	presence	of	glucose	analogs.	
	
5.3	Discussion			 In	E.	coli	the	function	of	aspartate	aminotransferase	(AspC)	can	be	substituted	by	tyrosine	aminotransferase	(TyrB),	which	catalyzes	the	formation	of	aspartate	from	OAA	with	a	lower	Vmax	than	the	dedicated	AspC.	Although	ΔaspC	mutant	grows	well	in	the	absence	of	stress	due	to	TyrB	activity,	its	growth	is	inhibited	on	glycerol	with	αMG	and	fructose	with	2DG	(Figures	5.1B	and	5.2A,	Table	
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5.2).	If	glucose	analogs	interfere	with	carbon	metabolism,	tricarboxylic	acid	cycle	(TCA)	could	experience	reduced	flux,	which	would	affect	OAA	levels.	Deletion	of	
aspC	would	further	reduce	production	of	OAA	from	aspartate,	potentially	inhibiting	recycling	of	CoA,	production	of	citrate	and	TCA	progression,	offering	an	explanation	as	to	why	ΔaspC	mutant	shows	sensitivity	to	glucose	analogs	(Figures	5.1B	and	5.2A,	Table	5.2).	OAA	also	participates	in	gluconeogenesis,	which	would	be	important	if	glucose	analogs	block	upper	glycolysis.			 Previous	studies	indicate	that	aspartate	supplementation	partially	relieved	growth	inhibition	of	ΔppsA	mutant	growing	with	2DG	[124],	potentially	due	to	AspC-catalyzed	conversion	of	aspartate	to	OAA,	which	is	than	converted	to	PEP	by	Pck.	Our	current	findings	show	lack	of	stress	related	growth	inhibition	of	Δpck	mutant	(Figures	5.1B	and	5.2A,	Table	5.2),	suggesting	that	conversion	of	OAA	to	PEP	is	not	particularly	important.	On	the	other	hand	higher	sensitivity	to	2DG	of	ΔppsA	mutant	indicates	that	PEP	to	pyruvate	ratios	play	a	role	during	glucose	phosphate	stress,	which	was	observed	in	the	previous	studies	[208].	Supplementation	with	aspartate	could	increase	availability	of	both	OAA	and	PEP,	explaining	partial	relief	of	inhibition	of	ΔppsA	strain	observed	by	Kornberg	[124]	and	importance	of	aspC	observed	in	our	study	(Figures	5.1B	and	5.2A,	Table	5.2).		 Our	analysis	of	mutant	strains	indicated	that	αMG	and	2DG	have	different	toxicity	depending	on	the	sugar	(i.e.	fructose,	glycerol)	used	as	carbon	source.	For	example,	supplementation	of	glycerol	medium	with	2DG	resulted	in	growth	inhibition	of	all	strains,	including	WT,	while	αMG	had	a	more	modest	affect	(Figures	5.1B	and	5.2B,	Table	5.2).	Distinction	between	αMG	and	2DG	is	also	highlighted	by	their	selective	uptake	via	PtsG	and	ManYZ	transporters,	respectively	[207].	Such	differences	could	be	indicative	of	the	dissimilar	modes	of	αMG	and	2DG	toxicity.	Data	presented	here,	clearly	indicates	that	addition	of	αMG	and	2DG	simultaneously	to	fructose	medium,	at	otherwise	non-inhibitory	0.1%	concentration	(Figures	5.1A	and	5.2A),	results	in	a	synthetic	lethal	phenotype	in	the	WT	strain	(Figure	5.3A,	Table	5.2).	This	is	highly	suggestive	of	αMG	and	2DG	acting	via	distinct	mechanisms	or	in	redundant	pathways.	Nonetheless,	while	they	likely	act	via	distinct	mechanisms,	both	glucose	analogs	elicit	the	SgrS-mediated	response.		
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	 For	a	long	time	non-metabolizable	αMG	has	been	used	to	study	sugar	transport	and	helped	with	elucidation	of	PEP-PTS	in	bacteria	[91,	118,	126,	215].	αMG	is	often	used	as	growth	modulator	or	to	study	effects	of	perturbations	in	carbon	metabolism	in	bacteria	[41].	A	recent	study	draws	a	connection	between	slow	growth	with	αMG	and	induction	of	stringent	response	[148].	In	general,	it	is	believed	that	αMG	cannot	be	used	as	a	substrate	by	phosphoglucose	isomerase	(PGI)	enzyme,	resulting	in	accumulation	of	phosphorylated	form	of	αMG	in	the	cytoplasm.			 Similarly,	some	studies	in	eukaryotes	have	determined	that	2DG	inhibits	phosphoglucose	isomerase	(PGI)	and	hexokinase	(HK)	[38,	238,	280].		However,	analogous	inhibition	of	PGI	(encoded	by	pgi)	or	HX	(encoded	by	glk)	in	E.	coli	has	not	been	studied	and	would	not	explain	growth	inhibition	of	WT	strain	on	glycerol	with	2DG	(Figure	5.2B,	Table	5.2),	which	was	not	observed	in	the	presence	of	αMG	(Figure	5.1B,	Table	5.2).		Glycerol	enters	the	cytoplasm	via	facilitated	diffusion	through	glycerol	channel	GlpF.	There,	it	gets	phosphorylated	by	glycerol	kinase	(GlpK)	and	converted	to	dihydroxyacetone	phosphate	(DHAP)	by	glycerol-3-phosphate	dehydrogenase	(GlpD).	None	of	these	reactions	require	PGI	or	HK,	and	DHAP	produced	from	glycerol	would	be	sufficient	to	drive	glycolysis	to	generate	energy.	Therefore,	inhibition	of	glycolytic	enzymes	upstream	of	DHAP	does	not	explain	2DG	toxicity	to	WT	E.	coli	growing	on	glycerol	(Figure	5.2B).	Another	study	in	eukaryotes	indicates	that	2DG	effects	on	growth	are	multifactorial	and	are	not	limited	to	inhibition	of	glycolytic	enzymes	[203].	If	also	true	in	bacteria,	this	would	further	complicate	the	understanding	of	2DG-induced	glucose-phosphate	stress	in	E.	
coli.			 Independently	of	their	action,	growth	inhibition	due	to	αMG	and	2DG	can	be	relieved	by	providing	CAA	in	the	media	(Figure	5.4,	Table	5.2).	Amino	acids	can	be	catabolized	by	E.	coli	to	generate	energy	and	building	blocks	for	growth,	which	explains	why	phenotypes	associated	with	αMG	and	2DG	are	less	pronounced	in	LB	media	(data	not	shown),	which	is	rich	in	amino	acids.	Therefore	toxicity	of	αMG	and	2DG	can	be	prevented	in	WT,	suggesting	that	the	metabolic	steps	inhibited	by	these	compounds	are	bypassed	when	cells	are	growing	on	amino	acids.	However	it’s	important	to	note	that	supplementation	of	amino	acids	in	the	presence	of	both	αMG	
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and	2DG	did	not	restore	growth	of	ΔsgrS	mutant	(Figure	5.4,	Table	5.2),	highlighting	the	central	role	of	SgrS	sRNA	in	glucose-phosphate	stress	response.		 In	conclusion,	we	demonstrated	that	αMG	and	2DG	function	through	diverse	mechanisms,	and	conversion	of	aspartate	to	OAA	is	important	during	this	process.	Our	data	also	shows	that	toxicity	associated	with	αMG	and	2DG	can	be	bypassed	in	WT,	but	not	in	ΔsgrS	mutant,	by	supplementing	amino	acids	in	the	growth	media.	
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5.4	Tables	and	Figures	
	
	
	
Figure	5.1	Growth	of	E.	coli	mutants	in	the	presence	of	αMG.	E.	coli	wild-type	(WT)	and	mutants	with	single	gene	deletions	ΔppsA,	ΔaspC,	Δpck,	or	double	gene	deletions	ΔppsA	ΔaspC	and	ΔppsA	Δpck	were	grown	on	agar	plates	with	M63	minimal	medium	at	37°C.	Growth	media	was	supplemented	with	either	(A)	0.2%	D-fructose	or	(B)	0.4%	glycerol	and	varying	concentrations	of	αMG	(0,	0.1,	0.25,	0.5	%).	Plates	were	scanned	after	24	and	48	hrs	of	growth.		
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Figure	5.2	Growth	of	E.	coli	mutants	in	the	presence	of	2DG.	E.	coli	wild-type	(WT)	and	mutants	with	single	gene	deletions	ΔppsA,	ΔaspC,	Δpck,	or	double	gene	deletions	ΔppsA	ΔaspC	and	ΔppsA	Δpck	were	grown	on	agar	plates	with	M63	minimal	medium	at	37°C.	Growth	media	was	supplemented	with	either	(A)	0.2%	D-fructose	or	(B)	0.4%	glycerol	and	varying	concentrations	of	2DG	(0,	0.1,	0.25,	0.5	%).	Plates	were	scanned	after	24	and	48	hrs	of	growth.				
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Figure	5.3	Growth	of	E.	coli	mutants	in	the	presence	of	αMG	and	2DG	together.	
E.	coli	wild-type	(WT)	and	mutants	with	single	gene	deletions	ΔppsA,	ΔaspC,	Δpck,	or	double	gene	deletions	ΔppsA	ΔaspC	and	ΔppsA	Δpck	were	grown	on	agar	plates	with	M63	minimal	medium	at	37°C.	Growth	media	was	supplemented	with	either	(A)	0.2%	D-fructose	or	(B)	0.4%	glycerol	and	varying	concentrations	of	αMG	(0.1,	0.25	%)	with	2DG	(0.1,	0.25	%).	Plates	were	scanned	after	24	and	48	hrs	of	growth.		
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Figure	5.4	Growth	of	E.	coli	mutants	in	the	presence	of	glucose	anaogls	
supplemented	with	amino	acids.	E.	coli	wild-type	(WT)	and	mutants	with	single	gene	deletions	ΔppsA,	ΔaspC,	Δpck,	ΔsgrS,	or	double	gene	deletions	ΔppsA	ΔaspC	and	ΔppsA	Δpck	were	grown	on	agar	plates	with	M63	minimal	medium	at	37°C.	Growth	media	containing	0.2%	D-fructose,	αMG	(0.1	%)	and	2DG	(0.1	%),	was	supplemented	with	Casamino	acids	(CAA)	or	amino	acid	solutions	(AA1-10)	containing	groups	of	amino	acids	specified	in	Table	5.1.	Plates	were	scanned	after	48	hrs	of	growth.	
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	 1	 2	 3	 4	 5	
6	 adenine	(5	mM)	 guanosine	(0.3	mM)	 cysteine	(0.3	mM)	 methionine	(0.3	mM)	 thiamine	(0.05	mM)	
7	 histidine	(0.1	mM)	 leucine	(0.3	mM)	 isoleucine	(0.3	mM)	 lysine	(0.3	mM)	 valine	(0.3	mM)	
8	 phenylalanine	(0.3	mM)	 tyrosine	(0.1	mM)	 tryptophan	(0.1	mM)	 threonine	(0.3	mM)	 proline	(2	mM)	
9	 glutamine	(5	mM)	 asparagine	(0.32	mM)	 uracil	(0.1	mM)	 aspartate	(0.3	mM)	 arginine	(0.6	mM)	
10	 thymine	(0.32	mM)	 serine	(4	mM)	 glutamate	(5	mM)	 DAP	(0.1	mM)	 glycine	(0.13	mM)		
Table	5.1	Amino	acid	solutions	used	for	supplementation.		Table	shows	appropriate	amino	acid	solutions	used	in	Figure	5.4	at	final	concentrations	specified	[216].						
D-fructose	 Glycerol	
Genotype	 control	 αMG	 2DG	 αMG+2DG	 αMG+2DG+CAA	 control	 αMG	 2DG	WT	 +++	 +++	 +++	 -	 +++	 +++	 +++	 -	
ΔppsA	 +++	 +++	 +	 -	 ++	 +++	 ++	 -	
ΔaspC	 +++	 +++	 -	 -	 +++	 +++	 -	 -	
Δpck	 +++	 +++	 +++	 -	 +++	 +++	 +++	 -	
ΔppsA	ΔaspC	 +++	 +++	 -	 -	 ++	 +++	 -	 -	
ΔppsA	Δpck	 +++	 +++	 +	 -	 -	 +++	 +	 -	
ΔsgrS	 +++	 -	 -	 -	 -	 -	 -	 -		
Table	5.2	Summary	of	growth	phenotypes	associated	with	glucose	analogs.	E.	
coli	wild-type	and	specified	mutants	were	grown	on	agar	plates	containing	either	D-fructose	or	glycerol	and	supplemented	with	specified	glucose	analogs	and	Casamino	acids	(CAA).	Varying	degrees	of	growth	are	marked	with	“+”	(+++	good	growth,	++	medium	growth,	+	slow/weak	growth)	and	lack	of	growth	with	“–“.	
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CHAPTER	6	
DISCUSSION	AND	FUTURE	DIRECTIONS			 SgrS	is	a	well-characterized	sRNAs	in	E.	coli	and	yet,	we	continue	to	uncover	novel	mechanisms	of	post-transcriptional	control	exerted	by	this	regulatory	molecule.	Besides	being	an	exemplary	sRNA,	SgrS	also	encodes	a	small	protein	SgrT,	making	it	uniquely	dual-function.		Like	other	trans-encoded	sRNAs,	SgrS	relies	on	Hfq	chaperone	for	stability	and	uses	short	discontinuous	base	pairing	to	control	translation	and/or	stability	of	the	target	mRNAs.	Considering	the	plasticity	of	such	sequence-dependent	regulatory	arrangement,	we	hypothesized	that	SgrS	might	regulate	genes	additional	to	the	known	ptsG,	manXYZ	and	yigL	during	glucose-phosphate	stress	response.			 In	this	study,	we	identified	and	characterized	several	novel	genes	regulated	by	SgrS	at	the	post-transcriptional	level	(Chapter	3),	which	more	than	doubled	its	known	regulon.	Importantly,	we	characterized	two	novel	mechanisms	of	SgrS	regulation.	Specifically,	SgrS	repression	of	purR	translation	occurs	via	pairing	within	its	CDS	and	recruitment	of	Hfq	(Chapter	3)	[19].	Here,	SgrS	pairing	is	outside	of	the	translation	initiation	region	(TIR),	suggesting	that	SgrS	alone	cannot	inhibit	translation	initiation	of	purR	mRNA.	Therefore	we	think	the	primary	regulatory	role	belongs	to	Hfq,	which	could	block	translation,	while	SgrS	might	serve	as	a	specificity	factor	and	had	little	effect	on	purR	translation	in	the	absence	of	Hfq.	This	is	contrary	to	the	canonical	sRNA-mediated	repression	via	direct	base	pairing	near	the	RBS	of	the	mRNA	target	(i.e.	SgrS	regulation	of	ptsG)	Chapter	3.	SgrS	might	use	similar	“Hfq-dependent”	mechanism	of	repression	when	regulating	manX.	It	was	previously	noted	that	SgrS	pairing	with	manX	occurs	downstream	of	the	region	occupied	by	the	ribosome,	so	repression	has	to	occur	through	binding	of	another	associated	factor	[207].	Similar	mechanism	was	previously	described	for	sRNA	Spot42	regulation	of	
sdhC,	encoding	Fe-dependent	succinate	dehydrogenase.	In	this	example,	however,	Spot42	binding	occurred	upstream	of	the	sdhC	TIR,	which	resulted	in	Hfq	recruitment	and	translation	inhibition	[57].	It’s	possible	that	regulation	of	targets	through	role-reversal	with	Hfq	is	more	common	than	previously	believed.	Usual	
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approaches	to	study	sRNA-mediated	target	regulation	concentrate	on	pairing	within	the	leader	sequence	of	the	mRNA,	but	in	light	of	the	new	mechanism	described	above,	it	is	important	to	reevaluate	this	tactic	to	include	sequences	within	the	CDS	even	if	they	are	located	far	downstream	of	the	TIR.			 In	our	efforts	to	characterize	SgrS	targets	we	also	uncovered	regulation	of	
asd	mRNA	that	occurs	via	binding	at	two	distinct	locations,	around	asd	RBS	(site	I)	and	farther	downstream	within	the	CDS	(site	II)	(Chapters	3	and	4).	We	also	determined	that	SgrS	pairing	sites	are	located	at	the	tips	of	the	two	stem	structures	formed	by	asd	mRNA.	Moreover,	SgrS	binds	cooperatively	to	sites	I	and	II	of	asd	mRNA	which	results	in	optimal	repression	of	asd	(Chapter	4).	This	is	the	first	mechanism	describing	optimization	of	sRNA-mediated	post-transcriptional	repression	via	two	cooperative	binding	events	within	a	monocystronic	mRNA	(Chapters	3	and	4).			 Aspartate	semialdehyde	dehydrogenase,	the	enzyme	encoded	by	asd,	lies	in	the	first	branch	point	in	the	pathway	for	aspartate	conversion	to	amino	acids	lysine,	methionine,	threonine	and	isoleucine,	as	well	as	cell	wall	component	diaminopimelate.	This	pathway	is	unique	to	bacteria,	fungi	and	higher	plants,	but	is	absent	in	mammals,	making	it	a	good	potential	target	for	antimicrobials	[85].	While	potentially	important,	regulation	of	the	asd	gene	is	not	well	characterized.	Considering	the	secondary	structure	of	asd	mRNA	and	SgrS-mediated	repression	described	here	(Chapters	3	and	4),	it	is	possible	that	asd	is	primarily	regulated	at	the	level	of	mRNA,	which	explains	lack	of	established	transcriptional	regulators	for	this	important	metabolic	gene.	Such	regulation	could	involve	an	attenuation	mechanism	involving	the	two	stem	structures	described	in	Chapter	4.	Additional	future	work	is	required	to	test	SgrS	effects	on	asd	transcription,	which	would	provide	first	evidence	for	transcriptional	control	by	a	trans-encoded	sRNA.		 This	study	more	than	doubled	the	known	SgrS	regulon,	however	further	elucidation	of	SgrS	targets	is	still	important.	Glucose-phosphate	stress	has	a	global	effect	on	bacterial	metabolism,	which	results	in	extensive	deregulation	of	many	genes	(RNA-Seq	data	not	shown).	SgrS	alone	affected	expression	of	at	least	21	genes,	only	6	of	which	confirmed	as	direct	SgrS	targets	using	translational	fusions	to	lacZ	
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reporter.	Considering	the	variety	of	mechanisms	SgrS	utilizes	to	regulate	its	targets,	including	stabilization	of	yigL	transcript	by	pairing	to	the	upstream	gene,	it	is	possible	that	sequence	for	SgrS	interaction	was	simply	not	included	in	our	translational	fusions.	Therefore	it	is	vital	that	SgrS	regulation	of	some	of	the	genes	from	Table	3.1	is	reexamined	with	alternative	methods	that	would	not	exclude	a	possibility	of	SgrS	interactions	farther	downstream	of	the	TIR,	within	3’	UTR	or	within	other	genes	of	the	polycistronic	mRNAs.		 Although	SgrS	regulon	might	be	yet	incomplete,	we	considered	several	targets	of	SgrS	and	demonstrated	their	differential	regulation	by	SgrS.	Comparison	of	efficiency	of	regulation	for	each	target	gene	demonstrated	that	ptsG	is	the	“strongest”	target	of	SgrS	and	purR	is	the	weakest	(Chapter	4).	Differences	in	efficiency	of	target	regulation	imply	existence	of	a	temporal	order	in	which	SgrS	affects	its	target	mRNAs	during	stress.	Interesting	is	that	the	target	priority	does	not	correlate	with	the	strength	of	base	pairing	with	SgrS	(Chapter	4).	In	other	words,	good	base	complementarity	does	not	imply	strong	regulation	of	a	given	mRNA.	It’s	likely	that	the	determinants	of	target	prioritization	are	multifactorial	and	dependent	on	the	mechanism	of	regulation	for	each	particular	target.	Our	data	demonstrates	that	yigL	activation	reaches	its	maximum	level	at	fairly	low	expression	levels	of	SgrS,	while	targets	that	are	repressed	demonstrate	improved	repression	with	each	increase	in	SgrS	expression	(Chapter	4).	This	could	be	related	to	the	mechanistic	differences	of	sRNA-mediated	activation	vs.	repression.	Some	previous	studies	demonstrated	that	during	repression,	sRNA	is	co-degraded	with	its	target	mRNA,	making	this	process	irreversibly	and	therefore	non-catalytic	[158].	However,	positive	regulation	does	not	involve	target	degradation	and	may	result	in	sRNA	recycling,	which	would	be	a	catalytic	mode	of	regulation.	Previous	study	of	Vibrio	
harveji	determined	that	catalytic	and	non-catalytic	regulation	of	two	targets	by	Qrr	sRNA	affects	physiological	outcome,	specifically	optimization	of	bacterial	quorum	sensing	[68].	Additional	work	is	required	to	determine	whether	yigL	regulation	is	indeed	catalytic	and	how	it	affects	other	genes	in	the	context	of	SgrS-mediated	hierarchy.	
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	 Although	we	established	a	simplified	regulatory	hierarchy	for	SgrS	targets	in	
E.	coli	(Chapter	4),	this	arrangement	might	differ	in	other	organisms.	SgrS	is	conserved	in	many	γ-proteobacteria,	but	it	can	differ	in	size	and	sequence	[94].	While	regulation	of	ptsG	is	conserved	among	several	enteric	bacteria	[274],	regulation	of	some	other	targets	is	clearly	species-specific	(Chapter	3)[19,	207].	For	example,	SgrS	regulation	of	horizontally	acquired	virulence	gene	sopD	only	occurs	in	
Salmonella,	as	this	gene	is	not	present	in	E.	coli	[195].	Therefore,	SgrS-dependent	target	prioritization	in	other	species	remains	to	be	established	and	might	differ	depending	on	the	nutritional	or	environmental	requirements	of	the	organism.			 This	leads	to	additional	questions	regarding	the	evolution	of	sRNAs	and	the	regulatory	hierarchies	they	establish.	SgrS	likely	belongs	to	the	group	of	ancient	sRNAs	such	as	Spot-42,	GcvB,	RyhB,	all	of	which	are	involved	in	crucial	metabolic	processes.	Initial	evolution	of	sRNA	probably	occurs	through	gain	of	base	pairing	interactions	with	a	primary	target	mRNA,	which	puts	it	under	the	selective	pressure	to	be	maintained	[197].	SgrS	evolved	around	the	time	of	acquiring	stable	Hfq	molecule	that	likely	facilitated	its	initial	interactions	with	the	older	target	ptsG,	with	other	target	interactions	evolving	later	[197].	Regulation	of	ptsG	is	the	most	efficient	out	of	the	tested	targets	of	SgrS	(Chapter	4),	posing	the	question	of	whether	regulatory	efficiency	depends	on	the	evolutionary	age	of	the	given	SgrS-target	interaction?	Additional	effort	to	study	target	prioritization	in	other	sRNA	regulons,	as	well	as	SgrS	regulons	in	other	enteric	bacteria,	will	offer	clues	to	answering	this	question.			 In	conclusion,	dual	function	and	extensive	regulon	of	SgrS	make	it	an	excellent	model	to	study	sRNA	regulation	in	bacteria.	Further	research	into	SgrS-mediated	target	regulation	might	not	only	uncover	more	novel	mechanisms	of	gene	regulation,	but	also	improve	our	understanding	of	complex	physiology	of	glucose-phosphate	stress.	
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